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Abstract 
 
Complex networks of protein-ligand interactions underpin cellular function and 
communication. Disease can arise from disruption of these networks through the 
alteration of protein-ligand interaction affinities, for example by protein mutation or 
ligand modification. Understanding the mechanisms and principles that define affinity is 
therefore critical to both understanding and engineering biomolecular interactions, e.g. 
optimising drug molecules to interact effectively with their biomolecular targets. 
Thermodynamics reveals that affinity can be expressed in terms of the Gibbs free 
energy change upon interaction. In turn, this is composed of enthalpic and entropic 
terms, which can be thought of loosely as arising from structural and dynamic factors 
respectively. Though enthalpic terms can be estimated to a reasonable degree using 
structural data, a better understanding of entropic contributions from dynamic 
processes is required.  
 The mouse major urinary protein (MUP) has been successfully established as a 
model system to investigate the thermodynamics of protein-ligand interactions. This 
work uses MUP, and employs a wide range of biophysical techniques, to develop our 
understanding of the dynamic factors in the thermodynamics of protein-ligand 
interactions. Four factors are addressed. Protein solvation is addressed by investigating 
proposed entropic solvation of the MUP binding pocket, and the possibility of 
engineering a new binding profile through manipulation of sidechains and solvation in 
the binding pocket. Ligand conformational entropy is addressed by performing the first 
systematic assessment of the widely predicted, yet inconsistently observed, benefits of 
removing and restricting ligand bonds. The greatest entropic loss upon binding, that of 
ligand rotational and translational entropy, is addressed by assessing MD predictions of 
significant residual translation and rotational motion of IBMP bound to MUP. This is 
achieved by using a combination of NMR techniques. Finally, protein dynamics are 
addressed by undertaking a preliminary investigation of a potentially promising novel 
technique for probing site-specific changes in protein dynamics upon ligand binding. 
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 1 
Chapter 1 
 
General Introduction 
 
 
1.1  Biomolecular interactions and thermodynamics 
 
1.1.1  Affinity underpins biology, and thermodynamics 
underpin affinity 
 
In a reductionist view, biomolecular interactions are the root cause of all biological 
phenomena. Networks of molecular interactions, interference with which can cause 
diseases such as cancer, take place in a crowded and diverse cellular milieu. This fine 
line between health and disease is predicated on the exquisite specificity of molecular 
interactions, i.e. the affinity of two partners to interact. 
Understanding the mechanisms and principles that define affinity is therefore 
critical to both understanding and engineering biomolecular interactions, for example 
optimising drug molecules to interact effectively with their biomolecular targets. 
Protein interactions with small molecules, henceforth referred to as ligands, are 
responsible for many of the key interaction networks, such as hormonal signalling or 
neurotransmission. A seemingly modest difference in the chemical structure of a 
protein or ligand can result in a great change to affinity, and effect a pronounced 
change in biological phenomenon.    
Despite the increasing body of protein and protein-ligand structural data, its 
use in computational drug design, and the understanding of molecular interactions in 
general, is currently inefficient. Biomolecular interactions are governed by 
thermodynamics, wherein binding affinity, Ka, is dictated by the change in the standard 
free energy upon binding, ∆G°b. This is in turn composed of enthalpic and entropic 
terms, ∆H°b and T∆S°b, as demonstrated below. Protein, P, and ligand, L, can interact 
to form a protein-ligand complex, with the binding affinity represented by the ratio of 
free species to complex at equilibrium, as shown in Equations 1.1 and 1.2.  
 P+ L ⇌ PL 
Equation 1.1 
 2 
 K! = PLP L = 1K! 
Equation 1.2 
 
Kd, the inverse of the association constant, Ka, is also commonly used to represent 
affinity. It has units of concentration, whereby the lower the concentration, the tighter 
the binding. At a given temperature, affinity is represented thermodynamically by the 
change in standard Gibbs free energy of binding, ∆G°b, calculated from Ka using 
Equation 1.3.  
 ∆G°! = −RT lnK! 
Equation 1.3 
 
R is the gas constant of 8.314 J mol-1 K-1 and T is the absolute temperature. ∆G°b is 
composed of two terms, the standard enthalpy change of binding, ∆H°b, and standard 
entropy change of binding, T∆S°b. Spontaneous, i.e. favourable, processes are those 
where the free energy is minimised, such that the enthalpy change is negative and 
entropy change positive. 
 ∆G°! = ∆H°! − T∆S°! 
Equation 1.4 
 
Understanding the mechanisms and principles that define affinity can therefore be 
achieved through understanding the physical factors that define the sign and magnitude 
of ∆H°b and T∆S°b. This requires a framework, including the contribution of solvent, 
for experimentally decomposing these contributions. 
 
 
1.1.2  Dissecting affinity: thermodynamic decomposition 
using a perturbation approach 
 
We can overcome the inherent complexity of unravelling binding thermodynamics, and 
analyse the structural basis of thermodynamic contributions more simply, by 
considering the differences observed when comparing very closely related systems. 
 3 
This is called the perturbation approach. This could be the contribution of a single 
factor, such as a water molecule, a bond or a functional group. Such comparisons allow 
many thermodynamic contributions to binding to either cancel out, or become zero to 
first order. The thermodynamic values defining a biomolecular interaction are state 
functions, meaning that they are independent of the path followed by the interaction: 
only the initial and final states matter. As such we can represent the biomolecular 
interactions of two closely related ligands to the same protein using the following 
Born-Haber thermodynamic cycle.1 
 
 
 
Figure 1.1 Born-Haber thermodynamic cycle for comparison of two ligands binding 
to the same protein. Reproduced from reference 1. The back plane of the cube 
represents the binding of one ligand, L1, and the front plane corresponds to the 
binding of another ligand, L2. The top of the cube pertains to the difference in the 
interactions in the absence of solvent, termed ‘intrinsic’, and the bottom in the 
presence of solvent.  
 
 
Each interaction can be described using the following equation, wherein ∆G°b is 
referred to as the observed free energy of binding, ∆G°obs 
 ∆G°!"# =   ∆G°!   + ∆G°!" −   ∆G°!"  
Equation 1.5 
 4 
where subscripts represent b for binding, i for intrinsic, sb for complex solvation and 
su for the solvation of uncomplexed components. Intrinsic refers to the interaction in 
the absence of solvent. Therefore when comparing the difference in binding of two 
related ligands to the same protein, the difference in the observed free energy changes 
can be expressed as Equation 1.6. 
 ∆∆G°!"# =   ∆G°!"#$ −   ∆G°!"#$=   ∆G°!" −   ∆G°!"   + ( ∆G°!"# −   ∆G°!"# − ∆G°!"# −   ∆G°!"# ) 
 
Equation 1.6 
 
1 and 2 refer to the ligands being compared. Equation 1.6 can also be written for the 
enthalpy or entropy of binding in place of the free energy. This framework allows the 
physical contributions to be addressed separately as the terms on the right hand side 
of the equation; those arising from solvent behaviour and interactions, and those 
arising from factors internal to the protein or ligand. Using the same protein, the 
contribution from the solvation of the unbound protein cancels out. Likewise, using 
the same ligand, for example comparing binding to two mutants or versions of the 
same protein, the ligand desolvation term cancels out. 
 The observed thermodynamic parameters are obtained by isothermal titration 
calorimetry (ITC), described in §1.3.1. Using decomposition with a perturbation 
approach necessitates an appreciation of the main physical sources of intrinsic and 
solvent enthalpic and entropic contributions, and a range of techniques capable of 
measuring, or at least approximating, them.  
 
 
1.1.3  Main sources of intrinsic and solvent enthalpy and 
entropy, and methods for their measurement or 
approximation 
 
1.1.3.1  Intrinsic enthalpy 
 
In chemical reactions, enthalpy arises from the making or breaking of covalent bonds. 
Alternatively in biomolecular interactions, enthalpy arises from the making or breaking 
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of non-covalent interactions. These most commonly include hydrogen bonds, 
dispersive forces such as vdW interactions and electrostatic interactions such as salt 
bridges. These are distance, permittivity and orientational dependent, and therefore 
their energy may fluctuate somewhat as the system undergoes thermal motion. Upon 
ligand binding, intrinsic enthalpy changes can arise from protein conformational change 
and the formation of protein-ligand interactions upon complexation. The enthalpic 
content of non-covalent interactions can be calculated to a close approximation using 
high resolution structural data from X-ray crystallography and NMR. Energies can be 
calculated using known relationships, such as the Lennard-Jones 12-6 or 10-12 
potentials and Coulomb’s Law. These formulae are used in molecular dynamics (MD) 
both to study the time evolution of biomolecular systems and in computational ligand 
docking calculations, §1.3.3.2-4  
 
 
1.1.3.2  Intrinsic entropy 
 
Entropic contributions arise from changes in disorder and therefore dynamics in the 
system. Unlike enthalpic changes, which are approximated relatively easily from 
structural data, entropic changes are more elusive. 
The largest source of unfavourable intrinsic entropy upon protein-ligand 
binding is considered to be the loss of rotational and translational entropy of the ligand. 
Due to the size difference, complexation affects protein rotation and translation very 
little, whereas a ligand is presumed to lose almost all independent rotation and 
translation in assuming its bound position. Theoretical calculations predict that for 
most small organic molecules, this loss is on the order of -40 to -60 kJ mol-1.5 Residual 
ligand motion is usually predicted using MD simulations, or inferred by looking for high 
B-factors in x-ray crystal structures, which are an approximate indicator of disorder.  
Intrinsic entropy changes can also arise from ligand conformational dynamics.  
Upon assuming its bound position, ligand bond rotations that allowed sampling of 
multiple conformational states in solution are restricted, resulting in an unfavourable 
intrinsic entropy contribution. This has been proposed as costing approximately 5 to 6 
kJ mol-1 per restricted bond.5 Many attempts have been made to experimentally 
observe this contribution by observing the effects of ligand constraints on binding 
affinity, yet have led to inconsistent results.6,7  
Finally, changes in protein conformational dynamics, e.g. torsional and 
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librational degrees of freedom, are known to occur on ligand binding. Flexibility can 
again be inferred by high B-factors in an x-ray crystal structure. Nuclear magnetic 
resonance (NMR) structural calculations, which result in an ensemble of structures 
that fit the solution state experimental data, inherently capture aspects of 
conformational dynamics.8 However, differences in NMR relaxation measurements 
upon ligand binding allow the approximation of site-specific changes in entropy across 
the protein, as outlined in §1.3.2.6. 
 
 
1.1.3.3  Solvent enthalpy and entropy 
  
Solvent water contributions to binding enthalpy and entropy arise from reorganisation 
of solvent-solvent and solvent-solute interactions upon binding. This mainly takes the 
form of desolvating the ligand and protein to allow their interaction.  
Water molecules can form hydrogen bonds to themselves, and ligands or 
protein surfaces that are polar. This is enthalpically favourable, again in a distance, 
permittivity and orientationally dependent manner. Non-polar ligands or protein 
surfaces do not provide this hydrogen bonding opportunity, therefore water is 
believed to order at these surfaces to maximise the distance and orientation 
dependence of inter-solvent hydrogen bonds.9 Though improving enthalpy, this process 
decreases entropy. Hence, the desolvation of non-polar ligands is enthalpically 
unfavourable and entropically favourable. Ligand desolvation enthalpies and entropies 
can potentially be experimentally measured using air-solvent partition equilibria 
experiments.10 Unfortunately, these experiments are not practicable for some ligands, 
because sufficient volatility is required to obtain a measurable concentration in gas 
phase.  However, an additive technique for calculating these parameters was developed 
using an extensive pool of published experimental data, and gives close experimental 
agreement for hydrocarbons at 298 K and 1 atm.11  
 Some non-polar protein surfaces are pockets whose solvating waters are not 
contiguous with bulk water. Consequently, there may be an insufficient number of 
water molecules to form an ordered but enthalpically favourable hydrogen bond 
network. In such cases, entropic solvation has been proposed, whereby the solvating 
water molecules, without any electrostatic interactions to restrict them, have higher 
entropy than bulk water.12-15 Enthalpies and entropies of protein desolvation are 
notoriously difficult to calculate. A few theoretical and experimental estimates exist, 
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and these reveal no clear overall pattern, with different thermodynamics being 
observed dependant on the individual system.16,17  
 
 
 
1.2  The Major Urinary Protein (MUP): a model 
system 
 
The decomposition and perturbation approach is only tractable when a protein fulfils 
two main criteria.  Firstly that protein or ligand structure can be perturbed, and 
binding is still observed.  Therefore the protein must be relatively promiscuous. 
Secondly, the protein must be amenable to experimentation using all the biophysical 
techniques required to observe the various intrinsic and solvation contributions; ITC, 
NMR, MD and X-ray crystallography. Medically-targeted proteins, in which ligand 
affinity optimisation might reap a direct benefit, do not usually meet the first criterion 
due to their biological function usually necessitating a lack of, or only minimal, 
promiscuity.  
The first quantitative decomposition of binding thermodynamics for a single 
protein-ligand interaction was achieved using the mouse major urinary protein (MUP) 
as a model system.18 MUP is a 20 kDa pheromone binding protein from mouse urine 
that has an eight-stranded beta barrel plus alpha helix structure typical of its lipocalin 
superfamily. Various MUP isoforms are produced naturally in mice. The homogenous 
isoform produced recombinantly and used in this thesis is MUP-I, which will be 
referred to throughout as MUP.19 As part of its function, MUP binds a wide range of 
small hydrophobic ligands in its internal hydrophobic pocket. This promiscuity is 
possible because interactions are dominated by weak, non-polar, non-directional 
interactions that appear to scale with hydrophobic surface area.1,20 Tyr 120 is the single 
H-bond donor in the binding pocket. The structure of MUP and an example of some 
ligands so far investigated are displayed in Figures 1.2 and 1.3 respectively. MUP is 
amenable to all the required techniques, and therefore many of these interactions have 
been analysed using NMR, MD, X-ray crystallography and ITC.1,18-26 
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Figure 1.2 MUP structure (PDB 1QY1). IBMP is shown bound in the pocket (green 
and blue sticks), and the sidechain of Tyr120 is shown (grey sticks).  
 
These analyses have revealed four key characteristics of MUP as a ligand binding 
system. Firstly, binding is observed for a wide range of ligand structures with variable 
associated affinities. The ligands shown in Figure 1.3 bind with dissociation constants 
that range across one order of magnitude: 0.3 to 2.9 µM.1,23 A wider range of 
accessible affinities was recently demonstrated with the recent report of Kd = 32 nM, 
for the binding of N-phenyl-naphthylamine to MUP.20   
 
 
 
Figure 1.3 Examples of MUP ligands. a) 1-heptanol. b) N-acetylated phenylalanine 
methyl ester (NPOME). c) 2-methoxy-3-isobutyl pyrazine (IBMP). d) 2-methoxy-3-
isopropyl pyrazine (IPMP).  
 
 
A second characteristic of MUP as a ligand binding system is that interactions of the 
hydrophobic MUP pocket and hydrophobic ligands invert the thermodynamic signature 
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of the classical hydrophobic effect. The classical hydrophobic effect is believed to result 
from the ordering of polar solvent around non-polar groups and surfaces to maximise 
enthalpic H-bond interactions with neighbouring solvent molecules.9 Desolvation of 
non-polar groups removes this ordering, therefore resulting in an entropically 
favourable process.27 Though the hydrophobic effect is widely regarded as being 
dominated by entropy, the biophysical description above is still not universally 
accepted, due to little experimental evidence of such solvent ordering. Despite the 
hydrophobic nature of the MUP pocket, a non-classical enthalpy driven hydrophobic 
effect has been consistently observed. This is due to a sub-bulk water density, ~0.2 gm 
cm-3, in the occluded MUP binding pocket, as observed by MD and X-ray 
crystallography.21 Therefore there is minimal order to disorder gain by ejecting these 
molecules upon binding. Moreover, it has been suggested that MUP pocket water 
molecules may actually lose entropy upon release to bulk, meaning the apo pocket is 
‘entropically solvated’.15,21 Incoming ligands form better enthalpic contacts with the 
pocket than the displaced water, resulting in enthalpically favourable binding. This was 
demonstrated by generating a Y120F MUP mutant which has no water in the pocket, 
as observed by MD and X-ray crystallography. Binding of IBMP was observed to be less 
enthalpically favourable with Y120F MUP than MUP, due to lack of the enthalpically 
favourable water ejection. Furthermore, the enthalpic non-equivalence of water-
protein and ligand-protein dispersive forces as a driver for association was observed as 
a surface area dependent enthalpic benefit across a panel of alcohols.1 
NMR relaxation measurements performed before and after IBMP binding 
revealed site-specific changes in dynamics and entropy, calculated as outlined in 
§1.3.2.6.23 Overall these result in zero entropy change within error, but with 
decreasing flexibility in some areas being offset by increasing flexibility at others, Figure 
1.4. Consequently, a mechanism was proposed whereby affinity is improved by 
redistribution of protein conformational entropy upon binding.23  
The acquisition of x-ray crystal structures of mutant MUP, such as Y120F, 
demonstrate that the protein is very structurally resilient to mutations of binding 
pocket residues: RMSD values are small between mutants, with no change to overall 
structure even with the introduction of ionisable residues to the binding pocket 
(unpublished, see Figure 2.4). Throughout this thesis, RMSD values between structures 
are calculated using the Pymol ‘align’ command, with the default iterative outlier 
removal disabled to avoid artificially low RMSD values being returned.  
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Figure 1.4 Stereo view of changes in MUP protein backbone (N-H) dynamics upon 
binding IBMP, as observed by NMR relaxation measurements. Reproduced from 
reference 28. IBMP is shown in the pocket (green sticks). Contributions to protein 
conformational entropy upon binding are indicated as blue for positive and red for 
negative changes. 
 
 
 
1.3  Techniques employed in this thesis  
  
1.3.1  Isothermal titration calorimetry (ITC) 
 
Expulsion or uptake of heat is a function of most biomolecular interactions. Direct 
measurement of the heat change associated with an interaction is possible by using 
ITC. It is the only technique that allows detection of all the thermodynamic 
parameters of binding: ∆G°b, , ∆H°b, and T∆S°b. These parameters observed by ITC 
represent the total contributions from all sources, and are henceforth interchangeably 
referred to as the observed parameters, with subscript obs. Ka, Kd, ∆G°b and ∆G°obs 
are henceforth used as representations of affinity.   
 The ITC instrument contains two cells, manufactured using an inert 
alloy with high thermal conductivity, whose temperatures are controlled by a feedback 
driven electric heater in a highly sensitive thermocouple circuit, Figure 1.5. An 
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adiabatic jacket surrounds the cells. The experiment takes the form of titrating precise 
aliquots of a ligand solution of known concentration into a protein solution of known 
concentration in the sample cell. The integrated power input required to return this 
cell to thermal equivalence with the reference cell is monitored, giving the heat change 
of the interaction. To ensure equilibration of the interacting solution between 
injections the syringe tip functions as a constantly rotating stirrer. Though the whole 
titration process is computer controlled, sample and instrument preparation are 
critical to successful experiments. Thorough degassing of solutions is necessary to 
minimise the chances of spontaneous bubble formation, a process that will change the 
heat of the system and result in aberrant data. Cleaning the sample cell between runs 
is also necessary to ensure no contamination from previous runs, with a strong alkali 
(1M NaOH) being the most potent cleaning agent available.  
 
 
 
Figure 1.5 Isothermal titration calorimeter schematic. Precise aliquots of a ligand 
solution of known concentration are titrated into a protein solution of known 
concentration, and mixed by rotation of the syringe needle. Power to the sample cell is 
modulated to maintain equivalent temperature to the reference cell.  The integral of 
the power is the heat change of the interaction. 
 
 
 The plot of molar ratio (ligand:protein) versus the integrals of the power 
fluctuations for each injection is the isotherm.  Thermodynamic parameters of binding 
are extracted through least-squares fitting of an appropriate model to the isotherm. 
The Wiseman model29, given in Equation 1.8 for the 1:1 binding of ligand X to protein 
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M, describes the following for a given injection: the change in heat, dQ, normalised to 
the total number of moles ligand added thus far, Xtot, in terms of the volume of the 
sample cell, V0, and the absolute ratio of ligand and protein concentrations, Xr. Mtot is 
the total moles of protein in the sample cell. 
 X! = X!"! M!"! 
Equation 1.7 
    dQdX!"!   =   ∆H°!V! 12+ 1− X! − r1+ X! + r ! − 4X!!  
Equation 1.8 
 
Fitting gives the enthalpy of binding, ∆H°b, and the value r, from which Ka is calculated 
according to Equation 1.9. 
 1 r = M!"!K! = c 
Equation 1.9 
 
It is worth noting that ∆H°b is temperature dependent, and for some interactions may 
be zero within the physiological and ITC accessible range, resulting in no ITC signal. 
Therefore for some interactions, it may be necessary to repeat the experiment at 
alternative temperatures before concluding that no binding occurs.  
 The stoichiometry of the interaction, n, is also reported, Figure 1.6. A deviation 
from n=1 for interactions that should have a 1:1 stoichiometry may have one of the 
following causes: the one site model is not appropriate; solutions are impure, 
containing other interacting entities; protein is unfolded, therefore the effective 
concentration is lower than calculated; or protein and ligand concentrations are 
inaccurately calculated. Therefore large, > 0.1, deviations from n=1 must be 
investigated to ensure that impurities or unfolding are not the cause. Presence of 
either would invalidate the experiments due to potential alternative interactions 
contributing to the observed data. It has been adequately demonstrated that MUP has 
a single binding site that can only accommodate one molecule.1,21-23 The single 
exception was the accommodation of two pentanol molecules in the pocket, due to its 
small size.1 All ITC solutions were filtered, and NMR allows estimation of both the 
purity of the solution and the folding state of the protein. As solutions were pure and 
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MUP fully folded, stoichiometric deviations can only arise due to inaccurate protein 
and ligand concentration measurements. Due to the critical influence of these 
concentrations on the extracted parameters, it is essential to ensure their accuracy, 
for example by empirical calculation of spectrophotometric extinction coefficients.   
 
 
 
Figure 1.6 ITC isotherm and interpretation. (top) Differential power to the sample 
cell as a function of time.  Each spike in power is due to a single titration injection, 
during which a finite amount of heat is released, followed by the cell temperature 
returning to baseline. The return to baseline, i.e. equivalent temperature to the 
reference cell, is achieved through the action of the thermocouple controlled feedback 
circuit. (bottom) Integrated peaks from the top half as black squares. The initial point is 
removed from the integrated data to account for equilibration of protein and ligand 
solutions at the syringe tip, before fitting the one-site Wiseman model (red line) to the 
isotherm. ∆H°b is the distance between the two plateaus of the curve.  The interaction 
stoichiometry (n) is observed as the molar ratio value where the fit curve is exactly 
halfway between the plateaus. Ka, and subsequently ∆G°b, are defined by the curvature 
of the transition, captured by the r value in Equation 1.8. 
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 The instrument was typically described as allowing measurement of interactions 
with Ka = 10
3 to 108 M-1. Turnbull and Daranas showed this range can be extended to 
encompass lower affinity systems, down to Ka = 10
2 M-1, if the ligand concentration is 
sufficiently higher than Kd.
30  Nonetheless, very weak interactions can be investigated 
using displacement ITC, wherein the binding thermodynamics of a weakly interacting 
molecule are obtained by observing its displacement by a stronger competitor for 
which the thermodynamic binding parameters have been determined.31,32 The function 
used for least squares fitting of the isotherm in displacement ITC is described by 
Sigurskjold in reference 33, and is displayed below, wherein strong ligand, A, displaces 
weaker ligand, B, from protein, P.  
 Q! =   V!  [P]!     ΔH!   x!",! −    f!  x!",!!! +   ΔH!   x!",! −    f!  x!",!!! +   q! 
Equation 1.10 
 
[P]0 is protein concentration, V0 is sample cell volume, ∆H are enthalpies of binding, 
and the terms in square brackets incorporate the change in mole fractions, molar 
ratios, c values (Equation 1.9) and sample volume with each titration. qd is the heat of 
dilution upon injection of ligand.  
 
 
1.3.2  Nuclear magnetic resonance (NMR) 
 
Nuclear magnetic resonance (NMR) spectroscopy provides both temporally and 
spatially resolved information regarding protein structure and dynamics on timescales 
between picoseconds to microseconds, and with some types of experiments, even 
hours. This resolution, coupled with the experiments taking place in solution, contrasts 
with X-ray crystallography, from which higher resolution structures of entire proteins 
are obtained at the expense of introducing non-physiological temperatures (110 K) and 
crystal packing constraints on protein behaviour.    
A wide range of NMR experiments has evolved for analysis of protein 
dynamics, each pertaining to motion averaged over different timescales. Relaxation 
experiments are the most prominently used, and measure protein dynamics at per-
residue resolution on the ps-ns timescale, §1.3.2.6.34 Residual dipolar couplings, which 
measure the relative orientation of interatomic vectors of a molecule with respect to 
the applied magnetic field in a partially aligned sample, are well established in structural 
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determination and refinement, §1.3.2.3.35 Their use is now being extended to dynamics, 
and they can probe dynamics on the nanosecond-millisecond timescale, for example 
the observation of long-range correlated motions in allosteric mechanisms.36 NMR 
experiments and derived values either measured or utilised in this thesis are 
summarised below. 
 
 
1.3.2.1  Basics of NMR 
 
Some atomic nuclei possess a property called spin, which is a form of angular 
momentum. They possess a magnetic moment due to the presence of both charge and 
spin. The proportionality of the spin and magnetism is defined by the gyromagnetic 
ratio, γ, which is a constant for a particular nuclear isotope. Therefore the nucleus has 
a magnetic dipole moment, meaning it both produces a magnetic field and is affected by 
a magnetic field. The overall spin of NMR active nuclei can be ½ or an integer multiple 
of ½, depending on the balance of protons and neutrons in the nucleus.  Spin ½ nuclei, 
such as 1H, have only two possible orientations for their magnetic moment, the 
energies of which are equivalent in the absence of a magnetic field. However, when 
placed into a magnetic field, the energies are non-equivalent, such that the nuclei are 
distributed between the two energy levels according to the Boltzmann distribution. 
The marginal energy difference results in a slightly larger population of nuclei in the 
ground state. This allows for the excitation of these nuclei into the higher energy state 
through the absorption of a photon of equivalent energy to the difference between 
states. The energy difference and therefore frequency of the absorbed photon is 
defined by the gyromagnetic ratio and the strength of the magnetic field at the nucleus. 
The electrons of an atom provide a nuclear shielding effect: they result in a difference 
between the applied magnetic field and that felt at each nucleus. Therefore, for each 
nucleus the immediate chemical environment modulates the frequency of the absorbed 
photon. The shift of this frequency from a reference resonance frequency is the 
chemical shift, the basic parameter measured by NMR spectroscopy. The chemical shift 
crucially provides the capacity to observe individual nuclei, and allows us to gain 
exquisitely sensitive information on their local chemical environment. There is typically 
a requirement for spin ½ nuclei in NMR such that naturally occurring 12C and 14N 
atoms in biological samples (spin 0 and spin 1 respectively) are replaced with their spin 
½ stable isotopes, equivalent to 13C and 15N, for effective measurement of spectra. 
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 1.3.2.2  Relaxation 
 
When at equilibrium in a magnetic field, slightly more magnetic moments align with the 
field than against it, and this defines the ground state. Thus the net magnetisation 
vector is parallel to the field, which is described as the longitudinal bulk magnetisation. 
The main B0 field is defined as the z axis, giving two orthogonal axes describing the xy 
plane. When excited, the vector precesses around the B0 field at the Larmor 
precession frequency, defined as the product of the gyromagnetic ratio and the applied 
external field. The magnitude of the bulk magnetisation vector is dependent upon the 
concentration of spins, the external field strength and the gyromagnetic ratio. Motion 
of the bulk magnetisation vector away from equilibrium is achieved by applying 
radiofrequency pulses. The vector can be detected when moved away from equilibrium 
onto the xy plane. The process by which the bulk magnetisation vector returns to its 
equilibrium value is termed relaxation.  
There are two major forms of relaxation: longitudinal and transverse. 
Longitudinal relaxation, T1, occurs when spins excited onto the z axis return to 
equilibrium due to vibrations and rotations within the sample, which result in a 
changing magnetic field local at a nucleus. A nuclear magnetic moment will relax back 
to equilibrium if components of the local field are equivalent to to its Larmor 
precession frequency. Transverse relaxation, T2, arises from any process that 
decreases the phase coherence of the excited spins in the xy plane.  
 
 
1.3.2.3  Couplings 
 
Interactions between groups of NMR active nuclei due to their spin state manifest as 
splittings of the peaks in NMR spectra, and are known as scalar couplings. The value of 
a coupling is defined in Hz. 
Indirect interactions between bonded nuclei, which are mediated by the 
bonding electrons, are known as scalar or J-couplings. The values of J-couplings are 
proportional to the product of the gyromagnetic ratios of the nuclei involved. 
Couplings are well defined for bonds, and are used to transfer magnetisation 
selectively between nuclei in many solution state biological NMR experiments, 
underpinning two dimensional spectra such as the heteronuclear single quantum 
correlation (HSQC) experiment. In a HSQC experiment, proton magnetisation is 
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selectively transferred to a directly bonded heteronucleus, using the one bond J-
coupling. After the chemical shift is evolved, the magnetisation is finally transferred 
back again to the proton for detection. Overall this allows signals overlapped in the 
proton dimension to be resolved in the heteronuclear dimension.  
Easily measurable J-couplings typically extend over one to three bonds, and in 
case of the 3-bond 3J-coupling the value is dependent on the torsional angle of the 
bonds. The 3J-coupling can therefore be used to define local geometry. Karplus 
described an empirical relationship for the torsion angle dependence of the 3J-coupling, 
Equation 1.11. J(Φ) is the coupling and Φ is the torsional angle. A, B and C are 
empirical parameters that depend on the atoms involved.37 Accurate parameterisation 
of the relationship for a given system is therefore necessary: multiple efforts have been 
made to perform this for protein systems.38,39 
 J(Φ)=  A  cos2  Φ  +  B  cos  Φ    +  C  
Equation 1.11 
 
Another form of coupling is the through-space interaction of magnetic dipoles, 
referred to as dipolar coupling. The coupling, D, is dependent upon the magnetic 
properties of the two nuclei, κ, their distance, r, and the orientation of the 
internuclear vector with respect to the external magnetic field, θ.  
 D = κr! cos!θ − 13  
Equation 1.12 
 
κ is a function of the gyromagnetic ratios of the two nuclei, γ, and some fundamental 
constants. 
 𝜅 = − 38𝜋! 𝛾!𝛾!𝜇!ℏ 
Equation 1.13 
 
In solution, molecules tumble isotropically due to Brownian motion and (cos2θ - 1/3) 
averages to zero, so the overall coupling is lost. The distance dependent effect of 
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dipolar coupling is exploited as the basis of the nuclear Overhauser effect (NOE), 
§1.3.2.5.  
When molecules are partially aligned with respect to the magnetic field, i.e. not 
tumbling isotropically, part of the angular dependence of the dipolar coupling is again 
observable as an addition to the observed J-coupling. When measuring couplings for 
directly bonded atoms, the distance dependence is removed due to the average bond 
length, leaving the primary variable as θ. Thus the difference between couplings in 
isotropic and partially aligned samples, namely the residual dipolar coupling, rdc, 
contains an angular dependence of the internuclear bond vector with respect to 
average alignment with the magnetic field, which contains structural and dynamic 
information.40 Rdc values are averaged over the nanosecond to millisecond timeframe. 
A principal obstacle to performing rdc experiments is finding an alignment medium for 
a given system. Fortunately several systems have been devised that align with the 
magnetic field and induce partial alignment through steric restriction or electrostatic 
interactions with the protein, such as polyacrylamide gels, bicelles or bacteriophage 
solutions.35 Five rdc values from a known rigid unit containing non-colinear vectors 
spanning the three dimensional space can be used to define an alignment tensor. The 
alignment tensor is a description of the average alignment with the magnetic field of 
the molecular coordinate frame, such as that found in a pdb file.41 The alignment 
tensor is described by 5 parameters, three are Euler angles, which define the rotation 
from the molecular frame to the orthogonal tensor frame, and the other two 
parameters describe the degree of alignment: Aa is the magnitude of alignment along 
the z axis, and Ar is the rhombicity of the xy axes. The overall RDC can be described 
by Equation 1.14.42  
 D!" =   A!   3  cos!θ − 1 +   A!   32    sin!  θ cos 2Φ  
Equation 1.14 
 
Aa and Ar are the axial and rhombic components of the alignment tensor. θ and Φ are 
angles relating the internuclear vector to the alignment tensor. 
 
 
 
 
 19 
1.3.2.4  COSY and TOCSY  
 
Correlation spectroscopy (COSY) is a technique which generates homonuclear or 
heteronuclear spectra of 2 or more dimensions.  In homonuclear correlation spectra 
the diagonal peaks are those that appear in a 1d spectrum, whereas cross peaks 
represent J-couplings between nuclei, and are therefore observed for nuclei within 
typically 2-3 bonds of each other. The horizontal and vertical intersections of 
crosspeaks with the diagonal reveal the shifts of coupled spins. These spectra are 
commonly used to assign the chemical structure of molecules. Total correlation 
spectroscopy (TOCSY) gives spectra that are superset of COSY, but transfers 
magnetisation over all bonds within a given spin system. In crowded spectra, this can 
help to reveal the peaks belonging to a particular spin system and improve assignment 
of that spin system. 
For a protein, HCCH TOCSY and 13C TOCSY HSQC experiments involve 
magnetisation transfer from all sidechain protons to sidechain carbons in a 13C labelled 
sample. The signals are then transferred between connected 13C nuclei, and finally are 
transferred back to sidechain protons or carbons for detection. Because all hydrogens 
attached to carbons in the same side chain appear as cross peaks, these experiments 
allow assignment of amino acid sidechains.  
 
 
1.3.2.5  NOESY  
 
When there is a dipolar interaction between two spins close in space, as described in 
§1.3.2.3, they can exchange magnetisation. This transfer is referred to as cross-
relaxation, and forms the basis of the NOE, which has an r-6 dependence on 
internuclear distance, assuming that the dipolar coupling is the main mechanism of 
relaxation. Protons are primarily used to observe NOEs, because their larger 
gyromagnetic ratio and magnetic moment leads to a more effective magnetisation 
transfer. Typically for most proteins, if r is less than about 6 Å the cross-relaxation can 
be observed. As per COSY and TOCSY, in a NOESY experiment cross-peaks appear 
in the spectrum, in this case representing a through-space connection. In this thesis, 
‘NOE’ is henceforth used interchangeably with ‘NOE crosspeak’. The relative strength 
of NOE crosspeaks therefore approximately indicates the relative internuclear 
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distances. Combining HSQC and NOESY experiments correlates the crosspeaks to 
assigned resonances, improving the structural interpretation of NOEs. 
NOEs require a sufficient mixing time to build up and become observable. 
However, at longer mixing times, multi spin interactions, so called spin diffusion, result 
in NOEs being observed between spatially-distant protons due to multi-step 
magnetisation transfer through networks of close protons. This generates crosspeaks 
that cannot be directly interpreted in terms of internuclear distance. Spin diffusion 
occurs faster for larger molecules, due to an inverse dependence on the global 
correlation time. A mixing time of 120 milliseconds is typically used for proteins as a 
compromise, to minimise spin diffusion whilst maximising useable NOE intensity.  
 
 
1.3.2.6  Relaxation-derived dynamics 
 
 
 
Figure 1.7 The ‘diffusion in a cone’ motional model commonly used for physically 
interpreting backbone amide S2 parameters obtained by model-free analysis of NMR 
relaxation data. Here the S2 describes an effective ‘cone of diffusion’.  As S2 decreases 
bond vector motion increases, represented by a larger cone of diffusion. Figure taken 
from reference 34. 
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 ‘Model free’ analysis of NMR relaxation parameters, so called because it only specifies 
a timescale and amplitude, is the main source of NMR-derived information about site-
specific dynamics on the ps-ns timescale.43,44 Relaxation parameters can be acquired for 
backbone amide or sidechain methyl bond vectors. The analysis results in a number of 
parameters for each site at which relaxation parameters were measured. The most 
commonly cited is the square of the generalised order parameter, S2, which can be 
related to the degree of motional restriction and therefore bond vector dynamics. 
Multiple physical models are available for interpretation of the S2. A model used 
commonly for backbone amide S2 values is that of diffusion in a cone, Figure 1.7. As the 
S2 decreases, the effective ‘cone of diffusion’ of the bond vector increases, represented 
by θc˚. Therefore an S2 of 1 describes a rigid bond vector attached to the molecular 
frame, whereas a value of 0 would describe a bond vector tumbling isotropically.  
 As the distribution of bond vector orientations described by the order 
parameter will be related to disorder and therefore entropy, a method for obtaining 
an approximate upper estimate of conformational entropy change between two states 
was devised by Yang and Kay.45 This is calculated using the generalised order 
parameter before and after binding, Sapo and Sholo respectively, and the gas constant R. 
 
𝑆! = ln 3− 1+ 8𝑆!!"!3− 1+ 8𝑆!"# 𝑅 
Equation 1.14 
 
 This approach currently offers the best and most resolved method for 
measuring conformational fluctuations/disorder in proteins at an atomistic level, and 
therefore approximating their associated entropy. The parameters apply only to the 
bond vector analysed, which assumes independent motion for each vector, and 
captures motions only on the ps-ns timescale. Nonetheless, the common use of these 
values to represent flexibility changes and calculate entropy changes is supported by 
examples of close agreement with independent measurements.46  
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1.3.3  Molecular Dynamics (MD) 
 
Molecular dynamics (MD) solves Newton’s equations of motion for an atomic 
resolution system, generating a time evolution of a system as a sequence of atomic 
positions and velocities termed the trajectory. The energy of the system configuration 
sampled at each step is calculated using a potential energy function.  
 
 
 
Figure 1.8 CHARMM MD potential energy function. The energy of the system is 
calculated using bonded and non-bonded terms. k values are force constants and 
subscript 0 refers to equilibrium values generated by parameterisation. All terms with 
equilibrium values are harmonic functions. Figure provided by Dr Emanuele Paci 
(personal communication). 
 
 
The potential energy function represents a compromise between the speed and 
accuracy of the calculation, as terms that could be accurately calculated quantum 
mechanically at greater computational expense are approximated into classical forms. 
Contributions from both bonded and nonbonded terms are summed over a number of 
terms to calculate the potential energy. These terms include bond lengths and angles, 
dihedral angles, and van der Waals and electrostatic interactions. For nonbonded 
terms, the first is a Coulombic term for point charges, and the second a Lennard Jones 
term for calculation of vdW attraction and atomic repulsion. The various K values are 
force constants, and the use of subscript 0 is to indicate the equilibrium value of the 
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relevant parameter. All bonded terms are evaluated as harmonic functions, with the 
energy minimum at the equilibrium value.  
 Equilibrium values are contained in the parameter files generated for each 
molecule. The generation of parameter files, namely parameterisation, can be a lengthy 
process involving quantum mechanical calculations: fortunately efforts are being made 
to parameterise molecules on a faster timescale.47 Combined, the potential energy 
function and parameters are referred to as the forcefield.  
 MD trajectories are maximally temporally and spatially resolved, presenting an 
ideal method for investigating the structure and dynamics of biomolecules. Almost any 
parameter or experimental observable is potentially calculable from a trajectory using 
MD software itself, or external trajectory analysis tools such as wordom for 
CHARMM48. Some observables that can be calculated are NMR S2, radius of gyration, 
average structures, and rmsd or rmsf values between frames of the trajectory. 
Assuming sufficent accuracy of the forcefield, as simulation length tends toward the 
experimental timescale an increasingly representative set of system configurations 
should be sampled. Accordingly, extending the practicable limit of simulation 
timescales has received much attention.49  
 However, the forcefield is an approximation, optimised for the native states of 
proteins. The requirement for accurate sampling of non-native states, for example in 
protein folding simulations, resulted in recent modifications of the backbone torsional 
energy term in both the major MD packages, CHARMM and AMBER.50-53 Further 
approximations are available that reduce the number of particles in the system and 
thus the computational cost of MD. These include implicit solvent models that replace 
the need to include explicit solvent atoms by representing solvent as a continuous 
medium,54 and coarse-grained protein models wherein entire amino acid residues are 
represented as single particles with averaged characteristics.55 Therefore MD of all 
types contain degrees of approximation, and for every new purpose, new 
approximation or new timescale, need to be corroborated against experimental 
measurements to be used with confidence.  
 Fortunately, average parameters extracted from short timescale all-atom MD 
have been robustly corroborated by NMR, the only experimental technique that can 
measure at atomic resolution on timescales easily accessible by MD, i.e. picosecond-
nanosecond.50 
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1.4  Aims and scope of this thesis 
 
Though techniques exist for the computational estimation of ∆H°b to a reasonable 
degree56, a better understanding of dynamic entropic contributions to binding 
thermodynamics is required for truly rational manipulation and optimisation of 
interactions.  
 This thesis addresses four important questions regarding the dynamics and 
thermodynamics of protein-ligand interactions, using MUP as a model system and 
employing a wide range of biophysical techniques. Some work directly utilises the 
perturbation-decomposition approach described herein. Other work capitalises on 
avenues of inquiry that have arisen due to the wealth of data regarding protein-ligand 
interactions in MUP. 
Chapter 2 is an investigation into the proposed entropic solvation of the MUP 
binding pocket, and the possibility of engineering a new binding profile through 
manipulation of sidechains and solvation in the binding pocket. Chapter 3 is the first 
systematic assessment of the widely predicted and presumed benefits of minimising 
ligand conformational entropy loss by removing and restricting ligand bonds. The 
effects of such modifications on intrinsic entropy are considered across a wide panel of 
ligands. Chapter 4 investigates the biggest entropic loss, that of ligand rotational and 
translational entropy, an under-investigated question addressed for the first time using 
a combination of NMR approaches to assess MD predictions of significant residual 
translation and rotational motion when bound. Finally, Chapter 5 constitutes a 
preliminary investigation into a potentially promising novel technique for probing site-
specific changes in protein dynamics upon ligand binding.  
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Chapter 2 
 
Protein Solvation 
 
This chapter is divided into two parts, a and b. a is an investigation into the proposed 
entropic solvation of the MUP binding pocket. b is an investigation into the possibility 
of engineering a new binding profile through manipulation of sidechains and solvation in 
the binding pocket. The two sections are summarised together in §2.4.  
 
 
2a.1  Introduction 
 
2a.1.1  A slippery understanding of protein desolvation 
contributions to binding thermodynamics 
 
Almost all biomolecular interactions take place in an aqueous environment, and the 
contribution of water to molecular interactions is critical. In fact their contribution can 
be the thermodynamic driver for a particular interaction or the folding of a protein, as 
described by the classical hydrophobic effect, §1.2. 
 Estimation of protein desolvation thermodynamic contributions to 
biomolecular interactions is therefore critical. Despite many theoretical predictions of 
the cost of trapping/releasing waters at binding interfaces, most notably those of 
Dunitz, who calculated entropic limits of 0 to 29 kJ mol-1 for release of a single water 
molecule to bulk (and free energy limits of 0 to ~8 kJ mol-1)57, little thermodynamically-
detailed experimental data are available.16 MD and NMR studies have demonstrated 
that changes in the size, shape and chemical nature of a protein’s binding cavity greatly 
alter its solvation thermodynamics. Denisov et al used NMR relaxation-dispersion 
experiments to estimate the entropy of seven bound water molecules in a single 
protein pocket. The estimates span a wide range, suggesting that solvation of non-polar 
pockets may be entropically driven.12 This is further supported by other NMR 
experiments, which suggest large hydrophobic cavities have crystallographically 
unobservable waters that may have significant dynamics13. Furthermore, MD studies 
have shown the protein desolvation, though always accompanied by enthalpic benefits, 
can also result in an entropic penalty.14,15,17  
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2a.1.2  The elusive solvation thermodynamics of MUP’s 
sub-optimally hydrated and large non-polar cavity 
 
A non-classical hydrophobic effect is observed in MUP interactions.1,21 This has been 
attributed to very low density solvation of the unbound MUP pocket as observed by 
high residency waters in crystal structures: compared to the standard hydrophobic 
effect model, this results in reduced entropy gain and reduced enthalpy loss from 
pocket desolvation.  
Relying on changes in crystallographically observed water to interpret binding 
thermodynamics is problematic. Firstly, structures must be resolved < 2 Å to ensure 
observation of water. Secondly, attributive error can arise during structure generation: 
water molecules may be incorrectly modelled into experimental electron density. 
Thirdly, as mentioned in §2a.1.1, crystallographically unobservable water may also play 
a significant thermodynamic role. The first issue can be resolved by using crystal 
structures of sufficiently high resolution. The second and third issues can be addressed 
by employing independent techniques to support the crystallographically derived 
observations. 
Experimental quantitation of MUP pocket desolvation upon ligand binding was 
recently attempted using Quartz Crystal Microbalance (QCM) experiments performed 
by Miss Julie Roy at the University of Nottingham. QCM calculates the change in mass 
of a substrate deposited upon the surface of a resonating quartz crystal, using the 
change in resonant frequency upon binding. Though QCM is not established as a 
technique for distinguishing between masses of proteins with differential water 
content, it is sufficiently sensitive, Figure 2.1c. The mass change was calculated for 
three versions of the protein, MUP, Y120F MUP and A103S MUP, binding to IBMP. 
Apo and holo crystal structures were obtained at below 2 Å resolution, Figure 2.1. 
These two MUP mutants were generated to adjust the number of crystallographically 
observable water in the apo binding pocket from the four observed for MUP. Y120F 
removes the single H-bond donor from the pocket, resulting in no water being 
crystallographically observable in the pocket.21 A103S introduces an additional H-bond 
donor, resulting in an additional water molecule in the binding pocket being 
crystallographically observable, unpublished. The changes in mass upon IBMP 
association from QCM, when attributed to water molecules, agree with the 
crystallographic observations other than for the MUP-IBMP interaction, Figure 2.1. 
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These observations provide support to using the patterns of water observed 
crystallographically to assess protein desolvation upon ligand binding. 
 
 
  
 
 
 
 
 
 
 
 
# of water displaced MUP A103S MUP Y120F MUP 
Crystallography 4 (4→0) 3 (5→2) 0 (0→0) 
QCM 1.9 ± 0.3 3.1 ± 0.4 0.0 ± 0.5 
 
Figure 2.1 MUP (grey), A103S MUP (blue) and Y120F MUP (red) binding IBMP. A) 
and b) are crystal structures of the apo and holo protein respectively, showing the 
sidechains of residues 103 and 120. c) changes in pocket water upon binding: 
comparison of crystallography and QCM (personal communication, Julie Roy). 
 
 
MD analysis of water occupancy of the MUP pocket was also performed. Four water 
molecules were observed by MD, as observed crystallographically, corresponding to a 
density one fifth that of bulk, ~0.2 g cm-3.21 In conjunction with enthalpic data, these 
MD results supported “the absence of ordered water in the binding site”, suggesting 
dynamic water may be present.21 Therefore these data corroborate the 
crystallographic water, yet also indicate dynamic, crystallographically unobservable, 
water. The presence of two such water molecules in the MUP-IBMP complex may 
explain the QCM-crystallography discrepancy for this interaction. No experimental 
approach yet exists to accurately quantify the thermodynamics of dynamic water 
molecules. An assumption that the change in their contribution upon binding is zero or 
minimal remains a caveat.  
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Thermodynamic decomposition of MUP makes this assumption, and includes 
only the change in crystallographically observable water molecules in analysis of 
differential protein solvation upon ligand binding. Previous decomposition estimates of 
the thermodynamic cost of ejecting a water molecule from the MUP pocket upon 
ligand binding are shown in Table 2.1, with their associated caveats. 
Given the many caveats, no reliable estimate of MUP desolvation entropy has 
yet been made. It has been assumed that the release of water from the cavity upon 
ligand binding would be accompanied by an entropic benefit, from the classical 
understanding that water has less entropy in the bound than bulk phase. The studies 
mentioned in §2a.1.1 challenge this understanding: one of these studies addresses MUP 
directly, proposing entropically unfavourable desolvation.15 Syme recently proposed 
the same as a possible source of the negative heat capacity change associated with 
MUP interactions.28  
A better estimate of MUP desolvation entropy would answer these proposals 
and enable comprehensive thermodynamic decomposition in MUP.  
 
 
Interaction T∆S° (kJ/mol) Caveats / not direct measurement 
MUP-IBMP vs  
A103S MUP-IBMP58 
-5.8 Interactions differ by one water ejected. Assumes no 
other differences between two interactions 
MUP-IPMP18 0.1 Entropy assumes ligand is ‘frozen’ upon binding. 
Enthalpy assumes solute:solute enthalpy extrapolated 
from alcohol work1 
 
Table 2.1 Estimates of the entropic cost of ejecting a single water molecule from the 
MUP pocket, with caveats. The second entry was reported as a value for the loss of 
four water molecules, which was divided by four to generate the value in this table. 
 
 
2a.1.3  Opportunity to measure the entropic cost of 
ejecting a single water molecule from the MUP pocket 
 
Crystal structures (unpublished) of N-acetylated phenylalanine methyl ester (NPOME) 
bound to MUP and A103S MUP were solved to a resolution ≤ 2 Å. Their analysis 
revealed an opportunity to obtain a better-estimated value for the ejection of water 
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from the MUP pocket, Figure 2.2. The protein, ligand and solvent in the two 
complexes overlay almost exactly, RMSD = 0.37 Å, containing the same number of 
binding pocket water molecules. However, because the apo protein pockets contain a 
different number of water, the difference between the two interactions has two 
contributions: i) the ejection of one extra water molecule in A103S MUP-NPOME and 
ii) a potential change in S103 sidechain entropy upon binding. In decomposition terms, 
the ligand desolvation terms cancel, and the intrinsic terms almost cancel. Obtaining 
and comparing ITC data for the two interactions will reveal the binding contribution of 
these two factors.  
 
 
 
 
Figure 2.2 MUP (green) and A103S MUP (cyan) bound to NPOME. a) structure of 
NPOME. b) pocket before (apo) and after (holo) ligand binding, sidechain shown are 
Tyr120 and residue 103. c) serine schematic: N’-Hβ, C’-Hβ, and Hα-Hβ 3J couplings are 
torsion-angle dependent, revealing rotamer populations.  
 
 
The A→S mutation involves breaking methyl group symmetry and introducing three 
distinguishable sidechain conformations, potentially with a resulting entropic change 
upon ligand binding. The crystal structure shows the S103 hydroxyl has a different 
average orientation before and after ligand binding, Figure 2.2b. However, this does 
not reveal whether rotamer dynamics and thus entropy, represented by the relative 
populations of rotamers, change. Experimentally measuring the relative populations of 
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the rotameric states before and after binding could permit an entropy estimate. This 
could then be subtracted from the ITC observed differences, resulting in a more 
rigorous estimate for the entropic cost of water ejection from the MUP pocket. An 
assumption of zero entropy change can be made if the relative populations of S103 
rotameric states are unaffected by ligand binding. These populations can be estimated 
experimentally by ascertaining sidechain torsional angles using amino-acid sidechain 
parameterised Karplus relationships39 with Ser103 N’-Hβ, C’-Hβ, and Hα-Hβ 3J couplings 
measured for a 13C-15N labelled A103S MUP sample, Figure 2.2c.  
 
 
2a.1.4  Work undertaken 
 
A better estimate of the entropic cost of water ejection from the MUP binding site will 
aid future decomposition. It will also address the possibility of entropic solvation, i.e. 
bound waters having higher entropy than bulk water. This was sought using isothermal 
titration calorimetry to observe the difference in binding thermodynamics of MUP-
NPOME and A103S MUP-NPOME. To investigate and account for potential changes in 
rotamer sampling of S103 upon ligand binding, NMR experiments to measure N’-Hβ, 
C’-Hβ, and Hα-Hβ 3J couplings for a 13C-15N labelled A103S MUP sample were 
attempted. Samples for QCM were provided to Miss Julie Roy. Extinction coefficients 
were calculated for MUP, A103S MUP and the NPOME ligand, to ensure accurate ITC-
derived data. 
 
 
 
2a.2  Materials and Methods 
 
2a.2.1  Protein Expression and Purification 
 
2a.2.1.1  Standard procedure for MUP 
 
E.coli strain SG13009 containing the MUP gene, with a hexa-histidine tag, had been 
generated previously and stored in a glycerol broth.23 A single colony was picked from 
an agar plate containing 1 mg/mL carbenicillin and grown overnight at 37 ºC with 
vortexing in 100 mL LB medium containing 1 mg/mL carbenicillin. 10 mL of this was 
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used to seed 1 L of LB medium (in a 2 L flask), and the culture left to grow at 37 ºC 
with shaking at 220 rpm. Once the OD600 of the culture reached 0.6 to 0.8, isopropyl-
thiogalactosidase (IPTG) was added to 1 mM to induce gene expression. After 6 hours 
incubation at 37 ºC with shaking at 220 rpm, the cultures were centrifuged at 4 ºC, 
5000 g for 10 minutes to harvest the cells, which were frozen overnight. An equivalent 
process was also performed using a 30 L fermenter facility to provide greater 
quantities of protein. The cell pellet was resuspended in 5 mL phosphate-buffered 
saline (PBS, pH 7.4), containing 0.16 mg/mL lysozyme, per gram cell pellet and shaken 
at room temperature for 20 minutes. Deoxycholic acid was subsequently added (4 
mg/g pellet) and the solution was incubated at 37 ºC for 30 minutes, before addition of 
DNase I (10 µg/g pellet) and MgCl2 (to 5 mM) and further incubation at 37 ºC for 20 
minutes with vortexing. The solution was centrifuged at 4 ºC and 8400 g for 20 
minutes. The MUP was separated first by Ni-NTA affinity chromatography (Qiagen) 
and then size exclusion chromatography using Sephacryl or Superdex medium (Sigma 
and GE Healthcare respectively). An ethanol precipitation step was included to remove 
any endogenous ligands in the binding pocket by adding two volumes ice cold ethanol 
to 1 volume MUP (PBS pH 7.4) and incubating for 2 hours at 4 ºC, before centrifuging 
at 500 g. The pellet was lyophilised and then dialysed against water overnight before 
further lyophilisation to generate a protein stock.  
 
 
2a.2.1.2  Modification of procedure for 13C-15N labelled protein. 
 
The same procedure as described in §2a.2.1.1 was used apart from the following 
changes. M9 minimal medium containing 15N ammonium chloride and 13C glucose 
(Cambridge Isotopes) was substituted for LB medium.  Due to lower populations in 
minimal medium compared to LB, lower induction limits and longer 
incubation/induction times were used.  
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2a.2.2  Extinction coefficient (ε) calculations 
 
2a.2.2.1  MUP 
 
5.05 mg of lyophilised MUP, MW = 20359 Da, was reconstituted into 2 mL PBS (pH 
7.4) to an approximate concentration of 124 µM. The sample was split into 2 x 1 mL 
aliquots. One was diluted with PBS pH 7.4, the other to 6 M Guanidine Hydrochloride 
(GdnHCl). Serial dilutions were performed for each and a small amount of detergent 
(Brij 35, Aldrich) added to each sample, to avoid cuvette wall adhesion. Neither 
GdnHCl nor the detergent absorb at 280 nm. The resulting samples were measured 
using two independent spectrophotometers, a CE1021 (Cecil Instruments) and a 
Genesys 6 (Thermo Spectronic). This is because the CE1021 has been historically used 
for MUP measurements in the lab, yet gives different readings to the more modern 
Genesys 6.  
In order to obtain an accurate sample concentration, 200 µL of the most 
concentrated MUP PBS sample was sent for quantitative amino acid analysis. In this 
technique, the sample is boiled in HCl under vacuum for 24 hours and the resulting 
hydrolysed amino acids are reacted with ninhydrin, separated using ion exchange and 
measured using UV/VIS absorbance (ALTA Biosciences, University of Birmingham, 
UK).59 This type of analysis does not reliably measure the concentration of Cys, Gln, 
Asn Trp, Ser or Thr. It was assumed that the sample sent for analysis was 
uncontaminated, which was supported by the observation that the distribution of 
reliable amino acid concentrations closely matched their percentage composition in 
MUP. The concentration of the sample sent for analysis was calculated as the mean of 
the back-calculated concentration estimates from each reliable amino acid. These 
agreed with the expected concentration from weight only, further supporting the 
purity of the sample. Accurate concentrations of each sample in the series were 
calculated, accounting for the dilution by detergent. The discrepancy of the accurate 
concentrations and those calculated using the original extinction coefficient (10650 M-1 
cm-1) was used to generate an improved ε280. ε280 values for both samples and 
spectrophotometers are shown in Table 2.2. 
For the Cecil CE1021 spectrophotometer, subsequently used for all MUP 
quantifications, the original ε280 consistently calculated concentrations 0.755 that of the 
accurate concentration, in agreement with previously consistently observed ITC 
stoichiometries. Therefore the improved ε280 is 14105 M-1 cm-1  (=10650/0.755).  
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Spectrophotometric analysis of the GdnHCl (unfolded) sample using the 
Genesys 6 generated an ε280 equivalent to that calculated using the online ProtParam 
tool (http://www.expasy.ch/tools/protparam.html)60,61: 11538 M-1 cm-1 empirically 
compared to 11522 M-1 cm-1 computationally.  
The agreement of the unfolded protein in 6 M GdnHCl with the calculated 
value, Table 2.2, provides a potential route for faster calculation of ε280nm for MUP 
mutants. No MUP mutants change residues that absorb at 280nm, meaning that an 
ε280nm = 11538 M-1 cm-1 on a sample in 6 M GdnHCl using the Genesys 6 
spectrophotomer can be assumed to report the accurate concentration of protein in 
the sample, assuming no degradation of the sample. If an equivalent PBS pH 7.4 sample 
is also prepared, this concentration can be used to back-calculate an ε280nm for the Cecil 
CE1021. 
 
 
 Spectrophotometer 
Buffer Cecil CE1021 Genesys 6 
PBS, pH 7.4 14105 ± 209 (1.5%) 12227 ± 71 (0.5%) 
6 M GdnHCl 13067 ± 16  (0.15%) 11538 ± 63 (0.5%) 
 
Table 2.2 MUP extinction coefficients calculated from amino acid analysis, §2a.2.2.1. 
The ProtParam reported a value of 11522 M-1 cm-1. 
 
 
2a.2.2.2  N-acetylated Phenylalanine methyl ester (NPOME) 
 
A spectrophotometric UV absorbance measurement (Genesys 6 spectrophotometer) 
revealed 257.5 nm as an absorbance maximum for NPOME. Sonication is necessary to 
dissolve crystalline NPOME. 3.8 mg NPOME (Sigma-Aldrich Rare Chemicals Library), 
MW = 221 Da, was dissolved in 50 mL PBS (pH 7.4) by sonication. In order to track the 
dissolving of NPOME with sonication, A257.5 was measured in 10-minute intervals using 
the Genesys 6 spectrophotometer until a plateau was reached after 30 minutes (A257.5 
= 0.042). This was taken to represent all ligand having dissolved and therefore a 
concentration of 343.89 µM, resulting in a calculated A257.5 of 122 M-1 cm-1.  
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2a.2.3  Isothermal titration calorimetry 
 
2a.2.3.1  MUP or A103S MUP vs NPOME 
 
ITC experiments were performed on a MicroCal VP-ITC unit with a cell volume of 
1.4109 mL at 298 K.  MUP solution was prepared from freeze-dried protein in filtered 
and degassed PBS pH 7.4 containing 1 mM sodium azide. This solution was dialysed 
overnight at 4 °C, using 7 kDa molecular weight cutoff Snakeskin dialysis tubing 
(Thermo Scientific).  Post-dialysis the MUP solution was filtered using a SS-10 ES10 mL 
syringe (Terumo) and 0.2 µM Minisart filter (Sartorius Stedim).  MUP concentration 
was calculated using the CE1021 spectrophotometer (Cecil Instruments) using the 
extinction coefficient determined in §2a.2.2.1.  All MUP solutions were stored at 4 °C, 
and underwent 30 minutes of pre-experiment degassing at approximately 23 °C under 
vacuum in the ThermoVac temperature-controlled vacuum chamber (MicroCal). The 
PBS dialysate was re-filtered using a 0.2 µM cellulose membrane filter (Whatman) and 
thoroughly degassed before being used to make ligand solutions. Crystalline NPOME 
(Sigma-Aldrich Rare Chemicals Library) was dissolved via sonication and solution 
concentration was measured on the Genesys 6 spectrophotometer (Thermo 
Spectronic) using the extinction coefficient calculated in §2a.2.2.2. 
Experiments comprised a single injection of 2 µL after a 60 s initial delay, 
followed by 50 injections of 5 µL, at 240 s intervals using a 310 rpm stirring speed.  
The cell was cleaned between each run with 1 M NaOH, then extensively with both 
water containing 1 mM sodium azide and PBS dialysate.  Between runs of different 
ligands the syringe was extensively flushed using both these solutions, but only PBS 
dialysate was used between titrations with the same ligand.    
Data were analysed in Origin 5.0 (MicroCal). Blank experiments (ligand into 
dialysate) all showed consistent dilution heats and were fitted with a line of zero slope 
to get the average (blank) value. Blank values were subtracted, and the initial data point 
removed to allow for equilibration at the syringe tip, before data were fit to the 
standard one site model of the Wiseman isotherm.62 Arithmetic means and errors 
were generated from replicate experiments. Error was defined as the standard error 
in the mean of the observed parameters. The error was propagated upon subtraction 
between the datasets.  
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2a.2.4  NMR experiments of 13C-15N A103S MUP  
 
An NMR sample was generated containing 13C-15N A103S MUP, produced as detailed 
in §2a.2.1.2, in PBS pH 7.4 with 10% v/v D2O. All NMR spectra were gathered using a 
Varian Inova 600 MHz NMR spectrometer (Varian Inc., CA, USA) at 298 K. All 
experiments use sequences from the Biopack pulse sequence library supplied by Varian 
Inc. 1H 1D spectra were measured using the water experiment from the Biopack 
library. 1D spectra underwent phasing and baseline correction using iNMR software.63 
The 13C-1H and 15N-1H HSQC spectra were processed using NMRPipe.64 In these latter 
cases, phase correction was performed manually for 1H using NMRDraw (part of 
NMRPipe), and automatically by Biopack (Varian) for heteronuclei. Data are shown in 
§2a.5, an annex to this chapter. 
 
 
 
2a.3  Results and Discussion 
 
2a.3.1  Extinction Coefficient (ε) Calculations 
  
ε were empirically calculated for the MUP proteins and the NPOME ligand, §2a.2.2 and 
§2b.2.2, Tables 2.2 and 2.4, to aid concentration measurements for ITC experiments, 
the relevance of which is explained in §1.3.1. The ε280nm value for the folded A103S 
MUP, 11752 M-1 cm-1, lies close to the theoretically calculated unfolded protein ε280nm 
of 11522 M-1 cm-1. MUP has a higher ε280nm of 14105 M-1 cm-1. The NPOME ε257.5nm was 
calculated as 122 M-1 cm-1.  
 
 
2a.3.2  NPOME binding to MUP and A103S MUP 
 
2a.3.2.1  ITC 
 
The difference in binding parameters between two interactions that differ in the 
expulsion of a single water molecule from the MUP pocket, NPOME binding to MUP 
and A103S MUP, was observed using ITC, Table 2.3. The difference in the free energy 
of binding, ΔΔG°b, is unfavourable when expelling the extra water molecule, arising 
from a larger enthalpic penalty and a smaller entropic benefit.  Accounting for error, 
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the difference in the entropy of binding, TΔΔS°b, is definitely positive, and at least 0.9 
kJ mol-1. This is much more positive than the previous estimates of 0.1 and -5.8 kJ mol-
1, Table 2.1. 
 
 
 
Figure 2.3 Representative ITC isotherms for NPOME binding to a) MUP and b) 
A103S MUP.  
 
 
 ΔG°b ΔH°b TΔS°b 
MUP -32.7 ± 0.1 -49.1 ± 1.4 -16.4 ± 1.3 
A103S MUP -30.2 ± 0.2 -42.7 ± 2.7 -12.5 ± 2.7 
 ΔΔG°b ΔΔH°b TΔΔS°b 
MUP → A103S MUP 2.4 ± 0.2 6.3 ± 3.0 3.9 ± 3.0 
 
Table 2.3 Thermodynamic parameters from ITC, 298 K: MUP and A103S MUP 
versus NPOME. All values are in kJ mol-1 and to 1.d.p. Observed parameters are 
arithmetic means from repeat experiments, errors are standard errors of the mean. 
Errors in the difference value, final row, are propagated from above. 
 
 
The RMSD values for the crystal structures are low, indicating only a potential 
contribution from the A→S mutation as a non-solvent source of differential binding 
thermodynamics, as addressed in §2a.3.2.2. If the change in S103 sidechain entropy 
upon NPOME binding is between -6.9 and -0.9 kJ mol-1, the entropic benefit of water 
ejection is zero within error. If more positive than -0.9 kJ mol-1, water ejection has a 
positive entropic benefit.  If rotating freely, i.e. with no energy barriers, a serine side 
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chain has 11.6 kJ mol-1 of entropy at 298 K.65 This can be considered as an upper limit 
of entropy loss upon constraining a serine sidechain. The change for S103 upon the 
binding of NPOME, though unknown, is likely to be lower. Therefore experimental 
estimation of the change in sidechain entropy upon ligand binding is necessary for 
rigorous estimation of the magnitude and sign of the entropic cost of ejecting a water 
molecule from the MUP pocket. 
 
 
2a.3.2.2  NMR 
 
Experiments were started to investigate and account for potential changes in rotamer 
populations of S103 upon ligand binding. The goal was measurement of NMR N’-Hβ, 
C’-Hβ, and Hα-Hβ 3J couplings for a 13C-15N labelled A103S MUP sample before and 
after NPOME binding. However, due to a degraded sample, the experiments were 
aborted.  Details are contained in §2a.5, an annex to this chapter. 
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2b.1  Introduction 
 
2b.1.1  MUP as scaffold: mutating from hydrophobic to 
hydrophilic 
 
Another member of the lipocalin superfamily is the Histamine Binding Protein (HBP), 
which is released in the saliva of the brown tick and sequesters host histamine to 
evade inflammation and detection.66 The thermodynamics of this hydrophilic ‘cousin’ to 
MUP were recently investigated using panels of structurally related hydrophilic 
ligands.28 The HBP pocket contains multiple polar sidechains, such that in the bound 
state a dicationic cognate histamine is thought to be stabilised by a network of 
hydrogen bonds and ionic interactions, PDB 1QFT.66 Lipocalins have attracted 
attention beyond thermodynamic studies as structural scaffolds for biotechnological 
applications, due to their scavenging capacities and tolerance to mutation.67,68 
Furthermore, HBP’s anti-inflammatory activity proves that lipocalins could be safely 
administered into the bloodstream.69  
 Engineering MUP for a novel capacity was attempted by Dr Caitriona Dennis, 
namely to enable histamine binding in a mode similar to related hydrophilic HBP. This 
was performed by introducing the ionisable sidechain Asp40 (D40) into the MUP 
pocket. Crystal structures, all obtained to a resolution of below 2.1 Å, revealed an 
increased apo pocket water content, accompanied by capacity to bind histamine and a 
partial incapacity to bind IBMP, Figure 2.4. All the crystals were grown and soaked in 
the same way, and are of the same space group and unit cell dimensions as for MUP. 
Therefore these relative differences in IBMP and histamine binding are not an artefact 
of crystal preparation: they may represent a successful change in binding profile 
through mutation of pocket sidechains. 
Considering that large quantities of crystals (>50) can be produced with a small 
amount of material (<1 mg), crystallographic observations represent an attractive 
screening strategy for monitoring changes in binding profile as a result of MUP 
mutations. However, this approach must be validated by corroborating the putative 
changes in binding profile using ITC.  
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MUP crystallisation solution is pH 5.5 and 0.3 M salinity. MUP ITC is usually run at pH 
7.4 and 0.15 M salinity. Therefore in attempting to partially recreate the crystalline 
conditions in ITC experiments, the salinity can be increased or the pH decreased: in 
this investigation the latter was attempted.  Due to the potential risk of protein 
aggregation, increasing salinity was not attempted in this work. 
 
 
 
 
Figure 2.4 MUP mutants with increasing pocket water and crystallographically 
indicated shift in binding from IBMP to histamine. Mutant name (colour, # pocket 
water, ligands that bind to crystal [IB=IBMP, HA=Histamine]): MUP (green, 4: IB), 
A103S MUP (grey, 5: IB), A103S L40D MUP (blue, 7: IB, HA) and L40D MUP (red, 8: 
HA). a) overlay of all mutants, demonstrating close agreement of the backbone. b) 
increase in pocket water, showing Tyr120. c) structures of IBMP and histamine, the 
latter with associated pKa values for ionisable atoms. 
 
 
The pKa values for histamine dictate that it be mostly in dicationic form at pH 5.5, and 
therefore that the crystallographically observed interactions with MUP mutants involve 
salt bridges. However, pKa values of ionisable amino acid sidechains sometimes vary 
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greatly when incorporated into a folded protein structure.70 The pKa value in situ is 
determined by the permittivity, electrostatic interactions and the availability of proton 
donors and acceptors. Furthermore, lower permittivity in protein interiors renders 
charge separation increasingly energetically costly and therefore unfeasible. The pKa of 
Asp (D) in aqueous solution is 3.9, and a comprehensive meta-analysis of 139 
measured Asp residues in 78 folded proteins revealed an average in situ Asp pKa of 3.5 
± 1.2.71 Nonetheless, computational techniques are herein applied to MUP to 
appreciate the potential risk of D40 sidechains being neutral at pH 5.5, and therefore 
incapable of forming salt bridge interactions with dicationic histamine. These 
techniques have been devised to estimate approximate in situ pKa values using crystal 
structures of proteins, and report RMSD from experimentally-derived values of ~ 0.9 
pKa units, §2b.2.5.  
 
 
2b.1.2  Work undertaken 
 
Engineered lipocalins are promising for biotechnological applications. MUP and HBP 
are both lipocalins with hydrophobic (IBMP binding) and hydrophilic (histamine 
binding) binding profiles respectively. Histamine binding capacity, with an accompanying 
decrease in IBMP affinity, was putatively engineered in MUP by introduction of the 
ionisable sidechain D40 and increased solvent water content into the binding pocket. 
These observations were made using x-ray crystallography. Crystallography represents 
an attractive screening strategy for monitoring changes in binding profile as a result of 
MUP mutations, because large quantities of crystals can be produced with a small 
amount of protein.  
To validate the crystallographic observations, ITC was performed at the 
crystalline pH of 5.5, on the panel of MUP variants shown in Figure 2.4 binding to both 
IBMP and histamine. Despite the crystallographically-observed histamine binding, there 
may be a risk of neutralising D40 at pH 5.5 due to its in situ pKa being unknown. If the 
putative change in binding profile observed crystallographically is correct, then MUP 
and A103S MUP should not bind, or have distinctly lower affinity for, histamine. The 
same applies to L40D MUP-IBMP binding. All MUP variants used herein were 
expressed and purified, and checked by NMR. To ensure accurate ITC-derived data, 
extinction coefficients were calculated for all MUP variants used herein, and NMR was 
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used to calculate histamine concentration. An extinction coefficient for IBMP was 
previously calculated by Dr N. Shimokhina.58 
 
 
 
2b.2  Materials and Methods 
 
2b.2.1  Protein Expression and Purification 
 
 
2b.2.1.1  Generation of MUP mutants 
 
The MUP mutants A103S, A103S L40D and L40D were generated by Dr Caitriona 
Dennis and Ms Sue Matthews using QuikChange (Stratagene) site-directed 
mutagenesis, QIAprep spin miniprep kits (Qiagen) and XL1Blue competent cells 
(Stratagene) in accordance with a previously published procedure.21 Dr Caitriona 
Dennis and Ms Sue Matthews performed much of the subsequent expression and 
purification for these proteins using the procedure detailed in §2a.2.1.1. 
 
 
 Spectrophotometer / Buffer 
Protein Genesys 6 (µM) / 6M 
GdnHCl 
Cecil CE1021 (M-1 cm-1) / PBS pH 
5.5 
MUP 293 14105 
A103S MUP 195 11752 
A103S L40D MUP 222 11612 
L40D MUP 155 11844 
 
Table 2.4 MUP absolute concentrations assuming an accurate unfolded ε280nm for a 
protein sample in 6M GdnHCl using the Genesys 6 is 11522 M-1 cm-1. Cecil CE1021 
ε280nm calculated for the same concentration solution in PBS pH 5.5. 
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2b.2.2  Extinction coefficient (ε) calculations 
 
2b.2.2.1  MUP mutants 
 
As indicated in §2a.2.2.1, assuming ε280nm = 11522 M-1 cm-1 for unfolded 6M GdnHCl 
samples analysed with the Genesys 6 allows accurate calculation of MUP 
concentration. Samples derived from the same stock solution can then be used to 
measure ε280nm for any solution conditions and spectrophotometer. ITC samples 
produced for experiments detailed in §2b.2.6.2 were used as stock solutions to 
produce samples in both 6M GdnHCl, unfolded, and PBS pH 5.5, folded. The GdnHCl 
samples were measured using the Genesys 6 spectrophotometer, and the PBS samples 
were measured using the Cecil CE1021. Accurate concentrations from the GdnHCl 
sample and the Cecil CE1021 PBS pH 5.5 ε280nm were calculated, Table 2.4. 
 
 
2b.2.3  1H 1D NMR experiments on MUP mutants 
 
All NMR samples containing protein were measured with 10% v/v D2O. All NMR 
spectra were gathered using a Varian Inova 500 MHz NMR spectrometer (Varian Inc., 
CA, USA) at 298 K, Figure 2.6. All experiments use sequences from the Biopack pulse 
sequence library supplied by Varian Inc. 1H 1D spectra were measured using the water 
experiment from the Biopack library. 1D spectra were phased and baseline corrected 
using iNMR software.63  
 
 
2b.2.4  Crystallography of MUP mutants 
 
Crystallography was previously performed by Dr Caitriona Dennis, using previously 
defined MUP crystallisation conditions.23  
 
 
2b.2.5  Theoretical pKa calculation for MUP mutants 
 
Two online webservers, PROPKA and H++, were used (April 2010) to estimate the 
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pKa of the Asp40 sidechain mutated into the MUP pocket.
72,73 Both methods use 
original crystal structures, and add missing hydrogen atoms before calculation. 
 
 
2b.2.5.1  PROPKA 
 
PROPKA is a structure-based heuristic ‘fast empirical’ method for predicting protein 
pKa values that reports an RMSD from experimental values of 0.89.
73 The results are 
displayed in Table 2.5. 
 
 
2b.2.5.2  H++ 
 
H++ uses a Poissson-Boltzmann approach to calculate the change in pKa moving from 
known full solvation values to the position in the crystal structure. Adjustable 
parameters are salinity, external dielectric and internal dielectric. The latter two 
parameters refer to the dielectric constant (relative permittivity) at the surface and 
core of the protein respectively. An external dielectric constant of 80 was used, 
corresponding to water, and a salinity of 0.15 M, corresponding to the PBS buffer used 
for ITC experiments. The internal dielectric constant was set to both 4 and 15 and the 
range of values reported.  The values reported as ‘pK_(1/2)’ by the webserver are 
displayed in Table 2.5. A comparison of predicted and experimental values was used to 
calculate an RMSD for H++, using only entries with predicted values between 0 and 
14.74 The calculated RMSD is 0.9 pKa units.  
 
 
2b.2.6  Isothermal titration calorimetry 
 
 
2b.2.6.1  MUP mutants vs IBMP or Histamine 
 
The same procedure as detailed in §2a.2.3.1 was performed, except as follows. ITC 
experiments were performed on a MicroCal MCS-ITC unit with a cell volume of 
1.3047 mL at 298 K.  The dialysis buffer was adjusted to pH 5.5 using HCl and filtered 
before dialysis using a 0.2 µM cellulose membrane filter. MUP concentrations, all ~ 100 
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µM, were calculated using the CE1021 spectrophotometer (Cecil Instruments) and the 
extinction coefficients determined in §2b.2.2.3. IBMP (Sigma Aldrich) concentration, ~ 
1 mM, were calculated using ε220nm = 4980 M-1 cm-1 (calculated in reference 58) and the 
Genesys 6 spectrophotometer. Histamine concentration was estimated by weight, the 
solution adjusted to pH 5.5 using HCl, and then the solution concentration, ~ 1 mM, 
measured using 1H NMR acquired using a Varian Inova 500 MHz spectrometer as 
follows.  A tryptophan solution in PBS dialysate was made to a known concentration 
(~ 1 mM) using spectrophotometric measurement (Genesys 6 spectrophotometer, 
ε280nm = 5502 M-1 cm-1, taken from reference 75). Histamine and tryptophan solutions 
were mixed in equal volume with 10% v/v D2O, and histamine concentration was 
determined by measuring the ratio of 1H peak integrals arising from each species, 
Figure 2.5. A 60 s delay was used between scans to ensure the system had returned 
fully to equilibrium and therefore avoid relaxation artefacts in the peak intensities. 
Displacement ITC, described in §1.3.1, was performed by titrating IBMP into a 
solution containing the MUP and histamine samples mixed in equal volume, wherein 
concentrations of all constituents were calculated as above. Approximate 
concentrations were as follows; [MUP], 0.1 mM; [Histamine], 5 mM; [IBMP], 1 mM. 
Data were processed as per §2a.2.3.1, but instead of the Wiseman isotherm, the data 
were fit using the displacement model, §1.3.1 (files and instructions received in 
personal communication from Dr. Sigurskjold)33, incorporating data from the IBMP 
titrations herein performed. 
 
 
 
2b.3  Results and Discussion 
 
2b.3.1  Extinction Coefficient (ε) Calculations 
  
ε were empirically calculated for the MUP variants, §2a.2.2 and §2b.2.2, Tables 2.2 and 
2.4, to aid concentration measurements for ITC experiments, the relevance of which is 
explained in §1.3.1. The ε280nm values for the folded mutant protein, 11612 to 11844 M-1 
cm-1, lie close to the theoretically calculated unfolded protein ε280nm of 11522 M-1 cm-1. 
MUP has a higher ε280nm of 14105 M-1 cm-1. An ε220nm of 4980 M-1 cm-1 was used for IBMP 
(calculated in reference 58), and NMR was used to calculate histamine concentration, as 
detailed in §2b.2.6. 
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Figure 2.5 1H NMR measurements of histamine ligand concentration using a 
tryptophan solution. Molecular structures of tryptophan (top) and histamine (middle) 
are shown. 1H resonance frequencies are indicated next to the relevant proton 
positions in the structures, and correspond to the boxed signals in the spectra. 1H 
spectrum assignment for L-Tryptophan and 1H spectrum for histamine were obtained 
from the Biological Magnetic Resonance Databank (BMRB).76,77 The ratio of the 
indicated peak integrals from each species was used with the known tryptophan 
concentration to determine histamine concentration for ITC experiments. A 60 s 
delay was used between scans to ensure the system had returned fully to equilibrium 
and therefore avoid relaxation artefacts in the peak intensities. 
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2b.3.2  IBMP and Histamine binding to MUP mutants 
 
2b.3.2.1  Theoretical pKa calculations 
  
As already stated in §2b.1.1, the risk of D40 neutralisation at pH 5.5 was considered by 
using two webservers that utilise different calculation approaches, Table 2.5. Both 
estimates predict an increase of at least 1.5 pH units in the Asp pKa due to the MUP 
pocket environment. This is much greater than the average in situ Asp pKa of 3.5 ± 1.2 
revealed by the meta-analysis mentioned in §2b.1.1, which represents a decrease of 0.4 
pH units from the aqueous pKa of 3.9. However, the same meta-analysis revealed a few 
Asp whose pKa increased upon folding by multiple pH units, demonstrating that such 
predicted increases have been observed in a few cases. 
The empirical method PROPKA indicates that in both D40 versions of MUP, 
most of the D40 sidechains should be neutralised at pH 5.5. The H++ method, which 
calculates the in situ electrostatics by solving the Poisson-Boltzmann equation for each 
sidechain, reports a range of values depending on the internal dielectric constant 
variable. Nonetheless, at pH 5.5 most of the D40 sidechains in the sample are 
predicted to be neutralised. These predictions may guide further work, should the pH 
5.5 ITC fail to reflect the trends seen in structures acquired from pH 5.5 crystals. 
 
 
 
 A103S L40D MUP L40D MUP 
PROPKA 6.7 7.1 
H++ 5.4 to 10.4 5.4 to 8.8 
 
Table 2.5 Predicted pKa values for D40 in A103S L40D MUP and L40D MUP. The 
H++ row displays the range of values corresponding to a range of 4 to 15 in the value 
of the internal dielectric constant (relative permittivity). 
 
 
 
 47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 1D 1H NMR spectra of MUP 
variants, PBS pH 7.4 with 10% v/v D2O. The 
section of the spectrum between 2 and -1 
ppm is shown for comparison. All the spectra 
are very similar, demonstrating that the 
mutations introduce no change from MUP 
observable by NMR. Therefore mutation 
does not appear to result in unfolding.  
 48 
2b.3.2.2  NMR 
 
To assess whether the mutations introduce any structural changes under ITC 
conditions, e.g. unfolding, 1H spectra were acquired for all MUP variants to be 
investigated using ITC, Figure 2.6. These experiments used the same buffer as the ITC 
experiments, PBS pH 5.5 with 10% v/v D2O. All the spectra are very similar, indicating 
that the mutations do not introduce any obvious difference from MUP as observable 
by 1H NMR. Furthermore, the thermodynamic parameters for IBMP binding to MUP, 
Table 2.6, are sufficiently close to values at pH 7.4 to conclude that the protein is still 
folded and binding-competent upon titration to pH 5.5.23 Thus all MUP mutants should 
be folded and binding competent in these solution conditions. 
 
 
 
 ΔG°b ΔH°b TΔS°b 
 IBMP 
MUP -36.3 ± 0.3 -42.5 ± 0.5 -6.2 ± 0.9 
A103S MUP -36.2 ± 0.3 -46.9 ± 1.2 -10.8 ± 1.5 
A103S L40D MUP -35.4 ± 0.1 -45.9 ± 0.8 -10.5 ± 0.7 
L40D MUP -35.4 ± 0.1 -37.7 ± 0.7 -2.3 ± 0.6 
 Histamine 
MUP -14.4 6.5 20.9 
A103S MUP -16.7 ± 1.1 12.7 ± 3.1 29.4 ± 4.3 
A103S L40D MUP -18.7 ± 0.1 8.3 ± 0.1 27.0 ± 1.1 
L40D MUP -17.8 21.8 39.6 
 
Table 2.6 Thermodynamic parameters from ITC at pH 5.5, 298 K: MUP variants 
binding to IBMP and Histamine. All values are in kJ mol-1 and to 1.d.p. Observed 
parameters are arithmetic means from repeat experiments, errors are standard errors 
of the mean. No errors are reported for those values arising from a single experiment. 
The values for histamine binding refer to displacement ITC experiments as described 
in §2b.2.6.2. 
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2b.3.2.3  ITC 
 
Table 2.6 details the thermodynamic parameters for MUP variants binding to IBMP and 
Histamine at pH 5.5, 298 K. Representative isotherms are displayed in Figure 2.7. 
There is little change in binding affinity for IBMP across the variants, 0.9 kJ mol-1, 
despite the increasing number of pocket water molecules and the inability to obtain a 
crystal complex of IBMP bound to L40D. The histamine isotherms showed no 
evidence of binding after multiple titrations, despite a 50-fold excess of ligand (5 mM 
ligand and 0.1 mM protein), leading to abortion of the experiments. Displacement ITC 
was used to assess whether weak binding was occurring, as detailed in §2b.2.6.2.  IBMP 
was titrated into a pre-mixed solution of MUP and histamine, and by using the IBMP 
binding parameters acquired herein, the histamine binding parameters were extracted. 
Due to limited sample, only single displacement titrations were performed for both 
MUP and L40D MUP, as shown by the lack of errors for these values in Table 2.6. This 
limits the interpretation of changes in binding profile across the series. Nonetheless, 
crystallographically, A103S MUP does not bind histamine whereas A103S L40D MUP 
does. However ITC reveals only a 2 kJ mol-1 difference in binding affinity between the 
two interactions. 
The weak binding of histamine and continued binding of IBMP could be 
consistent with a neutralised D40, predicted by computational methods. Though large 
increases in Asp pKa upon burial are very rare, they have been observed.
71 
Alternatively, the D40 could still be charged. In this case, histamine affinity would be 
fundamentally weak and relatively unaffected by the presence of a charge in the pocket, 
despite the considerable enthalpic benefit of forming a salt bridge in a lower dielectric 
environment such as the MUP pocket. Additionally, the introduction of a charged D40 
would have to not affect IBMP affinity. Consequently, these data appear to support the 
computational predictions that D40 is neutralised at pH 5.5. It is possible that the 
salinity, which affects pKa values and differs between ITC and crystallography as 
detailed in §2b.1.1, needs to be adjusted to replicate the binding trends observed 
crystallographically. Alternatively, the trends may be reproducible at higher pH. 
Furthermore, the in situ D40 pKa could be directly measured using NMR, by 
performing a pH titration on a 15N-13C labeled protein sample and monitoring the 
chemical shift of the D40 sidechain atoms.  
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Figure 2.7 Representative ITC isotherms for MUP mutants binding to IBMP and 
histamine in PBS pH 5.5. The histamine isotherms show no evidence of binding. 
Subsequently, displacement ITC was used, wherein IBMP was titrated into a mixture of 
MUP and histamine. Details are in §2b.2.6.2. 
 
 
 
2.4  Summary and Conclusions 
 
A more reliable entropic estimate for the ejection of a single water molecule from the 
MUP pocket was sought, to aid future decomposition and investigate proposed 
entropic solvation. The difference in binding entropy of MUP-NPOME and A103S 
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MUP-NPOME was observed via ITC to be 3.9 ± 3.0 kJ mol-1, therefore a positive value 
of at least 0.9 kJ mol-1. Previous estimates suggested 0.1 or -5.8 kJ mol-1.  
In decomposition terms, ligand desolvation cancels between the interactions, 
and due to the close RMSD of the structures, 0.37 Å, the only difference in the 
intrinsic entropic contribution is presumed to be the possible change in S103 
rotameric entropy upon ligand binding. Therefore, to make this estimate reflect only 
the ejection of an extra water molecule, the entropic contribution of the serine 
sidechain rotamer sampling needs to be accounted for. If rotating freely, a serine side 
chain has 11.6 kJ mol-1 of entropy at 298 K, the temperature at which ITC was 
performed.65 Presuming the serine sidechain is not rotating freely in the pocket, any 
entropic difference arising from ligand binding is likely to be much lower than 11.6 kJ 
mol-1. Therefore, if the sidechain entropy change upon NPOME binding is between -6.9 
and -0.9 kJ mol-1, the entropic benefit of water ejection is zero within error. If more 
positive than -0.9 kJ mol-1, water ejection has a positive entropic benefit. S103 rotamer 
sampling measurements were sought using NMR, but a defective sample halted the 
experiments. Further work would include regenerating this sample.  
Crystal structures indicated that the histamine binding of HBP was successfully 
engineered into MUP through mutating ionisable sidechains into the binding pocket 
and increasing pocket solvation. The variants containing L40D appear capable of 
binding histamine, which is charged at the crystal pH of 5.5, and one variant even 
seems to no longer be capable of binding IBMP.  
Because large quantities of crystals can be produced with a small amount of 
protein, crystallography is an attractive screening strategy for monitoring mutation-
derived changes in MUP binding profile. However, this approach requires validation. 
ITC was performed on the MUP variants binding IBMP and histamine, to assess 
whether the same trends in binding across the panel of MUP mutants are observed. To 
attempt the closest possible comparison between the techniques, the ITC solution 
conditions were changed to partially mimic the crystalline conditions. The pH was 
lowered to 5.5, but the salinity was not increased in this work due to the potential risk 
of aggregation. Computational methods predicted a rare high pKa for the D40 residue, 
presenting a risk of neutralisation at pH 5.5 that would likely ablate the binding of 
charged histamine. 
Contrary to the crystallographic indications, no significant changes in IBMP or 
histamine affinity were observed across the series. Histamine affinity was consistently 
very weak for all MUP mutants. These results indicate that the computational 
 52 
predictions of D40 being neutralised at pH 5.5 are correct. Possibly the salinity needs 
to be adjusted to replicate the binding trends observed crystallographically, as it affects 
pKa values and differs between ITC and crystallography as detailed in §2b.1.1. It is also 
possible that the crystallographically observable trends may be reproducible at higher 
pH. Furthermore, ongoing work could be to directly measure the in situ D40 pKa using 
NMR, by monitoring the chemical shift of the D40 sidechain atoms whilst performing a 
pH titration on a 15N-13C labeled protein sample. In summary, this study has 
demonstrated that validating the use of crystals to screen interactions that are heavily 
pH dependent is non-trivial. The validity of the crystallographic observations in this 
case remains unresolved. 
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2a.5  Annex: NMR experiments on 15N-13C A103S 
MUP 
 
In order to experimentally estimate the change in rotameric sampling of S103 upon 
ligand binding, a sample of 15N-13C A103S MUP was produced for NMR experiments as 
detailed in §2.2.1.2 and §2.2.7. Initial 15N-1H HSQC spectra revealed a lack of peaks for 
the A103S MUP sample compared to an equivalently labelled MUP sample, Figure 2.8. 
To assess whether this was due to an insufficiently folded sample, the A103S MUP was 
unfolded using ethanol and refolded in buffer, as per the final step of protein 
purification detailed in §2.2.1.1, and a 15N-1H HSQC spectrum again obtained. 
However, more peaks are absent from the A103S MUP spectrum after refolding the 
protein. A 13C-1H HSQC spectrum revealed a similar comparative lack of peaks, 
especially in the methyl region of the spectrum, where no methyl peaks are observed 
below 0.5 ppm, Figure 2.9a. To assess whether these spectra are characteristic of 
A103S MUP or due to a defective sample, a 1H spectrum of unlabelled A103S MUP 
was acquired, Figure 2.9b. There are clearly defined peaks in the methyl region below 
0.5 ppm, concluding that this particular 15N-13C A103S MUP sample is defective. 
However, many of the peaks are present in both 2D spectra, and are similarly 
dispersed, indicating the presence of secondary structure.78,79 This is not consistent 
with proteolytic digestion, which would result in peptide fragments and lead to very 
narrowly dispersed peaks in 2D spectra.80 It would appear that much of the ‘core 
structure’ of the protein is preserved, indicating only a minor defect. This was 
confirmed by electrospray ionisation mass spectral (ESI-MS) analysis of a small aliquot 
of the 15N-13C A103S MUP sample. Whereas the expected weight is 21650 Da81, 
multiple peaks are present spanning a range of ~90-95% of the expected weight, Figure 
2.10. Therefore it appears that this sample is defective because limited amounts of 
protein mass, 5-10%, have been removed. SDS-PAGE run on aliquots of this sample 
confirms this observation, Figure 2.11. If proteolytic degredation had occurred, no 
band would be visible at ~21 kDa, and multiple lower weight bands would appear. On 
the contrary, the banding pattern appears the same, consistent with the subtle 
differences observed via mass spectrometry. Further work would be required to 
define the nature of this defect/degredation, and this sample would need to be 
regenerated for these experiments to continue.  
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Figure 2.8 15N-1H HSQC spectra of 15N-13C MUP (black), 15N-13C A103S MUP (red) 
and refolded 15N-13C A103S MUP (green). Many peaks observed in the MUP spectrum 
are absent in the A103S MUP spectra, especially after refolding the protein. 
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Figure 2.9 a) 13C-1H HSQC spectra of 15N-13C MUP (black) and 15N-13C A103S MUP 
(red). Many peaks observed in the MUP spectrum are absent in the A103S MUP 
spectra, especially in the methyl region, top right. No signals are observed lower than 
0.5 ppm (1H) for the A103S MUP sample. b) 1H NMR spectrum of unlabelled A103S 
shows clear peaks below 0 ppm. Therefore this particular 15N-13C A103S MUP sample 
is defective, rather than the discrepancies observed here and in Figure 2.8 being 
characteristic of A103S MUP.  
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Figure 2.10  Mass spectrum (ESI-MS) of 15N-13C A103S MUP. The expected weight is 
21650 Da.81 Multiple peaks are present on the mass spectrum up to a weight of 20340 
Da, indicating a partially degraded sample. 91-94% of expected weight.  
 
 
 
 
Figure 2.11 SDS-PAGE gel: 15N-13C A103S MUP sample and unlabelled A103S MUP. 
The NMR samples used in Figure 2.9 were run on a 12.5% polyacrylamide gel. a) 
molecular weight markers, b) unlabelled A103S MUP, c) 15N-13C A103S MUP sample. 
The main bands are seen at about the same molecular weight for both samples, 
corroborating the mass spectral indication of subtle degredation, Figure 2.10. 
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Chapter 3 
 
Ligand conformational entropy 
 
 
3.1  Introduction 
 
3.1.1  A received wisdom based on insufficient data 
 
Upon interacting with a protein, ligand flexibility is reduced. This incurs an entropic 
penalty that unfavourably contributes to the free energy of association, and therefore 
the affinity of the interaction. The most prominent loss, of rotational and translational 
entropy, is addressed in the following chapter. However, the second most prominent 
loss is that of conformational entropy, which arises from the restriction of bond 
rotation.  
The entropic penalty associated with decreasing accessible ligand rotameric 
degrees of freedom upon protein binding has long been considered avoidable by 
employing chemical modifications that constrain or decrease the number of rotatable 
bonds (rotors). Values of reclaimable entropy between 2 and 6 kJ mol-1 per rotor have 
been suggested and supported by various studies.5,82-85 Because a 5.7 kJ mol-1 change to 
the observed free energy of binding, ΔG°obs, corresponds to an order of magnitude 
difference in affinity, realizing these predictions is of significant interest to drug design. 
However, decreasing rotor numbers as a general principle has produced inconsistent 
results.6,7 Despite a lack of consistent experimental data, these predictions have already 
had an impact upon important decisions in drug development; computational ligand 
docking scoring functions currently apply these values as context-independent additive 
per-rotor penalties.  
Therefore these supposedly acheivable benefits remain to be experimentally 
evaluated for multiple systematic modifications in a protein-ligand system. It is also 
unknown whether any effects are significantly dependent upon the nature of the 
structural modifications employed. Decreasing the number of ligand rotors by one can 
be achieved in two ways, either restricting a rotor through introducing a double bond, 
or removing a rotor, e.g. shortening an alkyl chain by one methylene.  
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3.1.2  A tractable system is required to overcome major 
barriers for investigation 
 
There are two related obstacles to observing the effect of multiple systematic chemical 
modifications in a single system.  
Firstly, to quote Benfield et al., “there are few cases where association 
constants are determined for a pair of constrained and flexible ligands having the same 
number and type of heavy atoms, the same functional groups, and the same number of 
hydrogen-bond donors and acceptors.  Appropriate controls are thus generally 
absent”.86 Overcoming this requires a relatively promiscuous system tolerant to 
modification, necessary for multiple pairwise comparisons to be performed.  
Secondly, many protein-ligand interactions are dominated by specific polar 
interactions that are distance and angle dependent. This renders explicit assessment of 
the entropic effects of structural modifications that constrain or remove rotors 
difficult. A system wherein protein-ligand interactions are dominated by weak, non-
polar, non-directional interactions is necessary for an explicit assessment of the 
entropic effects of ligand structural modification.  
MUP meets both of these requirements, as described in §1.2, due to its large 
apolar binding cavity. Ligand interactions with MUP are dominated by weak, non-polar, 
non-directional interactions.  Combined with the size of the cavity, this allows MUP to 
be promiscuous, i.e. bind a wide range of ligands, allowing multiple pairwise 
comparisons to be performed.  
 
 
3.1.3  Thermodynamic decomposition 
 
Two parameters are most important in evaluating the effects upon binding of 
structural modifications that alter ligand conformational entropy. First is the change in 
binding affinity as represented by the change in the observed interaction free energy, 
ΔΔG°obs, which is directly accessible by comparing isothermal titration calorimetry 
(ITC) data. Second is the contribution arising from changes in the ligand 
conformational entropy as a result of structural modification, which requires 
decomposition of the changes in observed thermodynamic parameters of binding 
measured by ITC. These parameters, ΔΔG°obs, ΔΔH°obs and TΔΔS° obs, can be separated 
into contributions arising separately from differences in complex solvation, ligand 
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solvation, and ‘intrinsic’ factors.1  ‘Intrinsic’ is defined as ‘without effects of solvation’, 
i.e. contributions from ligand and protein only, therefore containing the ligand 
conformational entropy change.  This approach can be used equivalently for free 
energy, enthalpy and entropy, producing ΔG°i, ΔH° i and TΔS° i, as detailed in §1.1. 
 Decomposition has previously been performed for interactions of MUP18, and 
the theory is detailed in §1.2. Briefly, the observed thermodynamic parameters can be 
decomposed by focusing on the differences in binding thermodynamics across a panel 
of similar ligands, using a Born-Haber cycle to represent and analyse pairs of 
interactions.1 Giving an example in terms of entropy, assuming that the solvation of the 
two complexes is equivalent, the difference in intrinsic binding entropy (TΔΔS°i) 
between two related ligands is composed only of two terms: the difference in 
observed binding entropy (TΔΔS°obs), and the difference in ligand desolvation entropy, 
(TΔΔS°sL), Equation 3.1. 
 
TΔΔS°i = [TΔS°i2 - TΔS°i1] = [TΔS°obs2 - TΔS°obs1] + [TΔS°sL2 - TΔS°sL1] 
Equation 3.1 
 
TΔS°i is the intrinsic binding entropy, TΔS°obs is the observed binding entropy 
(measured using ITC), TΔS°sL is the ligand desolvation entropy, and the subscripts ‘2’ 
and ‘1’ refer to two closely related ligands that bind to a given protein.  
 
 
3.1.4  Accounting for solvent and protein contributions in 
thermodynamic decomposition 
 
When generating intrinsic thermodynamic parameters, decomposition should directly 
account for changes in ligand desolvation upon modification. Ligand desolvation 
entropy, TΔS°sL, can be measured experimentally from air-solvent partition equilibria, 
although this is not practicable for all ligands. Fortunately, an additive technique for 
calculating desolvation parameters, derived from an extensive pool of published 
experimental data, gives excellent experimental agreement for various hydrocarbons at 
298 K and 1 atm.11 If protein-ligand complexes are differentially solvated, then the 
calculated intrinsic values contain contributions from this difference. Furthermore, to 
obtain ligand-specific contributions to intrinsic entropy, decomposition must also 
account for differential protein dynamics. The most rigorous experimental method 
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would be to calculate entropy values from differences in NMR relaxation parameters 
obtained before and after ligand binding.87 NMR relaxation data acquired for MUP-
ligand binding23 demonstrate that the magnitude of error in the measurements, and 
subsequently computed entropy values, can be sufficiently high to render such time-
consuming experiments of little value to decomposition in this system. Furthermore, 
the magnitude of differential protein dynamics contributions are expected to be small, 
because those previously measured were zero within error.23  If not accounted for, 
Equation 3.1 can still be used, but the intrinsic values calculated will potentially contain 
contributions from these sources. 
Lacking an empirical value for differential complex solvation or useful NMR 
relaxation data, crystal structures can be analysed to appreciate the potential 
contributions from these two factors to reported intrinsic parameters.  
  
 
 
 
 
 
Figure 3.1 Saturated and unsaturated alcohols, including variation in cis/trans 
isomeric state and double bond position. Ligand abbreviations used throughout the 
chapter are shown in brackets. Pairwise comparisons, represented by arrows, describe 
the effect of restricting a rotor (introduction of a double bond) or removing a rotor 
(one less methylene group in the alkyl chain). Previously generated ITC28 and crystal 
data1 were used for 6, 7 and 8.  
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3.1.5  Work undertaken  
 
Removing a single ligand rotor in a model hydrophobic binding system was investigated 
by comparing MUP binding within and between panels of saturated and unsaturated 
alcohols, Figure 3.1. Using this panel of ligands allows two methods for decreasing 
rotor numbers to be assessed: rotor removal through shortening the molecule by one 
methylene group, and rotor rigidification (restriction) through introduction of a double 
bond. Restriction modifications were also assessed in both cis and trans isomers, and 
with the double bond placed at different positions. Therefore this work evaluates a 
large number of systematic modifications in a protein-ligand system. Observed and 
intrinsic thermodynamics of binding were obtained using ITC and calculated 
desolvation parameters. Crystal structures were obtained and analysed to appreciate 
potential contributions from differential complex solvation and protein dynamics to the 
intrinsic thermodynamic parameters.  
 
 
 
3.2  Material and Methods 
 
3.2.1  Isothermal titration calorimetry 
 
3.2.1.1  Experimental 
 
MUP protein was expressed and purified as described in §2.2.1.1. ITC experiments 
were performed on a MicroCal MCS-ITC unit with a cell volume of 1.3047 mL at 
298.15 K.  MUP solution was prepared from freeze-dried protein in filtered and 
degassed PBS pH 7.4 containing 1 mM sodium azide (Fisher Scientific). This solution 
was dialysed overnight at 4 °C, using 7 kDa molecular weight cutoff Snakeskin dialysis 
tubing (Thermo Scientific).  Post-dialysis the MUP solution was filtered using a SS-10 
ES10 mL syringe (Terumo) and 0.2 µM Minisart filter (Sartorius Stedim).  MUP 
concentration was calculated using ε280nm = 14105 M-1 cm-1 using a CE1021 
spectrophotometer (Cecil Instruments).  All MUP solutions were stored at 4 °C, and 
underwent 30 minutes of pre-experiment degassing at approximately 23 °C under 
vacuum in a ThermoVac temperature-controlled vacuum chamber (MicroCal).    
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The PBS dialysate was re-filtered using a 0.2 µM cellulose membrane filter 
(Whatman) and thoroughly degassed before being used to make ligand solutions.  
Alkenols (95% +) were obtained from Alfa Aesar.  Alkenol concentrations were 
estimated by weight and then concentrations measured using 1H NMR spectra 
acquired using a Varian Inova 500 MHz spectrometer.  A tryptophan solution in PBS 
dialysate was made to a known concentration (~ 1 mM) using spectrophotometric 
measurement (Genesys 6 spectrophotmeter, ε280nm = 5502 M-1 cm-1, taken from 
reference 75). Alkenol and tryptophan solutions were mixed in equal volume and 10% 
v/v D2O added. Alkenol concentration was determined by measuring the ratio of 
1H 
peak integrals arising from each species, as shown in Figure 3.2.  A 60 s delay was used 
between scans to ensure the system had returned fully to equilibrium and therefore 
avoid relaxation artefacts in the peak intensities. 
Experiments comprised a single injection of 2 µL after a 60 s initial delay, 
followed by 24 injections of 10 µL, at 240 s intervals using a 300 rpm stirring speed.  
The cell was cleaned between each run with 1 M NaOH, then extensively with both 
water containing 1 mM sodium azide and PBS dialysate.  Between runs of different 
ligands the syringe was extensively flushed using both these solutions, but only PBS 
dialysate was used between titrations with the same ligand.    
 
 
3.2.1.2  Data Analysis 
 
Data were analysed in Origin 5.0 (MicroCal). Blank experiments (ligand into dialysate) 
all showed consistent dilution heats and were fit with a line of zero slope to get the 
average (blank) value. Blank values were subtracted, and the initial data point removed 
to allow for equilibration at the syringe tip, before data were fitted to the standard one 
site model of the Wiseman isotherm.62 Representative isotherms for each ligand are 
shown in Figure 3.3. Arithmetic means and errors were generated for replicate 
experiments. ∆∆G°obs, ∆∆H°obs, T∆∆S°obs, were calculated directly from ITC values using 
Equation 3.1. ∆∆G°i, ∆∆H°i and T∆∆S°I values were calculated with measured ITC 
values in Table 3.2 and calculated desolvation values using Equation 3.1. Group 
averages were calculated by type of modifications and alkenol isomer. 
Error was defined as the standard error in the mean and calculated for ∆∆G°obs 
and ∆∆H°obs, then propagated through the Gibbs function to obtain errors for 
T∆∆S°obs. The standard error of the mean requires that a standard deviation be 
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calculated, which is not meaningful for datasets of less than three measurements. A 
publication that investigated random ITC error detailed a method for generating 
errors applicable to such datasets, which was used for experiments with less than 
three replicates.88 Errors in the calculated solvation parameters ∆G°h and ∆H°h, were 
defined as the average of errors reported in Tables 1 and 2 of Plyasunov et al.,11 
excepting data for monoterpenes, alkynes and diynes. These errors were propagated 
through the Gibbs function to obtain errors for T∆S°h. All errors were further 
propagated through Equation 3.1 to obtain errors for intrinsic and observed changes in 
thermodynamic parameters. Data are displayed in Tables 3.2 and 3.3. 
 
 
 
Figure 3.2 1H NMR measurements of alkenol ligand concentration using a 
tryptophan solution. Molecular structures of tryptophan (top) and t26 (middle) are 
shown. 1H resonance frequencies are indicated next to the relevant proton positions 
in the structures, and correspond to the boxed signals in the spectra. *1H assignment 
for L-Tryptophan was obtained from the Biological Magnetic Resonance Databank 
 64 
(BMRB).76 The ratio of the indicated peak integrals from each species was measured to 
determine alkenol concentration for ITC experiments. A 60 s delay was used between 
scans to ensure the system had returned fully to equilibrium and therefore avoid 
relaxation artefacts in the peak intensities. See §3.2.1.1 for further details.  
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Figure 3.3 Representative ITC isotherms for each ligand binding to MUP.  a) t26, b) 
c26, c) t36, d) c36, e) t27, f) c37, g) t28, h) c38, i) 56. Isotherms for ligands 6, 7 and 8 
are displayed in reference 28. 
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3.2.2  X-Ray Crystallography  
 
Crystallisation was performed by R Malham. Dr Chi Trinh performed all ligand soaking, 
data collection and data processing. Accordingly, methods for §3.2.2.2 and §3.2.2.3 
were provided by Dr Chi Trinh. Ligand soaking protocols were provided by Dr 
Caitriona Dennis.  
 
 
3.2.2.1  Crystallisation 
 
Optimal crystallisation conditions were previously identified; therefore crystals were 
obtained using reservoir solutions containing 45 to 70 mM CdCl2 and 0.1 M malate at 
pH 4.6 to 5.2. Using the hanging drop method, drops containing 1 μL of MUP solution 
(10 mg/mL) and 1 to 2 μL of reservoir solution were equilibrated against 1 mL 
reservoir solution. Crystals with space group P43212 grew within 2 days at room 
temperature. Ligand soaks were performed by immersing crystals in a 2 μL drop of 
reservoir solution before adding 1 μL of 30 mM aqueous ligand solution. Crystals were 
then equilibrated with the ligand for ~30 seconds. Prior to flash freezing in liquid 
nitrogen the crystals were transferred to another 2 μL drop, comprising reservoir 
solution with 1 μL of 30 mM aqueous ligand and 25% (v/v) PEG 400 as a 
cryoprotectant.  
 
 
3.2.2.2  Data collection and processing 
 
All MUP-ligand complex data were recorded at 100 K and gave resolutions between 
1.3 and 1.6 Å from a single crystal on the macromolecular crystallography beamline 
stations I02 and I03 at Diamond Light Source. For all data recorded, the diffraction 
images were integrated using MOSFLM89, then scaled and reduced using SCALA90 and 
CTRUNCATE91 from the CCP4 program suite91. Five percent of the reflections were 
selected and excluded from the refinement using the program FREERFLAG92 and 
constituted the Rfree set. The Rfree set from the previously recorded data for the MUP 
structure 1ZNH was used.1 The data processing statistics are shown in Table 3.1. 
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3.2.2.3  Structure determination 
 
All the crystal structures of MUP ligand complexes were determined using the Direct 
Fourier Transform method with the structure of a previously deposited MUP 
structure as a starting model (PDB accession code 1ZNH1). After initial rounds of rigid 
body and restrained refinement using REFMAC593, iterative manual model building and 
refinement were carried out using COOT94 and REFMAC5. The initial coordinates and 
restraint library file for the ligands were obtained from the PRODRG server95. All the 
ligands were manually fitted into both 2Fo-Fc and Fo-Fc maps in the program COOT. 
Water molecules were manually added in COOT for peaks over 3.5σ  in the Fo-Fc 
map, and where appropriate hydrogen bonds could be made to surrounding residues 
or other water molecules. Refinement was judged complete when the R factor had 
converged and no significant interpretable features remained in the Fo-Fc map. 
Structure validations were carried out with MOLPROBITY96. For all the MUP-ligand 
complexes, residue 1 of the N terminus is missing from the final structure due to 
poorly connected electron density for this region. All refinement statistics are shown 
in Table 3.1. 
 
 
3.2.2.4  Crystal Structure Analysis 
 
RMSD values between structures of MUP-ligand complexes were calculated using the 
Pymol ‘align’ command. All atoms in residues 1 to 155 were specified for alignment, 
and the default iterative outlier removal was disabled to avoid artificially low RMSD 
values being returned.  
B-factors were compared between complexes after adjusting each dataset as 
described by Ringe and Petsko.97 Briefly, of those structures to be compared, that with 
the highest overall B-factor is identified, and its lowest B-factor noted. B-factors of all 
other structures are scaled such that their lowest B-factor matches this value.  
The number of water molecules in the binding pocket was measured by visual 
inspection of the final structure.   
Ligand Molecular Surface Area (MSA) calculations were performed by Dr J 
Clements at the University of Texas at Austin. Connolly or molecular surface areas98 
were calculated for the ligands in their bound conformations using Macromodel v9.1 
(Schrödinger, LLC, New York, NY, 2007).  
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R2 values were calculated using the Microsoft Excel RSQ function.  
 
 MUP-T26 MUP-T27 
 
MUP-T28 MUP-C36 MUP-C37 MUP-C38 
Diamond 
beamline station 
I02 
23/10/10 
I03 
05/12/10 
I02 
23/10/10 
I03 
05/12/10 
I03 
05/12/10 
I03 
05/12/10 
Space group P43212 P43212 P43212 P43212 P43212 P43212 
a  (Å) 53.3 53.5 53.3 53.7 53.4 53.5 
b  (Å) 53.3 53.5 53.3 53.7 53.4 53.5 
c  (Å) 137.4 137.6 137.6 137.6 137.6 137.6 
Resolution  (Å)                                49.69-1.80 42.23-1.30 37.67-1.60 21.27-1.30 11.56-1.30 13.66-1.30 
Rmerge (%)§* 8.8 (33.8) 7.1 (37.1) 7.0 (31.2) 6.4 (34.5) 6.8 (41.1) 6.3 (35.5) 
Rpim (all I
+ & I-) 
(%)+* 
3.6 (13.4) 2.8 (14.4) 2.6 (10.7) 2.2 (11.3) 2.3 (13.4) 3.3 (19.0) 
Observed 
reflections      
137,325 368,624 222,624 498,181 472,585 211,581 
Unique 
reflections          
19,174 49,611 27,077 49,948 48,914 49,558 
Completeness 
(%)*                          
99.8 
(100.0) 
99.0 
(100.0) 
99.9 
(100.0) 
99.0 
(100.0) 
98.3 (97.7) 99.2 (99.7) 
Multiplicity * 7.2 (7.3) 7.4 (7.6) 8.2 (9.4) 10.0 (10.2) 9.7 (10.0) 4.3 (4.4) 
<I>/σ<I > (I/σ)*                      13.0 (4.7) 14.9 (5.0) 16.3 (5.4) 26.0 (6.1) 18.6 (5.8) 12.0 (3.7) 
Refinement  
Rfactor (%)                        18.8 15.8 17.6 16.1 15.8 16.1 
Rfree (%) †                                    20.9 17.6 20.7 17.2 17.1 17.6 
No. of  protein 
atoms               
1304 1304 1304 1304 1304 1304 
No. of solvent 
molecules           
169 169 168 169 169 169 
No. of ligand 
atoms 
7 8 9 7 8 9 
Average overall 
B-factor (Å2)        
23.0 16.8 18.1 16.7 15.8 16.7 
RMS bond 
lengths (Å) ξ  
0.011 0.011 0.013 0.010 0.010 0.011 
RMS bond 
angles (°) ξ  
1.2 1.4 1.4 1.4 1.4 1.4 
Ramachandran analysis, the percentage of residues in the regions of plot (%) ‡  
Most favoured 97.4 96.8 97.4 97.4 96.8 96.8 
Outliers 0 0 0 0 0 0 
 
* Values given in parentheses correspond to those in the outermost shell of the resolution range. 
§ ( ) ( ) ( )∑ ∑∑ ∑ −= hkl ihkl i imerge hklIhklIhklIR /   
+ Rpim - precision-indicating (multiplicity-weighted) Rmerge. 
† Rfree was calculated with 5% of the reflections set aside randomly. 
ξ Based on the ideal geometry values of Engh & Huber (1991). 
‡ Ramachandran analysis using the program MolProbity (Lovell et al., 2003). 
Table 3.1 Crystallographic data collection and refinement statistics, provided by 
Dr Chi Trinh. 
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3.3  Results and Discussion 
 
3.3.1  Changes in observed thermodynamic parameters  
 
Previous ITC (300 K, pH 7.4) experiments from 2005 investigated MUP binding to 
primary aliphatic alcohols from pentanol (C5) to nonanol (C9). Affinity was found to 
decrease incrementally by 3.9 kJ mol-1 with each methylene removed, spanning a range 
of -38.8 kJ mol-1 (C9) to -23.1 kJ mol-1 (C5). This was due to a less favorable ΔΔH°obs 
of 5.6 kJ mol-1 per methylene that dominated more favourable TΔΔS°obs of 1.7 kJ mol-1.1  
 For this work the observed parameters of binding, ΔΔG°obs, ΔΔH°obs and TΔΔS° 
obs, were measured using ITC at 298 K and pH 7.4 for all ligands in Figure 3.1. Data for 
6, 7 and 8, had previously been measured.28 Tables 3.2 and 3.3 show the observed 
parameters and the change in observed parameters calculated using Equation 3.1. 
Table 3.3 also shows average changes of each parameter grouped by type of 
modification and restrictions grouped by isomer type. 
 Changes in thermodynamics parameters resulting from methylene removal, 
averaged over all series, are the same within error as those previously reported. A 
small entropic benefit of 0.9 kJ mol-1 is overwhelmed by an enthalpic penalty of 5 kJ 
mol-1 resulting in an unfavourable change in affinity of 4.1 kJ mol-1.  
 The introduction of an internal double bond displays a similar trend of 
enthalpy-entropy compensation resulting in an unfavourable change to affinity.  
However there is a less unfavourable affinity change, 1.9 kJ mol-1, compared to 
methylene removal. This is because of a lessened entropy-enthalpy offset, which is 
slightly more pronounced for trans isomers due to slightly lower enthalpic penalties. It 
is noteworthy that compared to methylene removal, introduction of an internal double 
bond results in a much larger entropic benefit of 6.9 kJ mol-1, and a slightly larger 
enthalpic penalty of about 8.8 kJ mol-1. Introducing a terminal double bond has a 
distinct entropic effect, closer to that of methylene removal, also seen in the intrinsic 
values. 
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Ligand Number of 
experiments 
 ∆G°obs  
(kJ/mol) 
∆H°obs  
(kJ/mol) 
T∆S°obs 
(kJ/mol) 
 ∆G°h 
(kJ/mol) 
∆H°h 
(kJ/mol) 
T∆S°h 
(kJ/mol) 
6*  -28.5 ± 0.3 -49.3 ± 1.1 -20.8 ± 1.1 -18.2 ± 0.5 -66.1 ± 1.5 -48.0 ± 1.6 
t26 4 -27.3 ± 0.0 -44.3 ± 1.8 -17.0 ± 1.8 -22.0 ± 0.5 -65.4 ± 1.5 -43.4 ± 1.6 
c26 2 -25.8 ± 0.0 -40.4 ± 1.4 -14.7 ± 0.1  -22.0 ± 0.5 -65.4 ± 1.5 -43.4 ± 1.6 
t36 2 -26.4 ± 0.1 -39.4 ± 1.1 -13.0 ± 0.2  -22.0 ± 0.5 -65.4 ± 1.5 -43.4 ± 1.6 
c36 2 -26.0 ± 0.1 -39.0 ± 1.7  -13.1 ± 0.4 -22.0 ± 0.5 -65.4 ± 1.5 -43.4 ± 1.6 
56 2 -25.6 ± 0.1 -45.5 ± 1.5 -19.9 ± 0.3 -21.0 ± 0.5 -65.3 ± 1.5 -44.3 ± 1.6 
7*  -33.1 ± 0.2 -56.2 ± 0.4 -23.1 ± 0.4 -17.5 ± 0.5 -69.9 ± 1.5 -52.4 ± 1.6 
t27 15 -34.3 ± 2.1 -53.0 ± 3.9 -18.7 ± 1.9 -21.3 ± 0.5 -69.2 ± 1.5 -47.9 ± 1.6 
c37 5 -30.1 ± 0.1 -41.8 ± 0.2 -11.8 ± 0.3 -21.3 ± 0.5 -69.2 ± 1.5 -47.9 ± 1.6 
8*  -36.9 ± 0.6 -60.5 ± 0.5 -23.6 ± 0.8 -16.7 ± 0.5 -73.7 ± 1.5 -56.9 ± 1.6 
t28 16 -35.5 ± 0.2 -52.6 ± 1.3 -17.1 ± 1.3 -20.6 ± 0.5 -72.9 ± 1.5 -52.4 ± 1.6 
c38 4 -33.7 ± 0.1 -49.4 ± 0.6 -15.7 ± 0.6 -20.6 ± 0.5 -72.9 ± 1.5 -52.4 ± 1.6 
 
Table 3.2 Thermodynamics parameters: observed by ITC upon ligand binding (obs) 
and calculated desolvation parameters (h).  Ligand names are the abbreviations from 
Figure 3.1. All values are in kJ mol-1 and to 1.d.p. Values denoted with a * are 
reproduced from reference 28.  Observed parameters are from repeat experiments. 
Desolvation parameters were calculated as described above. See §3.2.1.2 for 
calculation of errors. 
  
 
3.3.2  Changes in intrinsic thermodynamic parameters 
 
The difference between observed and intrinsic values is simply the change in ligand 
desolvation thermodynamics upon modification. This is represented by the central 
horizontal arrows and accompanying values displayed in Figure 3.4. The type of 
modification results in significantly different changes to ligand desolvation. Though both 
modifications result in equally unfavourable changes to desolvation entropy, removal is 
preferable to restriction, due to a preferable desolvation enthalpy. Ultimately, 
introduction of a double bond incurs a greater overall desolvation penalty than 
removal of a methylene. 
Calculations were performed and error analysis carried out as detailed in 
§3.2.1.2. Desolvation and intrinsic parameters are displayed in Tables 3.2 and 3.3 
respectively, and graphed in Figure 3.4. The values discussed in this section may 
contain contributions from differential complex solvation or differential protein 
dynamics, which are considered in §3.3.3. 
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Both types of modification follow a similar pattern to that described in §3.3.1, 
namely that entropic benefits are offset by enthalpic penalties resulting in modest 
changes to affinity. Nonetheless, intrinsic affinity is improved by 2.0 kJ mol-1 with the 
introduction of an internal double bond. However, this is not translated into observed 
affinity gains, due to the critical impact of desolvation. As displayed in Figure 3.4, 
introducing a double bond results in a 3 to 4 kJ mol-1 penalty to the free energy change 
of ligand desolvation.  
 
  
Modification ∆∆G°obs  ∆∆H°obs  T∆∆S°obs  ∆∆G°i  ∆∆H°i  T∆∆S°i 
 8→7 3.8 ± 0.6 4.3 ± 0.6 0.6 ± 0.9 3.0 ± 0.9 8.1 ± 2.2 5.0 ± 2.4 
7→6 4.5 ± 0.4 6.9 ± 1.1 2.3 ± 1.2 3.8 ± 0.8 10.6 ± 2.4 6.8 ± 2.5 
t28→t27 1.2 ± 2.1 -0.4 ± 4.1 -1.6 ± 2.3 0.5 ± 2.2 3.4 ± 4.6 2.9 ± 3.2 
t27→t26 7.0 ± 2.1 8.7 ± 4.3 1.6 ± 2.7 6.3 ± 2.2 12.4 ± 4.8 6.1 ± 3.5 
c38→c37 3.7 ± 0.2 7.6 ± 0.7 3.9 ± 0.7 3.0 ± 0.7 11.4 ± 2.2 8.4 ± 2.3 
c37→c36 4.1 ± 0.2 2.8 ± 1.7 -1.3 ± 0.5 3.4 ± 0.7 6.5 ± 2.7 3.2 ± 2.3 
6→t26 1.3 ± 0.3 5.0 ± 2.1 3.7 ± 2.1 -2.6 ± 0.7 5.7 ± 3.0 8.3 ± 3.1 
6→c26 2.8 ± 0.3 8.9 ± 1.8 6.1 ± 1.1 -1.1 ± 0.7 9.6 ± 2.8 10.7 ± 2.5 
6→t36 2.1 ± 0.3 9.9 ± 1.5 7.8 ± 1.1 -1.7 ± 0.7 10.6 ± 2.6 12.4 ± 2.5 
6→c36 2.6 ± 0.3 10.3 ± 2.0 7.7 ± 1.2 -1.3 ± 0.7 11.0 ± 2.9 12.3 ± 2.5 
7→t27 -1.2 ± 2.1 3.2 ± 3.9 4.4 ± 2.0 -5.1 ± 2.2 3.9 ± 4.4 9.0 ± 3.0 
7→c37 3.0 ± 0.2 14.3 ± 0.4 11.3 ± 0.5 -0.8 ± 0.7 15.1 ± 2.2 15.9 ± 2.3 
8→t28 1.3 ± 0.6 7.9 ± 1.4 6.6 ± 1.5 -2.6 ± 0.9 8.6 ± 2.5 11.1 ± 2.7 
8→c38 3.1 ± 0.6 11.0 ± 0.8 7.9 ± 1.0 -0.7 ± 0.9 11.8 ± 2.3 12.5 ± 2.5 
6→56 3.0 ± 0.3 3.8 ± 1.8 0.9 ± 1.2 0.1 ± 0.7 4.6 ± 2.8 4.5 ± 2.5 
Grouped by type of modification 
<Remove> 4.1 ± 0.5 5.0 ± 1.1 0.9 ± 0.7 3.3 ± 0.6 8.7 ± 1.4 5.4 ± 1.1 
<Restrict> 1.9 ± 0.3 8.8 ± 0.7 6.9 ± 0.5 -2.0 ± 0.4 9.5 ± 1.0 11.5 ± 0.9 
Restrict modifications grouped by isomer 
<Trans> 0.9 ± 0.6 6.5 ± 1.2 5.6 ± 0.9 -3.0 ± 0.7 7.2 ± 1.6 10.2 ± 1.4 
<Cis> 2.9 ± 0.2 11.1 ± 0.7 8.3 ± 0.5 -1.0 ± 0.4 11.9 ± 1.3 12.8 ± 1.2 
 
 
Table 3.3 Changes in observed and intrinsic thermodynamic parameters, and means 
grouped according to modification type. The ‘modification’ column uses the 
abbreviations from Figure 3.1, repeated in Figure 3.4. 6, 7 and 8 values taken from 
reference 28. Observed and intrinsic values were calculated, and errors propagated, 
using Equation 3.1 and data in Table 3.2. Group means do not include values for ligand 
‘56’. All values are in kJ mol-1 and to 1 d.p. The same data are displayed graphically in 
Figure 3.4. 
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Figure 3.4 Intrinsic and observed values of ΔΔG°, ΔΔH° and TΔΔS°, and group 
means. Values, from Table 3.3, are grouped by modification (solid and dashed boxes), 
and different isomers are indicated (grey squares). The horizontal line in each box is 
the group mean. Group means do not include values for 56, which is indicated with an 
asterisk. Zero is indicated by a dashed line. Central arrows and values indicate the 
calculated desolvation parameters. All values are in kJ mol-1 and to 1.d.p. Abbreviations 
from Figure 3.1 are used: hexanol (6), heptanol (7), octanol (8), trans-2-hexenol (t26), 
trans-3-hexenol (t36), trans-2-heptenol (t27), trans-2-octenol (t28), cis-2-hexenol 
(c26), cis-3-hexenol (c36), cis-3-heptenol (c37), cis-3-octenol (c38), 5-hexenol (56). 
 
 
Both types of modification incur a significant ~9 kJ mol-1 ΔΔH°I penalty on average, as 
observed previously for methylene removal.1 Unlike previously, individual methylene 
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removal values span a wide range of 3.2 to 12.4 kJ mol-1, variation that is unexpected in 
a system dominated by weak, non-directional, non-polar interactions.   
A TΔΔS°i of 5.5 kJ mol-1 per methylene removed was previously suggested for 
saturated alcohols in this system at 300 K.1 The average TΔΔS°i value for methylene 
removal is the same within error, 5.4 kJ mol-1, and lies within the range of theoretical 
predictions. Introducing an internal double bond, i.e. any bond with two adjacent C-C 
bonds, results in significantly greater TΔΔS°i than methylene removal, on average 11.5 
kJ mol-1. Contrastingly, introducing a terminal double bond results in a TΔΔS°i of 4.5 kJ 
mol-1, in the range of the methylene removal values. This suggests that the TΔΔS°i 
values resulting from methylene removal are indeed due to the loss of a rotatable 
bond, and that the higher values for internal double bonds include additional entropic 
effects. 
It has been calculated that the effect of restricting or removing rotors on 
TΔΔS°i is more due to changes in the vibrational (torsional fluctuations within a 
conformation) than rotameric component of the entropy: in fact it has been proposed 
that up to 90% of the change arises from the vibrational component.99 However, these 
calculations were performed for inhibitor binding to HIV protease, which is not 
dominated by weak, non-polar, non-directional interactions like MUP. Adopting a 
vibrationally restrictive single bound conformation is less necessary in MUP. Analysis of 
crystallographic electron density (discussed in §3.3.3) supports this, indicating distinct 
ligand flexibility in the pocket for ‘restrict’ ligands. 
 
 
3.3.3  Crystallographic analysis to assess potential for 
contributions from differential complex solvation and 
protein dynamics 
 
An appreciation of contributions from differential complex solvation and protein 
dynamics to the intrinsic values may indicate the requirement for further work. This is 
achieved by observing changes in crystallographically-derived parameters and 
calculating their correlation to changes in intrinsic thermodynamic parameters, as 
detailed in §3.2.2.4. As ΔΔG°i is simply a function of ΔΔH°i and TΔΔS°I, correlations 
were only calculated for the latter two parameters. Modification type was also 
correlated to these parameters. A comparison of how much variance is explained by 
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changes in crystallographic observables as opposed to the type of modification 
indicates the degree to which trends in the reported intrinsic parameters can be 
simply related to the type of modification. Crystal structures were obtained for the 
complexes marked in Figure 3.1, to a resolution of < 1.5 Å, as detailed in §3.2.2.3. 
Crystal structures for 6, 7 and 8 were previously published.1  
 
 
Modification Δ Bound 
water Δ <B-factor> 
Δ Global 
RMSD 
Δ Ligand 
MSA 
Modification 
type 
8→7 2 -1.70 0.32 -18.30 1 
7→6 0 0.95 0.68 -14.80 1 
t28→t27 1 0.76 0.11 -17.75 1 
t27→t26 0 2.29 0.14 -18.25 1 
c38→c37 0 -0.93 0.03 -16.50 1 
c37→c36 0 -0.10 0.05 -15.35 1 
6→t26 -1 -0.53 0.56 -5.60 2 
7→t27 -1 -5.93 0.61 -2.15 2 
8→t28 0 -2.05 0.63 -2.70 2 
6→c36 -1 -3.41 0.61 -6.90 2 
7→c37 -1 -7.07 0.61 -6.35 2 
8→c38 1 -3.54 0.63 -8.15 2 
R2      
∆∆H°i 0.01 0.04 0.03 0.00 0.01 
T∆∆S°i 0.23  0.58  0.47 0.51 0.65 
 
Table 3.4 Changes in crystallographically-derived observations with each ligand 
modification, and correlation to corresponding values in Table 3.3 (which are not 
reproduced in this Table). All crystal structures have resolution < 1.5 Å. Abbreviations 
from Figure 3.1, listed again in Figure 3.4, are used in the ‘modification’ column. MSA is 
ligand molecular surface area. See §3.2.2.4 for calculation of values and R2.   
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Figure 3.5 Absolute change in bound ligand molecular surface area (ΔMSA) versus 
change in intrinsic enthalpy of binding (ΔΔH°i) for all crystallographically-analysed ligand 
modifications. Data and errors are tabulated in Tables 3.3 and 3.4. Alcohols data are 
from reference 28. ‘2005 alcohols’ data, acquired at 300 K, are taken from reference 1.  
  
 
Differential complex solvation was evaluated by comparing the number of high-
residency water molecules in the MUP binding pocket for each complex, as discussed 
in §2. The resolution of these structures is high enough to resolve high-residency static 
water molecules (below 2 Å). However, highly dynamic water molecules that could 
have important energetic contributions are currently experimentally unobservable, and 
therefore their potential contribution is an important caveat. An estimation of 
differential protein dynamics was performed by calculating both RMSD values and 
differences in protein all-atom B-factor averages between complexes. Though 
crystallographic B-factors can correlate to solution dynamics100, comparing these values 
between different data sets is non-trivial. The magnitudes of these values are 
influenced by multiple factors, including crystal defects and differential processing.  
Consequently there is no definitive method for performing such comparisons, and any 
results need to be treated with caution. The values reported here arise from datasets 
which were adjusted according to the method of Ringe et al.97 
Differences were seen in these crystallographic observables, Table 3.4. None of 
these changes correlated to the intrinsic enthalpy changes (R2 < 0.05), and therefore 
do not account for the wide range of values observed. The MUP-alcohol experiments 
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from 2005 show a narrow range of ΔΔH°i across four modifications, 7.6 to 9.7 kJ mol-1 
, attributed to a change in ligand molecular surface area, ΔMSA, interacting with the 
MUP pocket.1 This work shows no correlation between change in ΔMSA, calculated 
from a single conformation in the binding pocket, and ΔΔH°i using either the whole 
dataset or just the ‘remove’ values, as explored below. 
Figure 3.5 shows absolute ΔMSA of the bound ligand versus ΔΔH°i, Table 3.4, 
for those modifications analysed crystallographically, Figure 3.1, including the data from 
reference 1. For the latter data, the hexanol to pentanol modification is discounted 
because two pentanol molecules bind in the pocket. The absolute ΔMSA for the 
nonanol to octanol transition was calculated as 16 Å2 using UCSF Chimera.101 Focusing 
on the ‘remove’ values initially, ΔΔH°i values for methylene removal in saturated 
alcohols (black circles) sit close to the narrow spread of for the 2005 data (blue 
triangles). However, values for the two unsaturated series (green diamonds and red 
squares) diverge from these values and greatly widen the data range: this is greatest for 
trans-alkenols, which display the smallest and largest ΔΔH°i values for methylene 
removal. The small range of ΔMSA probed through methylene removal may preclude 
observation of any correlation. Nonetheless, all values are consistent with the 2005 
range within error, perhaps suggesting a standard ΔΔH°i for removing a methylene. 
Restrict values also incur a similar ΔΔH°i penalty, revealing that removing the entire 
methylene surface is enthalpically equivalent to removing two H atoms and introducing 
a polarisable bond. That the penalty is higher for cis than trans alkenols may reflect the 
relatively increased strain of a cis isomer. The equivalence of ΔΔH°i with modification 
shows that a simple correlation to ΔMSA is misleading because it ignores the equally 
important chemical nature of the ligand surface. 
Correlations of TΔΔS°i to the same crystallographic observables are much 
higher. The strongest correlation is with modification type (R2 = 0.65). There is only 
weak correlation (R2 = 0.23) to differential complex solvation, meaning that explicitly 
accounting for differential solvation could adjust the exact magnitudes of individual data 
points but would not affect trends in the data. However, differential protein dynamics 
upon ligand modification appear to explain almost as much of the variance (R2 = 0.51, 
0.58) in TΔΔS°i as the type of modification. Though the B-factor values must be treated 
with caution, this result clearly indicates that the reported intrinsic entropy changes 
contain potentially significant contributions from differential protein dynamics in 
addition to changes in ligand conformational entropy.  
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Furthermore, ligand electron density for alkenol complexes is less defined than 
for their alcohol counterparts, indicating that introduction of an internal double bond 
increases the number of ligand binding configurations. Though this observation does 
not affect the methylene removal data, an increase in ligand conformational entropy in 
the bound state could explain the additional TΔΔS°i benefit of restriction above and 
beyond removal. 
 
 
 
3.4  Summary and Conclusions 
 
This is the first systematic experimental evaluation, in a protein-ligand system, of the 
suggested entropic and affinity benefits of decreasing rotor numbers in a ligand 
molecule. The work also evaluates two possible modifications for decreasing rotor 
numbers, both removal and restriction of C-C bonds. The necessary tolerance to 
ligand modification and a thermodynamic decomposition approach identified MUP as 
suitable system. Observed and intrinsic thermodynamics of binding were obtained 
using measured ITC and calculated desolvation parameters. Crystal structures were 
obtained and analysed to appreciate potential contributions from differential complex 
solvation and protein factors to the intrinsic parameters. 
Analysis of crystal structures indicates a contribution from differential protein 
dynamics to intrinsic entropy changes. This would usually prompt further investigation 
using NMR relaxation experiments, however in this system errors are too high with 
this technique to be beneficial. A weak correlation between intrinsic parameters and 
differential complex solvation was found.  
Previously predicted penalties for rotamerically ‘freezing’ a single ligand C-C 
bond upon binding were observed as an average 5.4 kJ mol-1 TΔΔS°i benefit from 
methylene removal across multiple ligand series. The introduction of a terminal double 
bond gives a similar result of 4.5 kJ mol-1, vindicating methylene removal as effectively 
the deletion of a rotor in terms of intrinsic entropy. However, a significantly higher 
TΔΔS°i benefit of 11.5 kJ mol
-1 is obtained by introducing an internal double bond.  
This may arise from an increase in the number of bound configurations of the ligand 
upon introducing an internal double bond, an effect that relies on the specific 
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architecture and size of the pocket. These gains are considerable in terms of ligand 
design, where 5.7 kJ mol-1 represents an order of magnitude in affinity.  
In the case of this system these considerable entropic gains are compensated 
by unfavourable enthalpic and solvation contributions resulting in an unfavourable 
effect on affinity. Desolvation offsets to these gains are pronounced for restrictions, 
due to a large enthalpic penalty of desolvation.  
Despite being more comprehensive than other work in the field, there is still 
too little data to identify conclusive and reliable trends. Overall, these data support 
predictions of a TΔΔS°i benefit of ~5.4 kJ mol-1 from removing a rotor.  However, in 
hydrophobic alkyl chains that undertake nonpolar interactions with the protein, this 
modification also incurs desolvation and intrinsic enthalpy penalties that result in an 
unfavourable effect on affinity. Introduction of an internal double bond has a 
pronounced TΔΔS°i benefit, possibly due to a combination of both rotor restriction 
and an increase in bound configurations of ligand. This pronounced benefit is mostly 
offset by an increased intrinsic enthalpy penalty. Restriction modifications also incur a 
greater desolvation penalty than methylene removal, resulting here in an unfavourable 
affinity, albeit less unfavourable than for methylene removal.  
Reproducing the enhanced benefits of restriction over removal observed in this 
system will be unlikely if this effect does arise from an increase in the flexibility of 
bound ligand, because most other systems will not have similarly spacious and non-
specific binding pockets. However, introducing double bonds may bear fruit in certain 
disease-relevant systems: previous work showed a 10-fold improvement in binding 
affinity of a peptide ligand to a protein receptor due to a single internal bond 
restriction like those reported here102. 
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Chapter 4 
 
Ligand rotational and translational 
entropy 
 
 
4.1  Introduction 
 
4.1.1  The biggest penalty to binding entropy  
 
It is regularly stated that the most prominent entropic penalty in protein-ligand 
interactions is that of decreased translational and rotational entropy of the ligand. 
Though these losses are partially replaced by vibrations in the bound state, they have 
been previously calculated as ~56 kJ mol-1 in solution at 25 °C, with a range of -40 to -
60 kJ mol-1 for many small organic molecules.5 These predictions arise from a 
statistical-mechanical approach that extrapolates from gas phase, resulting in very high 
entropy for the ligand in its free state. However, recent analysis of the effect in the 
literature, one paper of which utilised a decomposed MUP interaction for 
experimental comparison103, demonstrates that models which consider free ligand to 
be constrained by solvent result in predictions closer to experimental estimates.104 
Either type of model requires accurately accounting for ligand translation and 
rotation when bound. Enzyme-substrate binding requires that ligands be held in a single 
bound conformation (binding mode) to enable a specific chemical reaction. 
Furthermore, computational, crystallographic and spectroscopic data indicate that 
most interactions still have either a single or a small number of defined binding 
modes.56 Therefore in many cases it is assumed that a (small) ligand loses all, or almost 
all, of its rotational and translational degrees of freedom upon binding to a (much 
larger) protein. However, because thermal energy can be on the same order as the 
energy of non-covalent interactions, the ligand bound state may have a degree of 
residual freedom.105 Consequently residual motion, including the volume the bound 
ligand can access, is sometimes estimated using computational methods to assess 
relative motion of ligand and protein in the complex.  
It is very difficult to experimentally measure and confirm predictions of ligand 
rotational and translational entropy loss upon binding, which can vary from 56 down to 
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~5 kJ mol-1.106 Until now, direct experimental assessment of predicted residual motion 
has never been attempted, due to a combination of practical difficulty and an 
expectation that any such motion would be below experimental resolution.  
 
 
4.1.2  Loss of ligand rotational and translational entropy 
upon binding to MUP 
 
Two MUP ligands have been sufficiently studied experimentally that decomposition has 
estimated a value for the loss of ligand rotational and translational entropy. These are 
2-methoxy-3-isopropyl-pyrazine (IPMP) and 2-methoxy-3-isobutyl-pyrazine (IBMP), 
displayed below. 
 
Figure 4.1 Chemical structures of 2-methoxy-3-isopropyl-pyrazine (IPMP) and 2-
methoxy-3-isobutyl-pyrazine (IBMP). 
 
Ligand ∆G°b (kJ/mol) ∆H°b (kJ/mol) T∆S°b (kJ/mol) Loss of ligand rot. 
and trans. 
entropy (kJ/mol) 
IPMP -33.9 ± 0.28 -44.5 ± 0.4 -10.7 ± 0.5 -25 
IBMP -38.5 ± 0.86 -47.9 ± 0.9 -9.4 ± 0.9 -27 to -78 
Ligand <Protein B-factor> <Ligand B-factor>   
IPMP 28.91 28.60   
IBMP 22.04 23.89   
 
Table 4.1 Thermodynamic parameters from ITC at 308 K, and B-factors from crystal 
structures, for MUP interactions with IPMP and IBMP. Data reproduced from 
references 23 and 18. Average B factors include all atoms in relevant segments, taken 
from pdb files 1QY1 (IBMP) and 1QY2 (IPMP).  
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IBMP binds more favourably to MUP, mainly due to a more favourable enthalpy of 
binding that may arise from burial of an increased non-polar surface area upon 
interaction. The entropies of binding are the same within error.  
 Crystallographic B factors can be used as indicators of dynamics.100 Intra-
structure comparison of the average all-atom ligand B-factor to that of the protein 
indicates the relative motion of the ligand in the pocket. Table 4.1 shows that for IPMP 
the ligand value is lower than that for the protein, whereas the opposite is true for 
IBMP. However, the difference in the IBMP B-factor values is small. Additionally, the 
occupancy of the ligand is 1, indicating it is in the same position in all units of the 
crystal. Consequently, both ligands were assumed essentially rigid when bound, despite 
the considerable size of the pocket as demonstrated in Figure 4.2.18,23 
  
 
 
Figure 4.2 Ligand in binding pocket from IBMP-MUP crystal structure, 1qy1. a) top 
view b) side view. The pocket is represented by black mesh indicating the amount of 
space for movement. Tyr120 is shown in red. It is the only polar pocket residue, to 
which a hydrogen bond is assumed. 
 
 
The predicted values of ligand rotational and translational entropy loss detailed in 
Table 4.1 incorporate this assumption. It was also assumed that all rotation of all bonds 
other than in the methyl groups were completely constrained upon binding. The final 
predictions, displayed in Table 4.1, were then generated using values from the 
literature that are based on the original statistical-mechanical approach for evaluating 
free ligand entropy.107,108 
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A recent theoretical paper, mentioned in §4.1.1, used the MUP-IPMP 
interaction as an experimental benchmark to test different approaches for calculating 
entropy of free ligand.103 A rigid binding pose was again assumed, where, upon binding, 
all translational and rotational motions were reduced to vibrations and librations 
respectively. Using an approach with a solvent-constrained free ligand entropy, a value 
of -25.7 kJ mol-1 was calculated, almost replicating the -25 kJ mol-1 generated by 
experimental decomposition. 
 
 
4.1.3  Significant residual translation and rotation predicted 
from µs molecular dynamics 
 
Because of the wealth of biophysical data regarding the MUP-IBMP interaction, e.g. 
NMR and ITC, it was recently investigated using long-timescale 1 µs molecular 
dynamics simulations.26 MD forcefields are not calibrated for or assessed at such long 
timescales, requiring that these simulations were carefully checked for forcefield 
artefacts. This was achieved for the protein by corroborating experimentally observed 
NMR chemical shifts with trajectory averaged calculated chemical shifts from the 
whole 1 µs trajectory.23,26 
 Unexpectedly, substantial ligand rotation and translation was observed in the 
binding pocket. The polar plot in Figure 4.3 (reproduced from the article), describes 
ligand movement through the projection of two orthogonal inter-ligand atom vectors 
over the 1 µs simulation. Though the movement is clustered, thus not completely 
isotropic, there is clearly substantial rotation of the ligand, and extended occupation of 
multiple distinct ligand poses. Clustering was performed by Dr Charlie Laughton 
(personal communication), and generated 10 populations. Representative poses from 
these clusters, above the population of each cluster as a timecourse for each replicate 
trajectory, Figure 4.4, reveal considerable movement between clusters even on a 
relatively short timescale. Given the MUP pocket’s non-polar character, it is expected 
that ligands which can interact with the single hydrogen bond donor Tyr120 would be 
energetically required to satisfy this interaction. Surprisingly, there are times during 
each of three replicate trajectories when none of the three IBMP H-bond acceptor 
atoms (the two ring nitrogens and the methoxy oxygen) are within the necessary 
distance of the Tyr120 hydroxyl proton to indicate a H-bond. 
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Figure 4.3 Polar plot of orthogonal ligand vectors over 1.2 µs simulation timecourse, 
reproduced from reference 26. Much rotation is observed, contrary to the assumption 
of a single ligand conformation indicated in the crystal structure.  
 
 
The loss of rotational entropy upon binding was reported from the 1 µs 
trajectories, using the Schlitter (analysis of covariance) method to compare the bound 
trajectory and a 1 µs trajectory of free ligand in water.109 Translational changes were 
estimated using an approximate 10 kJ mol-1 penalty generated from the ideal gas 
approximation. The final reported value was ~22 kJ mol-1, below the lower end of the 
IBMP prediction shown in Table 4.1, and similar to the recent calculation for IPMP 
assuming rigid binding. This unexpected motion, particularly the prolonged occupation 
of alternative poses, is herein investigated by direct experimental observation. This 
work provides the first dataset for experimental corroboration of ligand behaviour in 
long timescale MD simulations. 
Additionally, to assess whether this unexpected ligand motion is a simulation 
artefact arising from the MD forcefield (AMBER) used26, an explicitly solvated 100 ns 
trajectory of the MUP-IBMP complex was generated in CHARMM using parameters 
generated by the CHARMM general forcefield.47 Motion over 100 ns is compared 
between the two trajectories to observe whether significantly less motion is observed 
in CHARMM than that evident in AMBER, Figure 4.4.  
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Figure 4.4 Analysis of residual IBMP rotation and translation throughout the 1 µs 
simulations. Figure provided via personal communication from Dr Charlie Laughton, 
University of Nottingham. (top left) 10 ligand clusters were generated, and 
representative structures are shown (protein in same orientation in each but not 
displayed). (bottom left) The three different coloured symbols represent the three 
replicate trajectories of the MUP-IBMP complex. Population of each cluster over time 
is shown. (top right) The three h-bond acceptor atoms on IBMP. (bottom right) 
Trajectory frames where the ligand position allows hydrogen bonding to the Tyr120 
hydroxyl are shown from the three atoms indicated above. There are points in each 
trajectory where none of these three atoms are within H-bonding distance of Tyr120, 
indicated by dashed blue vertical lines.   
 
 
4.1.4  Directly assessing predicted residual ligand motion 
for the first time using NMR 
 
NMR residual dipolar couplings (rdcs) report the relative orientation of interatomic 
vectors within a molecular system for NMR-active nuclei, as described in §1.3.2.3. 
Using a sample containing NMR-active nuclei in both ligand and protein therefore 
allows the direct experimental observation of their relative orientation in complex, 
providing the closest experimental counterpart, albeit time-averaged, to the MD-
derived polar plot in Figure 4.3. This is obtained by observing the deviation of the 
measured ligand rdcs from those predicted using the protein alignment tensor, 
indicative of a different orientation with respect to the external magnetic field, §1.3.2.3. 
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 Measurement of rdcs requires production of protein and ligand samples which 
are labelled with NMR-active stable isotope. To achieve protein labelling, recombinant 
protein expression can be induced in ‘minimal’ medium, where the sole carbon and 
nitrogen sources are 13C-glucose and 15N-ammonium chloride respectively. The past 
two decades of protein NMR demonstrate that this is tractable for a large range of 
systems. Conversely, ligands must be synthesisable from labelled reagants. Fortunately 
IBMP can be synthesised organically from leucine, ammonium chloride, glyoxal and 
iodomethane, using published methodology.110-113 
 Rdcs were successfully measured previously for 15N-labelled MUP protein in 
the PF1 phage alignment medium114, dispensing the need to undertake lengthy 
alignment medium optimisation. When measuring rdcs, it is necessary to ensure that 
couplings are measured from the molecule in the required state, i.e. in complex and 
not in solution. Overlapping signals can frustrate this if both bound and unbound states 
are well populated during the experiment. Ideally, ligand rdcs need to be measured in 
the absence of free ligand, and protein rdcs need to be measured in the absence of 
free protein. Given the µM binding affinity of IBMP, it is expected that the exchange 
between free and bound ligand will be slow on the NMR timescale. Therefore ligand 
couplings were measured on a sample where ligand concentration is sub-
stoichiometric, both before and after alignment. Careful titration of ligand into the 
NMR sample containing protein is therefore necessary. Then after full saturation with 
ligand post alignment, protein couplings will be measured, with isotropic protein 
couplings obtained by removing the phage via centrifugation.  
Observed rdcs are averaged over all orientations sampled during the 
experiment, meaning they do not give atomic detail of each pose sampled, but rather 
indicate rigidity or deviation therefrom. NOE measurements also provide structural 
information regarding protein and ligand, but in the form of inter-nuclear distances, as 
detailed in §1.3.2.5. NOE spectra were measured to complement the rdc 
measurements in the assessment of residual rotation and translation of IBMP in the 
MUP pocket.  
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4.1.5  Work undertaken 
 
Whilst our understanding of the MUP-IBMP interaction so far presumes rigid binding, 
long MD simulations show pronounced occupation of heterogeneous orientations by 
IBMP, in the MUP binding pocket on the µs timescale. For the first time, predicted 
residual ligand motion has been directly experimentally observed/assessed by 
measuring NMR rdcs and NOEs for a sample of 15N MUP protein bound to 13C-15N 
IBMP. Complementary NOEs are obtained using a sample containing 13C-15N MUP and 
unlabelled IBMP, which allow assignment of crosspeaks to binding pocket protons. This 
work provides the first experimental dataset for corroboration of ligand behaviour in 
long timescale MD simulations. Ligand is synthesised from 13C-15N L-Leucine and 15N 
ammonium chloride. 15N-MUP protein was provided very generously by Girish Tampi. 
For comparison to observed NOE data, simulated NOEs were generated for the ligand 
pose from the crystal structure and representative poses from the 1 µs trajectory, 
using Prof Steve Homans ‘relaxmd’ software. Finally, ligand motion as a forcefield 
artefact is assessed by comparing a 100 ns explicitly solvated trajectory performed 
using CHARMM forcefield and parameters to the first 100 ns of the published AMBER 
results.   
 
 
 
4.2  Material and Methods 
 
4.2.1  Organic synthesis of IBMP 
 
The entire protocol is graphically summarised along with weights at each step, Figure 
4.5. 1H NMR spectra (Bruker, 500 MHz) for each step are shown with assignments for 
molecule and solvent peaks in Appendix 1.  
 
 
4.2.1.1  L-Leucine → BOC-L-Leucine 110 
 
1M sodium hydroxide (NaOH, 7.6 mL) and dioxane (3 mL) solution containing Leucine 
(500 mg, 3.61 mmol) was cooled to 0 °C, before the addition of further dioxane (2.3 
mL) containing BOC anhydride (915 mg, 4.19 mmol). After overnight stirring at room 
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temperature, the mixture was diluted with water and extracted twice with hexanes. 
Solid citric acid was used to acidify the aqueous component before extraction with 
ethyl acetate. The organic component was then washed with water and brine, dried 
over magnesium sulphate (MgSO4), filtered and finally concentrated under reduced 
pressure to yield BOC-L-Leucine (550 mg, 2.31 mmol).   
 
 
4.2.1.2  BOC-L-Leucine → BOC-L-Leucine amide 111 
 
BOC-L-Leucine (550 mg, 2.31 mmol) was dissolved in methanol (MeOH, 20 mL) with 
ammonium chloride (NH4Cl, 190mg, 3.47 mmol) and triethylamine (Et3N, 484 µL) 
before addition of the amide coupling agent 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (DMT-MM, 766 mg, 2.77 mmol). After stirring at room 
temperature overnight, the solvent was removed using a rotary evaporator. The result 
was dissolved in dichloromethane (DCM, CH2Cl2) and washed sequentially with 
saturated sodium carbonate, water and brine. After drying with MgSO4 and filtration, 
the sample was concentrated by rotary evaporator. Finally, a silica column in 1:1 
hexane : ethyl acetate was used to purify the BOC-L-Leucine amide. The sample was 
contaminated with trimethoxy triazine (visible in 1H NMR as 9H at 4.0 ppm115) due to 
a side-reaction of DMT-MM and MeOH. Because of lack of reactivity in subsequent 
reactions, this contaminant was left in the sample until the final IBMP purification step. 
However, mmol values cannot be calculated from weights due to this contamination, 
from this step until the final step. 
 
 
4.2.1.3  BOC-L-Leucine amide → L-Leucine amide 112 
 
Trifluoroacetic acid (TFA, 15 mL) was added to the BOC-L-Leucine amide (341 mg, 
1.43 mmol) and stirred at room temperature for an hour before rotary evaporation of 
solvent to yield L-Leucine amide (323 mg, 2.3 mmol). Half of this was taken forward to 
the next step. 
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4.2.1.4  L-Leucine amide → 2-hydroxy-3-isobutyl-pyrazine 
(IBHP) 113 
 
Glyoxal (40% aq., 173 µL) was added with rapid stirring to a solution of L-Leucine 
amide (161 mg, 1.15 mmol) in MeOH (2.7 mL) at -35 °C, before dropwise addition of 
12M NaOH (150 µL) over 5 minutes, maintaining a temperature of -35 °C. This 
mixture was left stirring at -35 °C for 30 minutes, then warmed to room temperature 
and stirred for 2 hours. The reaction vessel was cooled to 0 °C before neutralisation 
with 12M HCl (150 µL), addition of sodium bicarbonate (160 mg) and filtration. Water 
was added to filtrate before removal of MeOH via rotary evaporation. The solution 
was extracted with DCM, dried over MgSO4 and filtered before removal of solvent via 
rotary evaporation to yield IBHP (70 mg, 0.44 mmol). 
 
 
4.2.1.5  2-hydroxy-3-isobutyl-pyrazine (IBHP) → 2-methoxy-3-
isobutyl-pyrazine (IBMP) 113 
 
IBHP (70 mg, 0.44 mmol) was suspended in dry THF (1 mL) and cooled to 0 °C before 
addition of sodium hydride (60% in mineral oil, NaH, 30 mg, 0.75 mmol). After stirring 
for 30 minutes at 0 °C, iodomethane (MeI, 50 µL, 0.75 mmol) was added and the 
reaction was warmed to room temperature and stirred for 48 hours. The reaction 
mixture was then diluted with water, and THF removed using a rotary evaporator. 
The aqueous solution was extracted with DCM. The organic layers were then 
combined, washed with a 5% aqueous solution of sodium thiosulfate, dried over 
MgSO4, filtered and solvent removed via rotary evaporation. This crude product was 
then partially purified on a gel column in MeOH. After concentration through rotary 
evaporation, the partially pure product was purified on a silica gel column using 6% 
MeOH in DCM. Removing solvent through rotary evaporation yielded pure IBMP. 
Product analyses by 1H NMR, and for the final product, ESI-HRMS (Electrospray 
ionisation high resolution mass spectrometry), are detailed in Appendix 1. 
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Figure 4.5 (previous page) Organic synthesis protocol for IBMP. Reagants are listed 
next to arrows, and those in bold are sources of heteroatoms present in the final 
product. Mass weight, molecular weight, total mmol (millimoles) and yield are shown 
next to each product. Due to trimethoxy triazine contamination, weights in red cannot 
be accurately converted into mmol product and yield. 
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4.2.2  NMR 
 
4.2.2.1  Samples  
 
Protein buffer is 50 mM potassium phosphate pH 7.4, 1mM sodium azide and 0.2 mM 
DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid). IBMP stock solution concentration 
was measured as 13.4 mM spectrophotometrically using A220 (e220 = 4980 M
-1 cm-1). 
During titration, aqueous 15N-13C IBMP stock solution was added to the NMR sample 
using a 10 µL pipette, before the NMR tube was centrifuged and then the solution 
mixed using a long glass pipette. MUP concentration was estimated at ~0.7 mM.  
 
 
4.2.2.2  Experiments  
 
All NMR spectra were easured using Varian Inova (Varian Inc., CA, USA) NMR 
spectrometers with Z axis gradients and triple resonance probes at 298 K. All 
experiments use sequences from the Biopack pulse sequence library supplied by Varian 
Inc. 1H 1D spectra were measured using DPFGSE116 water suppression and the water 
experiment from the Biopack library. 1D spectra were phase and baseline corrected. 
Peak integration was carried out using iNMR software.63 All other spectra were 
processed using NMRPipe.64 In these latter cases, phase correction was performed 
manually for 1H using NMRDraw (part of NMRPipe), or automatically by Biopack 
(Varian) for heteronuclear spectra. NOE, and ongoing rdc, experiments were 
performed by Mr Phil Morrison and Dr Arnout Kalverda. NOE crosspeak intensities 
were calculated from the relevant spectral slices using NMRView.117 
 
 
 
4.2.3  CHARMM MD simulation of MUP-IBMP complex 
 
The crystal structure of MUP-IBMP (1qy1), with Cd ions removed, was used as the 
starting structure for the simulation. The ‘Quick MD Simulator’ functionality of 
CHARMM-GUI was used to generate ligand parameters, neutralise and solvate the 
system, and set up periodic boundary conditions.118 Protein parameters were taken 
from the CHARMM22 forcefield and the ligand parameters were generated by 
CHARMM-GUI using the CHARMM Generalised Forcefield (CGENFF).47 A disulphide 
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bridge was specified between residues 64 and 157 as observed in the crystal structure. 
Sufficient K+ and Cl- were placed using a Monte-Carlo method to achieve neutrality. 
The molecule was solvated in an octahedral box of ~7000 TIP3 water molecules with 
periodic boundary conditions. Long range electrostatic interactions were treated using 
the particle mesh Ewald method. SHAKE was applied to constrain all hydrogen bonds, 
allowing a 2 fs timestep. 
Minimisation involved 1000 steps using the Steepest Descent algorithm 
followed by 100 steps using the Adopted Basis Newton-Raphson algorithm. The 
system was subsequently heated from 50 K to 298 K over 25000 steps, before 
performing 100 ns of equilibrium trajectory at constant temperature and pressure (298 
K, 1 atm). Coordinates were saved every 1 ps. Wordom was used in generating a 100 
ns desolvated and aligned trajectory of 1 frame per 100 ps for visualisation.48 Julie Roy 
provided copies of the AMBER 1 µs trajectories26, edited to 1 frame per 100 ps. 
Wordom was also used on these trajectories to generate a desolvated and aligned 
trajectory of the first 100 ns of 1 frame per 100 ps. All trajectories were subsequently 
visualised and compared using VMD.119 RMSD and RMSF analysis were also undertaken 
using Wordom. 
 
 
4.2.4  NOE prediction from AMBER trajectory structures 
 
The trajectories provided by Julie Roy were also converted to 1 µs desolvated and 
aligned trajectories with the aid of Wordom, composed of 1 frame per ns. These 
trajectories were subsequently visualised and compared using VMD.119 Ligand poses 
populated for long periods were identified via visual inspection and representative 
frames were extracted, Figure 4.14. These frames were edited using Pymol to produce 
structures comprising only the IBMP ligand and any protein atoms within 7 Å of ligand 
atoms.  Simulated NOES for each of these representative poses from the AMBER 
trajectory were generated using ‘relaxmd’ software, using a spectrometer frequency of 
600 MHz, a correlation time of 9 ns23 and a mixing time of 0.12 s (Prof. Steve Homans, 
personal communication). Relaxmd is a package for the calculation of homonuclear and 
heteronuclear relaxation and NOE parameters via a full relaxation matrix approach.120 
Only simulated NOEs > 0.5% intensity were included in the analysis. For each pose 
NOEs were calculated from three groups probed experimentally: the methoxy and 
both methyls.  
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4.3  Results and Discussion 
  
4.3.1  Ligand synthesis and titration into protein sample  
  
Synthesised IBMP was characterised and purity was confirmed by a number of 
techniques. The 1H NMR spectrum of the 15N-13C IBMP stock solution is as 
published113, except for minimal (~1%) residual contamination by trimethoxy triazine, 
Figure 4.6. 1H -13C HSQC and 13C TOCSY HSQC experiments performed on the same 
sample probe the labelled butyl chain of IBMP, showing the correct resonances and 
connectivity thereof, Figure 4.7. High resolution electrospray ionisation mass 
spectrometry of the final sample measured a mass equivalent to the expected value 
(within 0.01 Da).  
 As described in §4.1.4, to minimise the chance of overlapping signals from free 
ligand frustrating the accurate measurement of couplings arising from bound ligand, the 
sample was titrated to sub-stoichiometric saturation. Titration of IBMP into MUP was 
monitored by three NMR experiments; 1H spectra to observe increasing MUP 
saturation; the first transient of 1H-13C HSQC specta to observe free ligand; and 1H-
15N HSQC were used to observe protein backbone changes accompanying IBMP 
binding.  
Changes in the methyl region of a 1D 1H NMR spectrum of MUP upon titration 
of IBMP were observed, Figure 4.8a. The relative peak intensities of the methyl peaks 
at approximately -0.5 and -0.8 ppm were used to measure the fraction of protein in 
the free and bound states respectively. 1H 1D spectra were obtained after each 
titration step and the relevant peaks integrated to obtain the approximate protein 
saturation, Figure 4.8b. The titration was stopped at ~65% protein saturation, which 
was obtained after three titration steps.  
A previous publication in 2004 has assignments for the 1H-15N HSQC spectrum 
for both unbound and IBMP-bound 15N MUP.23 In this study, 1H-15N HSQC spectra 
were obtained after each titration step. Overlaid spectra of the pre-titration and final 
HSQCs with the bound and unbound assignments reveals that the majority of peaks 
overlay exactly, Figure 4.9. Some peaks move or split, due to a residual unbound 
protein population, in accordance with the MUP-IBMP assignment. 
The first transient of a 1H-13C HSQC was obtained pre-titration and after each 
titration step to monitor for the presence of unwanted emergence of free ligand, 
Figure 4.10. Resonances for the butyl chain protons are clearly observed in the 
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aqueous stock solution of 15N-13C IBMP, and weak natural abundance breakthrough of 
the protein is observed in the 15N MUP sample pre-titration. Upon titration, peaks at -
0.1 and 0.15 ppm appear and increase in intensity, corresponding to the bound state 
methyl protons. A small amount of free ligand may be appearing at the final step due to 
a sharper peak at ~0.75 ppm.  
 
 
 
Figure 4.6 1H NMR spectrum of 13C-15N IBMP in H2O stock solution. Red boxes on 
the IBMP structure (top left) indicate 13C and 15N heteroatoms. A small amount of 
trimethoxy triazine (shown top right) is visible. δH (500 MHz, H2O/D2O); 7.5 (m, 1H, 
ArH), 7.37 (m, 1H, ArH), 4.02 (s, 9H, trimethoxy triazine), 3.57 (s, 3H, OCH3), 2.64 (d 
of m, 2H, JCH 127.4 Hz, CH2), 2.06 (d of m, 1H, JCH 132 Hz, CH), 0.91 (d of m, 6H, JCH 
124.4 Hz, CH3). See Appendix I for 
1H NMR details of all synthesis intermediates. 
Appendix I also contains a CHCL3 
1H NMR spectra for commercially available 
unlabelled IBMP, for comparison. 
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Figure 4.7 1H-13C HSQC and 13C TOCSY HSQC NMR spectra of synthesised 13C-
15N IBMP in H2O stock solution. Only the butyl chain contains protons bound to 
13C, 
in accordance with the resonances listed. The TOCSY shows the expected crosspeaks 
between all three peaks on the butyl chain.  
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Figure 4.8 NMR experiments tracking MUP saturation during titration of 15N-13C 
IBMP into 15N MUP. a) 1H 1D NMR spectra reveal a change in peak profile upon MUP 
titration. Relative intensities of the two rightmost peaks indicate saturation (indicated 
by arrows). b) Relative peak intensities over three titrations estimate the final sample 
as ~65% saturated.  
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Figure 4.9 NMR experiments tracking protein backbone changes during titration of 
15N-13C IBMP into 15N MUP. Amide protons are observed using 1H-15N HSQC NMR 
spectra, which are colour coded as per the figure legend. The titration does not 
significantly change the HSQC. Some peaks move or split, due to a residual unbound 
protein population. 
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Figure 4.10 NMR experiments monitoring ligand resonances during titration of 15N-
13C IBMP into 15N MUP. Ensuring no free ligand accumulates over the titration is 
achieved by obtaining the first transient of a 1H-13C HSQC NMR spectrum. Upon 
titration, two peaks at -0.1 and 0.15 ppm appear and increase in intensity, 
corresponding to the bound state methyl protons. A small amount of free ligand may 
be appearing at the final step as indicated by a sharper peak at ~0.75 ppm.  
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4.3.2  Assignment of 13C-15N IBMP in complex 
 
NMR experiments were performed to obtain 1H-13C HSQC and HCCH TOCSY 
spectra for the post-titration sample, Figure 4.11. Though some of the peaks in the 
sample are not of ligand origin and remain unassigned, two sets of peaks corresponding 
to free (green) and bound (blue) ligand are clear. The TOCSY indicates the free CH 
peak at 2.15 ppm, which is not shown on the HSQC, presumably due to low intensity, 
conclusively revealing the presence of a small amount of free ligand. Dispersion of the 
CH3 and CH2 peaks in the bound state indicates that the ligand is moving less freely 
than in solution. 
 
Figure 4.11 Assigning ligand resonances in the MUP-IBMP complex using HSQC and 
TOCSY NMR experiments. Two sets of peaks corresponding to free (green) and 
bound (blue) ligand are clear, revealing the presence of a small amount of free ligand. 
The dispersion of the CH3 and CH2 peaks in the bound state indicates that the ligand is 
moving less freely than in solution. This may indicate a well-defined pose in the pocket 
associated with different resonances for each methyl group and methylene proton. 
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4.3.3  2D 13C HSQC NOESY of 13C-15N IBMP bound to 15N 
MUP 
 
As described in §1.3.2.5, NOE crosspeaks indicate nuclei that are, upon average, within 
~6 Å of each other. NOE measurements were obtained before alignment of the 
sample to assess agreement of experimental and simulated NOEs, the latter derived 
from MD-observed poses, Figure 4.14 and §4.3.5. 
A 13C HSQC NOESY spectrum was obtained at 600 MHz with a 120 ms mixing 
time, Figure 4.12. The HSQC component results in only those crosspeaks seen to 
protons attached to 13C appearing ‘below’ the diagonal. Crosspeaks between bound 
ligand resonances are observed as expected. No crosspeaks between residual free 
ligand resonances are observed. This may be due to the small quantity of free ligand, 
which will have smaller intensity NOEs that take longer than 120 ms to build up. It is 
noteworthy that there are exchange crosspeaks between bound ligand and free ligand, 
revealing that the ligand exchanges between the free and bound state within the 
experimental timescale. 
There are some crosspeaks between the bound ligand and the protein, ‘above’ 
the diagonal.  Those seen between 6 and 7 ppm may be from IBMP methyl protons to 
either the unassigned IBMP aromatic protons or a phenylalanine sidechain in the 
protein pocket. The crosspeaks at ~9 ppm are to an unknown pocket residue: from 
the crystal structure the most likely candidate would be the Tyr120 hydroxyl proton. 
Directly assigning the observed NOEs was prevented by the protein having no 
13C label. Consequently, acquiring a NOESY spectrum for a second sample containing 
13C-15N MUP and an excess of unlabelled ligand complemented these NOE 
measurements.23  
 
 
 
Figure 4.12 (next page) 2D 13C HSQC NOESY NMR spectrum of 13C-15N IBMP 
bound to 15N MUP, provided by Phil Morrison. Resonances of the ligand protons in the 
free and bound state are listed, and are indicated next to the spectrum using blue and 
green bars for bound and free ligand respectively. Crosspeaks between 6 and 7 ppm 
are boxed with solid and dashed lines because it is unknown whether they correspond 
to intra-ligand or ligand-protein NOEs.  
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4.3.4  3D 13C NOESY HSQC of unlabelled IBMP bound to 
13C-15N MUP 
 
The 1H-15N HSQC spectrum of the sample containing 13C-15N MUP bound to 
unlabelled IBMP differs from that of the sample containing 15N MUP bound to 13C-15N 
IBMP, Figure 4.13a. The differences between the two arise from the differential 
saturation of the samples: the former contains saturated protein and therefore the 
chemical shifts correspond completely to the bound state, whereas the latter contains 
a mixture of bound and unbound protein, with accordant changes in chemical shift. 
To observe NOE crosspeaks from protein sidechain protons to ligand protons, 
a 13C NOESY HSQC spectrum was obtained at 600 MHz with a 120 ms mixing time, 
Figure 4.13b. Protein-protein NOEs are on the diagonal, whereas protein-ligand NOEs 
appear as crosspeaks. As expected, no intra-ligand NOE peaks appear due to the 
ligand being unlabelled.  
Crosspeaks are observed to the resonances at ~0 ppm and 3.5 ppm. The peaks 
around 0 ppm correspond to the IBMP methyl protons, as seen in Figure 4.11, 
whereas 3.5 ppm corresponds to a methoxy shift. NOEs to the ligand CH, CH2 and 
aromatic protons are presumably sufficiently weak to be below experimental 
detection. Spectra in the third dimension at the two above mentioned resonances of 
~0 and 3.5 ppm reveal NOEs to previously assigned pocket residues.23 Protons 
attached to the following sidechain carbon atoms show NOE crosspeaks to the ligand 
methyl protons: L42δ1, L42δ2, L54δ1, L54δ2, I92δ1, A103β, and L116δ2, Figure 4.13c. 
L40δ2, M69, V82γ2, L105δ1 show crosspeaks to the ligand methoxy protons, Figure 
4.13d. Upon simple inspection, the spatial distribution of these residues with respect 
to the relevant ligand protons suggests an average ligand pose close to that observed 
by crystallography, Figure 4.13e. However, the next section more comprehensively 
assesses the agreement between these observed NOEs and simulated NOEs arising 
from the many MD-observed ligand poses.  
The interpretation of relative NOE intensities as directly representing relative 
internuclear distances can be complicated by spin diffusion. A 120 ms mixing time was 
used as a compromise, to minimise spin diffusion whilst maximising useable NOE 
intensity. In the next section, experimental NOEs are compared to simulated NOEs 
that are calculated using the relaxmd software package that takes into account spin 
diffusion. 
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Figure 4.13 NMR spectra of unlabelled IBMP bound to 13C-15N MUP, provided by 
Phil Morrison. a) 1H-15N HSQC reveals much overlay of this sample to the 13C-15N 
IBMP bound to 15N MUP sample. b) 3D 13C NOESY HSQC spectrum with the carbon 
dimension collapsed. Blue and red lines represent crosspeaks to the bound IBMP 
methyl and methoxy peaks respectively. c) + d) 2D spectra extracted from the points 
indicated in b), showing crosspeaks to the relevant ligand protons. e) 1qy1 MUP-IBMP 
crystal structure indicating crosspeak residues from c) and d) in blue and red 
respectively. Methyl and methoxy protons are coloured blue and red accordingly. 
NOE data may support a ligand pose similar to that observed crystallographically.  
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4.3.5  Comparison of simulated and observed NOEs 
 
Representative structures of well-populated ligand poses from the 1 µs trajectories 
analysed in Figures 4.3, 4.4, and reference26 were analysed to generate simulated 
NOEs, as described in §4.2.4. Nine ligand poses populated for long periods were 
identified via visual inspection of MD trajectories, Figure 4.14, the first of which 
represents the crystallographically-observed pose. Three groups of ligand protons 
were chosen from which to simulate the NOEs: the methoxy and two methyl groups. 
Poses 1 and 2 show the best agreement between simulated NOEs and 
observed NOEs at a residue-level comparison, Table 4.2. They have the highest 
‘observed/simulated’ values, demonstrating that more of the simulated NOEs are 
observed for these poses.  Furthermore, they have the lowest ‘strong unobserved’ 
values. This number represents how many of the strongest 6 simulated NOEs are not 
observed in the experimental data. If the pose is correct, then the strongest simulated 
NOEs should definitely be present in the experimental data. Consequently a low value, 
wherein the strong simulated peaks are mostly observed, indicates good agreement. 
Pose 1 is almost identical to the crystal structure, and pose 2 is the structurally closest 
to Pose 1: the methyl remains in almost the same position but the ring and methoxy 
are moved, Figure 4.15. Accordingly, whereas pose 1 has the best overall agreement 
between simulated and observed NOEs, pose 2 still has good agreement for methyl 
NOEs due to its methyl group remaining in almost the same position.  
The above observation is strengthened by the comparison of the intensities of 
simulated and observed NOEs, as shown in Table 4.3. These data also confirm that the 
residue-level pattern in Table 4.2 arises from simulated NOEs to the exact protons 
assigned in the observed NOEs. The relative intensities of the simulated and observed 
NOEs were compared for those poses with multiple (>2) comparable simulated 
NOEs, i.e. poses 1 and 2. The only simulated NOEs missing for pose 1 are the two 
experimentally weakest NOEs: 92δ1 and 116δ2. Though NOEs to 42δ1+2 are weaker 
in simulation than experiments, the ranking is almost exactly the same as experiment. 
Pose 2 has a stronger 42δ1+2, but an overestimated 92δ1, leading to close but not 
perfect agreement with experiment. The correlation of methyl NOE intensities is 
equivalent for both, R2 ~0.6. Figure 4.15 displays poses 1 and 2, and demonstrates that 
despite having similar methyl NOEs, they still contain various conformations of the 
butyl chain. This scope for conformational flexibility of the butyl chain is important for 
interpretation of rdc data: the butyl chain may sample multiple bond orientations with 
 105 
respect to the protein whilst the ligand remains in effectively the same pose. A 
comparison of methoxy NOE peak intensities is only possible for pose 1, wherein the 
ranking is reproduced except for a simulated over-estimation of NOE intensity to 
residue 69.  It is worth noting that poses 3, 8 and 9, all of which have two comparable 
simulated NOEs, perform badly by possessing relative intensities inverse to those seen 
in experiment.  
The nine poses sample multiple different methyl and methoxy positions, Figure 
4.14, yet only poses 1 and 2 give the above mentioned agreement. Therefore these 
data support a situation wherein the ligand is oriented very close to the 
crystallographically-observed pose for the majority of the time.  
   
 
Figure 4.14 Crystal (1qy1) pose 
overlaid with all nine AMBER MD-
observed poses, demonstrating the 
translational and rotational 
heterogeneity of the latter.  The 
crystal pose is presented in grey. All 
MD-observed poses are coloured as 
follows: green for ring atoms, red for 
methoxy atoms and blue for butyl 
chain atoms. 
 
 
Figure 4.15 Crystal (1qy1) pose with 
AMBER MD-observed poses 1 and 2 
overlaid, coloured as per Figure 4.14. 
Pose 1 almost exactly reproduces the 
crystal pose. Pose 2 has a similar butyl 
chain position, but the ring is rotated 
to significantly reposition the methoxy, 
as seen in the greater agreement of 
methyl but not methoxy NOEs in 
Tables 4.2 and 4.3.  
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Pose Methoxy Methyl A Methyl B Observed / 
simulated 
Strong 
unobserved 
1‡ 40*, 54, 56, 69*, 
82*, 83, 84, 88, 
105*  
42*, 45, 54*, 56, 
103*, 120  
54, 56, 90, 103, 
105 
7 / 17 2 
2 103, 104, 105*, 
116, 117, 118  
42*, 45, 54*, 56, 
90, 103*, 120 
54*, 90, 92*, 
101, 103*, 104, 
120 
5 / 16 3 
3 42, 90, 92, 101, 
103, 120  
84, 90, 103*, 105, 
116*, 117, 120 
24, 90, 103*, 
104, 105, 116*, 
117, 118, 120 
2 / 15 4 
4 90, 91, 103, 104, 
105*, 116, 117, 
118 
54*, 56, 82, 84, 88, 
90, 105 
54*, 56, 82, 84, 
90, 105 
2 / 15 4 
5 24, 39, 40*, 41, 
56, 116, 120 
56, 69, 82, 84, 105 40, 56, 69, 105, 
116* 
2 / 14 5 
6 90, 103, 104, 105*, 
116, 117, 118, 120 
38, 40, 56, 69, 84, 
116* 
38, 69, 82, 84, 
105, 116* 
2 / 16 5 
7 90, 91, 103, 104, 
105*, 116, 117, 
118, 120 
40, 56, 69, 82, 88, 
105, 116* 
38, 40, 69, 105, 
116* 
2 / 17 5 
8 42, 54, 56, 90, 103, 
120 
38, 40, 56, 84, 
116* 
54*, 56, 69, 82, 
83, 84 
2 / 15 5 
9 24, 38, 39, 40*, 
41, 56, 116 
38, 90, 103*, 104, 
105, 116*, 117, 
118, 120 
24, 56, 90, 
103*, 104, 105, 
116*, 117, 118, 
119, 120 
3 / 19 4 
 
 
Table 4.2 Simulated ligand-protein NOEs by protein residue number for nine well-
populated ligand poses taken from the 1 µs AMBER trajectories.26 Only intensities 
above 0.5% were included. Residue numbers are grey if the intensity is calculated as 
between 0.5 and 1%, black if above 1%. Bold residues are the two with the strongest 
NOEs from the relevant proton. Values denoted with a * indicate residues with 
observed NOEs, Figure 4.13. ‡ Pose 1 represents the crystallographically-observed 
pose. Observed/simulated is the number of simulated residues with observed NOEs / 
the total number of residues in the simulated NOEs. ‘Strong unobserved’ is the 
number of strong (bold) simulated NOEs that are not observed experimentally.  
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Pose 1 2 3 4 5 6 7 8 9 Observed 
Atoms Methoxy 
40δ2 1.87  - - - 10.68 - - - 2.53 1.51 
69 3.66  - - - - - - - - 2.39 
82γ2 2.42  - - - - - - - - 2.52 
105δ1 3.25 2.83 - 1.63 - - 1.62 - - 2.71 
 Methyl 
42δ1 0.61 2.06 - - - - - - - 5.62 
42δ2 0.56 1.90 - - - - - - - 6.17 
54δ1 5.53 4.91 - 8.72 - - - 3.54 - 5.21 
54δ2 2.77 3.44 - 1.22 - - - - - 5.33 
92δ1 - 2.69 - - - - - - - 1.89 
103β 8.42 10.33 4.96 - - - - - 5.5 9.54 
116δ2 - - 13.63 - 1.82 8.98 7.62 7.62 10.63 2.95 
 
 
Table 4.3 (above) Intensities of simulated and 
observed NOEs (for simulated, between ligand 
groups used for calculation and protons attached 
to observed assigned carbons). Values are 
generated by addition of either percentage 
intensity values for simulated NOEs, or peak 
intensities for observed NOEs. For simulated 
NOEs, only values with intensity > 0.5% were 
included. (left) Ranking of NOE crosspeaks 
according to intensity (weaker to stronger) for 
poses with multiple comparable simulated NOES, 
i.e. poses 1 and 2. R2 are calculated using the 
intensities above. Experimental data supports 
poses close to, or population weighting close to 
1, which has a similar methyl position to pose 2. 
 
 
 
 
 
Observed Pose 1 Pose 2 
Methoxy 
40δ2 40δ2  
69 82γ2  
82γ2 105δ1  
105δ1 69  
Methyl 
92δ1 92δ1 116δ2 
116δ2 116δ2 42δ2 
54δ1 42δ2 42δ1 
54δ2 42δ1 92δ1 
42δ1 54δ2 54δ2 
42δ2 54δ1 54δ1 
103β 103β 103β 
R2 0.59 0.61 
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4.3.6  Rdc experiments: inconclusive data so far 
 
Experiments by Phil Morrison and Dr Arnout Kalverda to generate a sufficient rdc 
dataset to describe the relative rigidity of the ligand with respect to the protein are 
ongoing. Rdc prediction and analysis were performed by Dr Gary Thompson using the 
PALES program.121 The PF1 phage introduced partial alignment to the protein sample 
without affecting the structure, observed via comparison of HSQC spectra. A sufficient 
number of isotropic backbone amide protein couplings attributable to secondary 
structure residues in the bound state were resolved and measured before ligand 
saturation. Accordingly, unlike the plan described in §4.1.4, the phage did not need to 
be removed after ligand saturation to obtain bound state protein couplings. Protein 
backbone amide couplings were measured using J-modulated 15N HSQC experiments, 
and in conjunction with the 1QY1 crystal structure of the IBMP-MUP complex were 
used to calculate predicted rdc values for the ligand in the crystallographically-
observed pose, Table 4.4.  
 The measurement of ligand rdcs has been problematic. Only rdcs for the butyl 
chain have been acquired so far, using a combination of coupled HSQC and J-
modulated Constant Time Period experiments. The two unlabelled ring carbons and 
their associated protons have remained unassigned and therefore inaccessible, so no 
data exists for the orientation of the pyrazine ring. This is problematic, because the 
accuracy of the alignment tensor calculation scales with the number of non-parallel 
vectors measured. Moreover, so far the observed rdcs are weak and some have quite 
large errors. For illustrative purposes, a comparison of the predicted and current 
experimentally observed ligand rdcs is provided in Table 4.4, courtesy of Phil 
Morrison. The important observation so far in these preliminary data is the partial 
disagreement of expected and predicted rdcs (some predicted rdcs are within the 
error bounds of the observed values), perhaps indicating a non-crystal like orientation 
of the butyl chain bond vectors. Nonetheless, as mentioned in §4.3.5, the butyl chain 
may sample different conformations, and therefore multiple bond vector orientations 
relative to protein, whilst the ligand effectively remains in a crystal-like pose consistent 
with the NOE data. Limitations in the ligand rdc acquisition may be surmountable, for 
example increasing rdc strength through addition of more alignment medium, or 
accessing ring protons through use of natural abundance 13C experiments. The option 
also exists to use the residual labelled leucine amide, §4.2.1.3, with labelled glyoxal to 
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synthesise IBMP with all the aromatic heteronuclei labelled, but because the reagant is 
expensive other options will be considered first.  
 
Coupled 
Atoms 
Coupling Pair Experimental 
rdc (Hz) 
Predicted  
rdc (Hz) 
C-C Me(0) and CH 0.3 1.7/-0.9 
C-C Me(1) and CH 0.5 1.7/-0.9 
C-C CH2 (0) and CH 2.7 ± 1.3 -0.2 
C-C CH2 (1) and CH -0.1 ± 1.6 -0.2 
C-C CH2 (0) and C(ar) -1.2 ± 0.7 1.7 
C-C CH2 (0) and C(ar) 2.4 ± 1.1 1.7 
C-C Me(0) and CH -2.1 1.7/-0.9 
C-C Me(1) and CH 0 1.7/-0.9 
C-H CH3 (0) 0 n.a. 
C-H CH3 (1) -2.0 n.a. 
C-H CH 0.005 -6.8 
 
Table 4.4 Comparison of experimentally observed and predicted rdcs for IBMP butyl 
chain bond vectors. The predicted values were generated with the PALES program121 
using the 1qy1 crystal structure and backbone amide rdcs from residues in secondary 
structure elements, i.e. rigid parts of the structure. The experimentally observed rdc 
values are low. Where no error is quoted for experimental rdcs, HSQC peak 
optimisation quoted error as 0.00.  
 
4.3.7  CHARMM–AMBER MD comparison 
 
A limited assessment of whether the observed ligand motion is an artefact of the 
AMBER forcefield was performed. 100 ns of explicitly solvated trajectory was 
generated using the CHARMM forcefield and parameters and compared to the first 
100 ns of AMBER trajectory, as detailed in §4.2.3. The CHARMM trajectory was 
checked before analysis. Temperature and total energy are stable across the 100 ns. 
The RMSD, calculated with respect to the first frame, increases from ~1 Å up to ~2 Å 
as the trajectory explores conformational space further from the native state. There 
are some brief excursions to higher RMSD. Nonetheless, an increase of ~1 Å in the 
RMSD value over the trajectory is not indicative of protein instability. Therefore these 
three data reveal the trajectory to contain no obvious errors, Figure 4.16.  
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Ligand atom average RMSF values calculated from aligned trajectories are 3.0 
Å2 for CHARMM, and 15.3 Å2 for AMBER. This indicates that even within the first 100 
ns the ligand is much more mobile using AMBER than using CHARMM, and is 
confirmed by visual inspection of the trajectories, which reveals that using CHARMM 
the ligand mostly occupies a single pose, Figure 4.17a.  
 
 
 
Figure 4.16 Quality control of 100 ns MUP-IBMP CHARMM MD trajectory. a) 
temperature (K) vs time. b) total energy (kcal/mol) vs time. c) RMSD (Å) vs time, 
wherein each frame is aligned with the first frame. Energy and temperature are stable. 
The system explores further from the native state with time, with the RMSD value 
increasing by 1 Å over the course of the trajectory. These three data reveal the 
trajectory to contain no obvious errors. 
 
 
Though the ligand moves more using AMBER, there are only two heavily 
populated poses for both 100 ns AMBER trajectories analysed, Figure 4.17b+c. Figure 
4.17 shows all poses from the first 100 ns compared to poses 1 and 2 from the 
AMBER trajectory, §4.3.5, whose simulated NOEs agreed best with experiment. It is 
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clear that the CHARMM pose is quite different from pose 1 (the crystal pose) or 2, 
whereas the AMBER poses are close to either. Therefore the first 100 ns of AMBER 
could generate average NOEs close to experiment, whereas CHARMM could not, 
despite less ligand movement.  
 
 
 
Figure 4.17 Heavily populated poses from first 100 ns of MUP-IBMP MD simulations. 
a) crystal pose (black) with CHARMM pose (blue). b) pose 2 (grey) with AMBER pose 
(blue). c) pose 1 (grey) with AMBER poses (blue). Though the CHARMM pose is very 
different, the AMBER poses are close to pose 1 and 2, which gave the best agreement 
to observed NOEs, Tables 4.2 and 4.3.  
 
 
If the AMBER cluster residency times over the whole 1 µs are heavily weighted 
toward crystal-like poses or positions of methyl and methoxy groups, the AMBER 
simulations would not strongly disagree with the observed NOEs, and therefore not 
be obviously artefactual. However, if non-crystal-like poses are well populated, the 
trajectory would diverge from experimental agreement. Considering the good 
agreement between simulation and NMR for the protein reported by Roy and 
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Laughton26, such divergence would indicate that the observed ligand movement is a 
ligand-specific artefact for µs timescales.  
Clusters generated in analysis by Dr Charlie Laughton are shown with 
accompanying residence times over the 1 µs trajectory, Figure 4.4. The most highly 
populated clusters are 3, 4, 5, 6, 7, 8 and 10. By comparing average poses for these 
clusters with those for which NOEs were simulated, it is possible to assess whether, 
on average, crystal-like poses or methyl and methoxy positions are observed. Clusters 
5 and 10 are close to the crystal structure, Figure 4.18a.  However the other 5 highly 
populated clusters are not, Figure 4.18b. Cluster 3 is similar to poses 4, 6 and 7. 
Cluster 4 is similar to pose 3. Cluster 7 is similar to pose 8. Cluster 6 is not 
particularly similar to any of the poses for which NOEs were simulated. Cluster 8 has 
a methyl position similar to pose 2, therefore resulting in NOEs close to those 
observed, however a methoxy position similar to poses 5 and 9. Clusters 5, 6, 8 and 
10 are those most sampled at short timescales in the AMBER simulation, Figure 4.4, 
reinforcing the potential sub 100 ns simulation-experimental agreement mentioned 
above. 
In conclusion, the cluster populations observed by MD include significant 
population of non-crystal-like poses, indicating that the range of ligand orientations 
observed in the whole 1 µs simulation is inconsistent with experimentally observed 
NOEs. Rdc data is currently inconclusive, but the partial disagreement of current 
values may represent butyl chain conformational flexibility, rather than sampling of 
multiple poses. 
 
 
 
 
Figure 4.18 Representative structures from clusters in Figure 4.4 compared to the 
crystallographically-observed ligand pose. a) crystal (grey), cluster 5 (blue) and 10 
(green). b) crystal (grey) with clusters 3, 4, 6, 7 and 8. 
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4.4  Summary and Conclusions 
  
Loss of rotational and translational entropy is a major contributor to protein-ligand 
binding thermodynamics. 1 µs MD simulations observed significant IBMP movement 
and population of multiple distinct poses in the MUP pocket, and challenged the 
previous assumption, used in thermodynamic decomposition, that IBMP lost almost all 
rotational and translational degrees of freedom upon binding to MUP. For the first 
time, an attempt was made to directly experimentally observe/assess predicted 
residual ligand rotation and translation by measuring NMR rdcs and NOEs on a sample 
of 15N-MUP protein and 13C-15N IBMP. These experiments were complemented by 
NOE spectra performed on a sample containing 13C-15N MUP bound to unlabelled 
IBMP. The ligand was synthesised successfully from reagents labelled with stable 
isotopes, and titrated into labelled MUP to a sub-stoichiometric concentration with 
minimal excess ligand. Strong butyl peaks were observed for the bound ligand, with 
dispersion of methyl resonances indicating a restriction of rotation and translation 
compared to bulk.  
The NOESY spectrum acquired for the sample containing 15N 13C IBMP bound 
to 15N MUP demonstrated a bound-unbound ligand exchange occurring within a 120 
ms timescale. Assigning observed NOEs was obstructed by the protein having no 13C 
label, an intentional labelling strategy to aid resolution of ligand only rdcs. 
Complementary NOE spectra acquired for a sample containing 13C-15N MUP and an 
excess of unlabelled IBMP allowed assignment of NOEs from the ligand to pocket 
residue protons. Ligand orientations in the 1 µs trajectory were assessed for 
experimental agreement by simulating NOEs for heavily populated poses. The 
simulated NOEs were calculated taking spin diffusion into account, and indicated that 
poses close to crystal structure give good experimental agreement. Dr Charlie 
Laughton had clustered poses from the trajectory, with cluster vs residency time 
shown in Figure 4.4. A comparison of cluster average structures to simulated NOEs 
revealed that most of the extensively populated clusters are close to poses with poor 
experimental agreement, indicating that the orientational sampling represented in 
Figure 4.4, and thus the 1 µs trajectory, would not result in NOEs with good 
experimental agreement. However, the first 100 ns contains sampling closer to the 
crystal structure, suggesting that the forcefield is only insufficient at generating 
trustworthy ligand behaviour for longer timescale simulations. To control for AMBER 
specific issues in ligand sampling, a 100 ns trajectory was also produced in CHARMM. 
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This revealed less ligand movement than AMBER over 100 ns, but a comparison at 
longer timescales is needed.  
 Residual dipolar coupling measurements are being undertaken by Dr Arnout 
Kalverda, Dr Gary Thompson and Mr Phil Morrison. Butyl chain RDCs partially 
disagree with predicted values for the crystal pose. However, this does not necessarily 
mean that different ligand orientations are sampled. Experiments are ongoing to 
acquire a conclusive rdc dataset.  
Whilst protein behaviour seems to be well reproduced26, these experiments 
provide unique data that raises questions about the validity of ligand behaviour 
observed in long timescale simulations, which are becoming more commonly used.49 
These experiments also support the understanding, derived from the crystal structure, 
used in previous thermodynamic decomposition and challenged by the 1 µs simulation, 
that IBMP has minimal rotational and translation entropy when bound to MUP. 
However, residual ligand motion may not be completely absent. More extensive 
measurement of ligand rdcs in the complex should provide a better picture of the 
amount of residual motion present. 
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Chapter 5 
 
Protein Dynamics 
 
  
5.1  Introduction 
 
5.1.1  The importance of developing novel probes of site-
specific protein dynamics 
 
Many protein functions depend critically upon structural fluctuations (dynamics) of a 
picosecond or longer. Examples are the hinge motion critical to the enzymatic cycle of 
lysozyme122, or the transport cycles of ion-channels.123 These motions can be affected 
by ligand binding. This is most dramatically demonstrated by dynamic allostery, such as 
that observed in the binding of cyclic AMP to a mutant catabolite activator protein, 
wherein the protein’s affinity for DNA is altered through modification of ensemble-
averaged dynamics rather than structure.124 Site-specific changes in protein dynamics 
induced by ligand binding are well documented, such as in MUP.23  
Interesting both mechanistically and thermodynamically, changes in protein 
dynamics, comprising a number of different types of motion, can potentially be 
addressed using a range of theoretical and experimental techniques, Figure 5.1. These 
techniques, which can characterise structural or dynamic states of a protein to 
different degrees, include inelastic neutron scattering125, X-ray scattering126, ion-
mobility mass-spectrometry127, fluorescence polarisation128, Förster resonance energy 
transfer128 and analytical ultracentrifugation. Though some of these techniques report 
high time resolution, e.g. 100ps for x-ray scattering126, they generate only global 
protein parameters for size and shape such as radius of gyration, effective force 
constant, hydrodynamic volume or cross-sectional area. These can be useful in 
providing constraints for molecular dynamics (MD). However, higher resolution is 
required to investigate site-specific changes, and in this case NMR, working at atomic 
resolution and down to picosecond timescales, is the only sufficiently detailed 
experimental technique to corroborate MD. The benefits and limitations of NMR are 
considered below, highlighting the need for development of novel techniques with the 
potential for probing site-specific protein dynamics. 
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NMR gives information about dynamics in solution state both at atomic 
resolution and timescales easily accessible by modern MD. Analyses of NMR relaxation 
derived S2 values as a function of ligand binding constitute the experimental ‘gold 
standard’ for investigating site-specific changes to protein dynamics upon ligand 
binding, §1.3.2.6. A range of studies have used this approach, as detailed in Table 1 of 
reference 129. NMR residual dipolar couplings provide dynamics information on the 
nanosecond-millisecond timescale, §1.3.2.3. Furthermore, using NMR and MD in 
combination has started to address previously unanswerable questions regarding 
protein structure and dynamics; refining MD data using NMR data to generate 
experimentally-consistent conformational ensembles for intrinsically disordered 
proteins130; constraining MD simulations with NMR distance and orientation 
parameters to determine the structure and dynamics of a protein’s native state8; and 
identifying long-range correlated motions involved in functional allosteric 
mechanisms36.  
 
 
 
 
Figure 5.1 Timescales of molecular motions and techniques for their investigation. 
Modified from reference 131.  
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However, performing NMR relaxation experiments is time-consuming and 
involves multiple obstacles. The protein must be successfully produced in a form either 
fully or selectively labelled with stable isotope. There must exist NMR-compatible 
solution conditions in which the relaxation parameters can be measured. Furthermore, 
a sufficient number of the protein resonances must be assigned. Studies do not always 
conform to this ideal and can provide limited data sets. This is not a problem if 
sufficient information is acquired to answer the question at hand, but demonstrates the 
importance of developing quicker novel probes of site-specific protein dynamics when 
the opportunity arises.  
 
 
 
Figure 5.2 Entropy changes upon ligand binding calculated from NMR S2 values, 
calculated as described in §1.3.2.6. IBMP data are from reference 23 and hexanol data 
are from reference 28. Stars in the bottom right pane are binding site methyl groups. 
Dots under the structural schematic on the NH represent the residues for which 
measurements were performed, indicating the proportion of the protein covered by 
these measurements.  
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5.1.2  Site-specific changes to MUP protein dynamics upon 
ligand binding 
 
Site-specific changes in protein dynamics upon ligand binding to MUP have been 
observed using both NMR and MD. S2 for backbone amide and sidechain methyl bond 
vectors were acquired at 298 K for MUP-IBMP23 and MUP-hexanol28, both before and 
after ligand binding. Those backbone and sidechain ΔS2 above error were converted to 
TΔS values using the procedure outlined in §1.3.2.6, and the resulting figures from the 
respective studies are reproduced in Figure 5.2. The incomplete coverage of the 
measurements is clear, wherein out of a total 157 residues, 113 backbone amide 
protons were measured for hexanol and 82 for IBMP. Nonetheless, despite the small 
RMSD of the protein atoms before and after binding, < 0.7 Å, clear site-specific 
changes in flexibility were observed. This led to the suggestion of entropy-entropy 
compensation in MUP-ligand binding, whereby distal residues increase in flexibility to 
offset decreasing flexibility in the binding pocket.23 The 1 µs trajectories produced by 
Roy and Laughton similarly predict an entropy change of zero within error upon IBMP 
binding, through an offsetting of site-specific flexibility changes, with the most 
significant decrease in flexibility occurring around residue 49.26 Importantly, though the 
alignment of the protein crystal structures before and after ligand binding shows a 
small RMSD and therefore little conformational change, there are clearly site-specific 
changes in protein dynamics upon ligand binding.  
 
 
5.1.3  THz time domain spectroscopy as a novel probe of 
protein dynamics: a new system for protein crystals 
 
THz time domain (henceforth referred to as THz) spectroscopy of proteins has been 
proposed as an experimental technique for the investigation of collective protein 
vibrations (vibrational modes) relating to conformational or dynamic states.132 
Consequently, changes in such vibrations, for example as a result of ligand binding, are 
observable in THz spectra.133 This presents THz as a potential probe of site-specific 
dynamics, if the spectra can be interpreted in terms of residue level fluctuations. The 
capacity to observe changes in THz spectra as a function of conformation is proven, 
for example THz investigation of a photo-controlled reversible conformational change 
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in bacteriorhodopsin revealed distinct and reproducible THz spectra for each 
conformation.132 THz spectra also reflect changes in protein flexibility upon ligand 
binding, comprising a novel ligand binding assay133,134. Evidence of picosecond timescale 
collective protein motions in THz spectra has been observed very recently.135 
Though mainly used for small molecules, THz spectroscopy of protein samples 
has been performed using hydrated thin films, pellets and aqueous solutions.132,136,137 
These sample types suffer in that the structure and hydration of the sample being 
interrogated is variable.  Pellets and films can contain denatured protein.138 Water 
absorbs greatly in the THz range, and as such accounting for overwhelming water 
artefacts is an obstacle for solution studies.139 Additionally, hydration dependence of 
THz spectra is well established, due to the participation of hydration water molecules 
in vibrational motions140, making hydration control a key element of acquiring 
spectra.138 In all cases, a lack of narrow band features seen for small molecules is 
consistently observed with protein samples, due to vibrational mode overlap arising 
from the larger protein system.136,138  
Dr Kasia Tych at the University of Leeds recently developed a THz 
spectroscopy system that obtains THz spectra from protein crystals at 110 K. This 
results in exact knowledge of the protein structure because x-ray crystal structures 
are routinely obtained at 110 K. Likewise, the hydration of the sample is known from 
the crystal structure, and is kept constant throughout the experiment due to low 
temperature. Furthermore, whereas neutron scattering measurements may take many 
hours and possibly hundreds of milligrams of protein, these spectra are acquired within 
minutes using only micrograms of protein. Briefly describing the THz system, a protein 
crystal is mounted directly over a metal pinhole aperture and excess solution 
removed, before being flash-frozen using a nitrogen cryostream. The aperture, which 
resulted in no diffraction effects, is subsequently placed at the focal point of the THz 
beam, allowing the entire beam to interact with the sample. A time domain signal is 
then measured, Fourier transformed and converted into an absorption coefficient using 
Equation 5.1. 
 α ν =   − 2d    A(ν)A!(ν)(1− R ν )    
Equation 5.1 
 
 120 
This describes, at a given THz frequency, ν, the absorption coefficient, α, in terms of 
the crystal thickness, d, the time domain signal through crystal, A(ν), the time domain 
signal through empty sample cell, A0(ν), and the reflection coefficient at the air-sample 
interface R(ν), which is calculated using the refractive index.141 For further details see 
references 141 and 142.  
Subtracting spectra for two states of the crystal results in a difference 
spectrum, which can therefore be acquired for any crystallographically tolerable 
intervention, e.g. ligand binding or pH modification. The frequencies present in 
difference spectra can be interpreted as representing changes in collective vibrational 
motions of equivalent frequency as a function of ligand binding. Reference to IR 
spectroscopy, because THz is far-IR spectroscopy, justifies this approach by 
demonstrating that the spectrum is defined by the absorbance of the vibrational modes 
at a given frequency. In the commonly used double harmonic approximation, the 
intensity of absorption arising from mode i, Ai, is proportional to the square of the 
change in dipole moment as a function of the vibration, Equation 5.2.143 
 A! =   Nπ  d!3  c!    ∂µμ∂Q! ! 
Equation 5.2 
 
c is the speed of light, di is the degeneracy of the mode, N is Avogadro’s number and 
the term in brackets is the differential of the dipole moment, µ, with respect to the 
mode coordinate Qi. The time-dependent dynamics of multiple vibrational coordinates 
generate the spectrum, and thus the absorption coefficient. To briefly demonstrate 
this, Equation 5.3 is reproduced from reference 135, showing a definition of the 
absorption coefficient in terms of harmonic oscillations and the refractive index, the 
latter of which is accounted for in R(ν) in Equation 5.1. It defines the product of the 
absorption coefficient, α(ω), and refractive index, n(ω), as a time-correlation function 
of the total dipole operator, where ω is frequency, c is the speed of light, β = (kBT)-1, V 
is the volume, M is the total dipole of the system and M(t) is the time dependence of 
the total dipole moment.  
 
α ω n ω =   2πω!β3cV    dte!!!!∞!∞ 𝐌(0) ∙𝐌(t)  
Equation 5.3 
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Recent work with moist film samples has complicated the relationship of frequency to 
vibrational mode by observing that relaxational terms could also contribute to THz 
difference spectra, if there are changes in the solvent exposure and rotational motions 
of surface side chains as a function of binding.138 However, obtaining THz difference 
spectra at 110 K where motion is more limited, and between crystals wherein binding 
is known to effect no change to the crystalline lattice and negligible change to the 
hydration or structure of the protein, RMSD < 0.7 Å, means that these potential 
contributions are assumed as negligible for this work.  
Though the crystal environment at 110 K undoubtedly limits protein dynamics, 
it has been demonstrated that solution MD and crystallographic B-factors can both 
represent the same dynamic trends across a protein backbone.100 Accordingly, NMR S2 
and crystallographic B-factors can correlate.144,145 Therefore, this work is a preliminary 
analysis of THz difference spectra frequencies in terms of changes in collective 
vibrational modes, asking whether such analysis can indicate site-specific changes to 
dynamics similarly to the NMR observations detailed in §5.1.2. 
 
 
5.1.4  Normal mode analysis (NMA): a theoretical 
counterpart to THz spectroscopy  
 
The calculation of the frequency and collective motion of vibrational modes for a 
system is achieved through performing a normal mode analysis (NMA).  A non-linear 
system has 3N-6 normal modes, where N is the number of atoms. The first 6 modes 
are removed because they detail translational and rotational motions that do not 
report on the internal dynamics of the molecule. Modes do not interact with each 
other: each mode is independent of all others. The lowest frequency modes involve 
global motions with many atoms undergoing larger displacements. The highest 
frequency modes involve localised motions with displacement of smaller numbers of 
atoms. For proteins, a well-defined native state necessitates that the protein is in an 
energy basin, allowing the energy potential to be assumed as harmonic when the native 
structure is thoroughly minimised; the harmonic oscillations around the minimum are 
the normal modes. Neutron scattering and THz spectroscopy measurements reveal a 
‘dynamical transition’ whereby protein fluctuations start to deviate from harmonicity 
above 180 K.146,147 This limit has been recently shown to extend down to 110 K in 
some cases148, but for MUP was measured as ~130 K.141 Accordingly, at higher 
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temperatures the harmonic approximation of NMA is unsuitable. However, due to the 
110 K operating temperature of the new THz system, NMA is suitable to model the 
harmonic oscillations of MUP.  
In NMA, a Taylor expansion of the MD potential energy function around the 
minimum is performed. The second-order partial derivatives of the potential energy 
function, the force constants for the harmonic oscillations, are placed in a mass-
weighted matrix. Diagonalisation of this matrix results in the eigenvalues and 
eigenvectors corresponding to the collective atomic displacements and frequencies 
that define the modes.149 The procedure is quick, taking only a few hours on modern 
computers. Collective motions can be analysed for a single mode or superposition of 
multiple modes. The relative amplitudes of the collective motions are independent of 
temperature: the absolute amplitudes of the motions, sometimes useful for 
experimental comparisons, can be scaled using a temperature factor. In this work the 
amplitude of the modes is not considered, as only the frequencies in difference spectra 
are necessary to identify affected modes.  
 The structure and the hydration level used both affect the NMA, and therefore 
these two factors need to be considered carefully. The native well of an energy 
landscape contains multiple sub-minima, each of which can be approximated 
harmonically, Figure 5.3. Consequently, traditional single-structure NMA (SS NMA) 
results in some modes idiosyncratic to a single minimum in the native well. However, 
averaging NMA from multiple sub-minima in the native well has been shown to 
diminish idiosyncratic modes whilst enhancing the modes common to sub-minima, thus 
generating a more representative picture of native vibrational fluctuations.122,150 The 
speed of NMA is not greatly undermined because short trajectories are sufficient to 
generate the non-identical poses required.122 This refinement, native ensemble NMA 
(NE NMA), is used herein for the first time with THz spectroscopy. All-atom explicitly 
solvated MD trajectories were generated to sample the native basin, at both the THz 
and NMR experimental temperatures of 110 K and 298 K. Additionally, SS NMA is 
performed using the crystal structures. NE NMA trajectories simulating the crystal 
asymmetric unit are currently being developed, and trajectories of the crystal unit cell 
are being considered. 
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Figure 5.3 A protein energy landscape with detail of the native state energy well. 
Traditional single-structure NMA (SS NMA) results in some modes idiosyncratic to a 
single minimum in the native well. However, averaging NMA from multiple minima in 
the native well diminishes idiosyncratic modes whilst enhancing common modes. 
Multiple minima are sampled by generating a short MD trajectory.  
 
 
Water molecules are included firstly to avoid the collapse of protein surface 
elements during the thorough minimisation procedure. Secondly, the hydration 
dependence of THz spectra, whereby increasing water increases absorbance, 
demonstrates that hydration water contribute to vibrational modes.142 Likewise, 
increasing hydration increases normal mode densities at lower frequencies. Therefore 
a realistic hydration level must be applied in NMA.  This reveals another benefit of the 
new THz system, wherein accurate (i.e. closer to experimental) NMA hydration is 
simpler to achieve than for previous systems. This is because the unit cell hydration is 
known from the crystal structure, and remains consistent across the experiment due 
to low temperature. Accordingly, for SS NMA, the protein was hydrated to replicate 
the asymmetric unit water density observed in the crystal. This resulted in asymmetric 
hydration due to the structure of the asymmetric unit, with a depth of water 
molecules extending between 2 and 10 Å from the protein surface. Consequently, for 
this preliminary investigation, structures from the explicitly solvated MD trajectories 
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used for NE NMA were edited to only contain water molecules within 5 Å of the 
protein surface, approximately the middle of this range. 
Importantly for this work, the qualitative correspondence of fluctuations 
described by NMA and NMR S2 values has been described151,152. Therefore using NMR 
S2 as benchmark data for this preliminary investigation is justified. Herein NMA is used 
as a method of interpreting the frequencies in THz difference spectra in terms of 
changes in collective vibrational modes, and thus site-specific dynamics, upon ligand 
binding. Additionally, the capacity of NMA to predict ligand-induced site-specific RMSF 
changes without the use of THz difference spectra is considered, alongside the effect 
on mode densities of the different NMA approaches.   
 
 
5.1.5  Work undertaken 
 
This work is a preliminary investigation into the combination of two complementary 
and developing techniques to comprise a novel probe of site-specific dynamic changes 
upon ligand binding, namely NMA-interpreted THz difference spectra. ‘Gold standard’ 
NMR S2 data are used as a benchmark for site-specific changes in protein dynamics 
upon ligand binding to MUP. Protein, crystals and ligand solutions were produced for 
THz spectroscopy. Dr Kasia Tych acquired THz difference spectra for the binding of 
both IBMP and hexanol to MUP. The THz system acquires spectra at 110 K, thus 
NMA’s harmonic approximation of protein fluctuations is justified. MD trajectories are 
generated to provide conformational samples for NE NMA at temperatures 
corresponding to the THz and NMR experiments, 110 K and 298 K, and are checked 
for unexpected behaviour before being analysed. NE NMA is compared to traditional 
SS NMA with regards to the agreement of THz difference spectra-derived predictions 
with NMR S2 data. The capacity of NMA to predict ligand-induced changes without the 
use of THz difference spectra, and the effect on mode densities of the different NMA 
techniques are also considered.  
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5.2  Materials and Methods 
 
5.2.1  THz spectroscopy 
 
5.2.1.1  Production of crystals for THz spectroscopy 
 
Proteins and crystals were produced as described in §2.2.1.1 and §3.2.2.1. IBMP was 
introduced to the crystals through addition to reservoir solution and overnight 
vapour-diffusion as described in reference 21. Hexanol was introduced by soaking 
crystals in ligand-doped reservoir solution as described in §3.2.2.1. Soaking was 
performed by Dr Kasia Tych. 
 
 
5.2.1.2  Generation of THz difference spectra 
 
These experiments were performed by Dr Kasia Tych, with details summarised from 
reference 141. Crystals were transferred onto a pinhole aperture and excess solution 
removed using a paper wick before being flash frozen using a nitrogen cryostream. The 
aperture is positioned at the focal point of the THz beam, such that the entire beam 
interacts with the sample. No diffraction effects were observed due to the use of the 
aperture. A time domain signal is measured from a broad-bandwidth THz frequency 
pulse applied to the sample, Fourier transformed and the absorption coefficient 
calculated using Equation 5.1 and parameters measured as detailed in reference 141. The 
frequency components measured were from 0.3 up to 7.5 THz. All measurements 
were obtained at ~110 K. Reported absorption coefficients are from eight 
measurements of four crystals of each complex, and ten measurements of five crystals 
of the unbound protein, wherein each measurement itself is an average of five THz 
scans. Uncertainties in the THz absorption coefficients are propagated from 
uncertainties in the variables of Equation 5.1. Subtracting absorption coefficients and 
propagating their errors at each frequency resulted in difference spectra, Figure 5.6b. 
Frequencies at which the difference is zero within error were then discarded. Changes 
above error are displayed as absolute values minus the error, Figure 5.6c. A list of the 
accompanying frequencies was used with NMA as described in §5.2.2.3.  
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5.2.2  Normal mode analyses (NMA) 
 
5.2.2.1  Single structure normal mode analysis (SS NMA) 
 
The crystal structure of MUP (2ozq), MUP-IBMP (1qy1) and MUP-hexanol (Dr 
Caitriona Dennis, unpublished), were processed using CHARMM GUI ‘Quick MD 
Simulator’.118 A disulphide bridge was specified between residues 64 and 157 as 
observed in the crystal structure. The structure was solvated to the density observed 
experimentally in the asymmetric unit and neutralised using Na+ placed using a distance 
method. Protein parameters were taken from the CHARMM22 forcefield. The 
cadmium ion (from crystallisation solution) and ligand parameters for IBMP and 
hexanol were generated by CHARMM-GUI using the CHARMM Generalised 
Forcefield (CGENFF).47 These structures were then thoroughly minimised, to an 
energy gradient lower than 10-12 kcal mol-1 Å-1, and subsequently analysed using the 
VIBRAN module of CHARMM. RMSF values are obtained per mode or for all modes 
using scripts obtained from Dr Roland Stote (personal communication). 
 
 
 
5.2.2.2  Equilibrium simulations and native ensemble normal 
mode analysis (NE NMA) 
 
5.2.2.2.1  Generating trajectories 
 
The crystal structure of MUP (2ozq), MUP-IBMP (1qy1) and MUP-hexanol 
(unpublished), were used as the starting structure for the simulation. The ‘Quick MD 
Simulator’ functionality of CHARMM-GUI was used to generate ligand parameters, 
neutralise and solvate the system, and set up periodic boundary conditions.118 Protein 
parameters were taken from the CHARMM22 forcefield. The ligand parameters for 
IBMP and hexanol were generated by CHARMM-GUI using the CHARMM Generalised 
Forcefield (CGENFF).47 A disulphide bridge was specified between residues 64 and 157 
as observed in the crystal structure. Sufficient K+ and Cl- were placed using a Monte-
Carlo method to achieve neutrality. The molecule was solvated in an octahedral box of 
~7000 TIP3 water molecules with periodic boundary conditions. Long range 
electrostatic interactions were treated using the particle mesh Ewald method. SHAKE 
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was applied to constrain all hydrogen bonds, allowing a 2 fs timestep. Minimisation 
involved 1000 steps using the Steepest Descent algorithm followed by 100 steps using 
the Adopted Basis Newton-Raphson algorithm. The system was subsequently heated 
from 50 K to 298 K over 25000 steps, before performing 18 ns of equilibrium 
trajectory at constant temperature and pressure (298 K, 1 atm). Coordinates were 
saved every 1 ps.  
 
 
5.2.2.2.2  Checking trajectories 
 
Total energy and temperature as a function of time were obtained directly from 
CHARMM, Figure 5.4. RMSD and RMSF calculations, Figure 5.5 and Table 5.1 
respectively, were performed using Wordom.48 The latter were calculated for three 
subsets of atoms: alpha carbon (Cα), backbone nitrogen (N) or sidechain carbon 
(Cβ,δ,γ), using trajectories wherein each frame was aligned using the same subset of 
atoms. 
 
 
5.2.2.3  Processing of normal mode analyses 
 
Using Wordom48, 100 frames at equal spacing (1 per 180 ps, starting at frame 1) were 
extracted from each trajectory, and reoriented and aligned with respect to the first 
frame of the trajectory. All TIP3 water not within 5 Å of protein were removed using 
CHARMM. These structures were then minimised and processed as detailed in 
§5.2.2.1.  
 
The following procedures were performed on three datasets for both ligands: the 
single structure (§5.2.2.1) and the average over all 100 structures extracted from both 
110 K and 298 K trajectories. RMSF values are obtained per mode or for all modes, 
averaged over all 100 structures, using scripts mentioned in §5.2.2.1. Heat maps in 
Figure 5.7 were generated using JColorGrid software.153  
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5.2.2.3.1  Mode density calculations 
 
CHARMM reports the normal mode frequencies as wavenumbers. Equation 5.5 was 
used to convert wavenumbers to THz frequencies for comparison to difference 
spectra. Equation 5.5 is derived from Equation 4.4, which shows that frequency, ν 
equals the speed of light, c, divided by the wavelength, λ. Because the wavelength is the 
reciprocal of the wavenumber, Equation 5.4 becomes Equation 5.5. 
 
 ν  =  c  /  λ  
Equation 5.4 
 ν  =  c  *  wavenumber  
Equation 5.5 
 
For each structure, a histogram was generated of THz frequency versus number of 
modes, using a bin width of 0.05 THz. For the NE NMA datasets, the bin values were 
averaged over all 100 structures. The data are displayed in Figure 5.8. 
 
 
5.2.2.3.2  Treatment of NMR S2 values 
 
Raw NMR S2 values for hexanol-MUP were obtained from reference 28, and for IBMP-
MUP23 were obtained from Prof Steve Homans. Only those bond vectors with S2 for 
both bound and unbound samples were kept. Subtracting unbound from bound values 
yielded the change upon binding, ΔS2. The errors in the S2 were propagated and only 
those values with changes above error were kept. To report an increase in flexibility as 
a positive change, the signs of the ΔS2 values were inverted.  
Heat maps shown in Figure 5.7 use the following colour scheme. Those 
residues with no ΔS2 values are shown in red. ΔS2 values that are zero within error are 
shown as white, whereas those above error are represented in greyscale according to 
magnitude (dark = greater change).  
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5.2.2.3.3  RMSF calculations 
 
Per-atom RMSF values averaged over all modes (and over all 100 structures for the NE 
NMA calculations) were calculated, and the average per-residue value obtained. The 
per-residue variance was used as an estimate of error. Averages were subtracted 
(ligand bound versus unbound) and error propagated. Those residues for which an 
above-error RMSF change is observed as a function of ligand binding are displayed as 
black boxes in Figure 5.7c+d. 
 
 
5.2.2.3.4  Interpretation of THz difference spectra using normal mode 
analyses 
 
For each structure, modes were selected whose frequency corresponded to the THz 
difference spectrum above-error changes as defined in §5.2.1.2. For each selected 
mode, the per-residue RMSF was calculated and the ten residues with the highest 
values selected. These ‘top ten’ from every selected mode were then pooled, and the 
ten most often mentioned residues from these lists taken as the ‘top ten’ list for that 
structure. For NE NMA, these lists were then pooled for all 100 structures and the 
ten most often mentioned residues again selected. For each difference spectrum, this 
procedure was performed on both bound and unbound structures, as the mode-RMSF 
relationship is different in each case, and both will contribute to the observed 
difference spectrum. These ‘top ten’ datasets are presented in Figure 5.7a+b. 
 
 
 
5.3  Results and Discussion 
 
5.3.1  Analysis of trajectories used for native ensemble 
normal mode analysis 
 
To provide conformational sampling for NE NMA corresponding to the THz and NMR 
experimental temperatures, MD trajectories of MUP, IBMP-MUP and hexanol-MUP 
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were generated at 110 K and 298 K, as detailed in §5.2.2.2.1. It is critical that MD 
trajectories are checked for any unexpected behaviour before being analysed, as per 
§4.3.7, involving monitoring energy, temperature, RMSD and RMSF over the course of 
the simulation. 
 Energy and temperature values, Figure 5.4, are consistent across the entire 
trajectory. The energy reveals a very short (< 500 ps) equilibration period at 110 K 
due to slower sampling at the lower temperature. Energies at higher temperatures are 
expectedly observed due to increased thermal energy in the system. Energy differences 
are observed between the simulations, albeit smaller than those induced by 
temperature variation. These likely arise from bound ligand energies because no 
relation to greater protein instability is revealed by RMSD and RMSF analysis (below).  
To monitor drift from native state and sampling of partially unfolded states, 
RMSD versus time were analysed for all six MD simulations, and averaged over three 
subsets of atoms: Cα, N and Cβ,δ,γ, Figure 5.5. These values, calculated with respect to 
the initial frame of the trajectory, show no difference between the three systems 
despite the energy difference seen above. A temperature dependence is observed, 
whereby the greater temperature at 298 K allows increased conformational sampling 
than at 110 K, i.e. 0.5-2 Å, compared to 0.3-0.6 Å. Sidechain atoms are more variable 
than backbone atoms, though all increase gradually on average over the course of the 
trajectory as conformational sampling moves further from the native state with 
simulation length. However, these values are low enough to not indicate unfolding. 
The adherence to native like structure and lack of partial unfolding shown by 
the RMSD values is supported by protein RMSF analysis, performed for all atoms and 
different structural segments, Table 5.1. Low RMSF values are observed for all analyses 
whilst repeating the pattern of higher RMSF at higher temperature and higher values 
for sidechain atoms. Loop regions are expectedly far more mobile than residues in 
sheets and the binding pocket. There is no RMSF difference between the systems, 
rendering the energy differences observed in Figure 5.4 as most likely arising from the 
bound ligand itself.  
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Figure 5.4 NE NMA CHARMM MD simulations: total energy and temperature. Black 
is MUP, red is IBMP-MUP and blue is hexanol-MUP. (top) total energy versus time for 
all six simulations, with 110 K on the left and 298 K on the right. Values are in 
kcal/mol. (bottom) Temperature versus time. Values are in K. All values are consistent 
across the trajectory, and only a very short (< 500 ps) equilibration is observed at 110 
K, due to the slower sampling at lower temperature. The energies are higher at 298 K 
than 110 K, as a result of increased thermal energy in the system. Differences are 
observed in the total energy of different complexes, due to the energy of the bound 
ligands.  
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Figure 5.5 NE NMA CHARMM MD simulations: RMSD versus time for all six MD 
simulations averaged over three subsets of atoms: Cα (black), N (red) and Cβ,δ,γ 
(green). All values are in Å. RMSD are calculated for each frame with respect to the 
initial frame of the trajectory. Sidechain atoms are more variable than backbone atoms, 
though all increase gradually on average over the course of the trajectory as 
conformational sampling moves further from the native state. The increased 
temperature at 298 K results in greater conformational sampling than 110 K: 0.5-2 Å, 
compared to 0.3-0.6 Å. However, these values are too low to indicate unfolding.  
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 MUP IBMP-MUP Hexanol-MUP 
 110 K 298 K 110 K 298 K 110 K 298 K 
   OVERALL   
Cα 0.39 1.03 0.40 0.95 0.36 0.91 
N 0.38 0.99 0.39 0.92 0.35 0.87 
Cβ,δ,γ 0.49 1.50 0.51 1.39 0.49 1.37 
      LOOP     
Cα 0.43 1.23 0.45 1.07 0.37 1.11 
N 0.41 1.19 0.43 1.04 0.35 1.04 
Cβ,δ,γ 0.47 1.45 0.49 1.27 0.44 1.38 
      HELIX     
Cα 0.33 0.82 0.32 0.82 0.37 0.86 
N 0.31 0.80 0.32 0.82 0.38 0.83 
Cβ,δ,γ 0.41 1.20 0.40 1.21 0.49 1.17 
      POCKET     
Cα 0.30 0.76 0.28 0.66 0.31 0.56 
N 0.30 0.72 0.28 0.60 0.30 0.57 
Cβ,δ,γ 0.37 1.00 0.34 0.86 0.39 0.70 
     SHEET      
Cα 0.32 0.76 0.32 0.70 0.31 0.67 
N 0.32 0.73 0.32 0.67 0.31 0.66 
Cβ,δ,γ 0.40 1.07 0.40 1.02 0.41 0.92 
 
   
Table 5.1 NE NMA CHARMM simulations: RMSF values by atom type and structural 
element for each simulation. All values are in Å2.  Values were generated as described 
in §5.2.2.2.2. All values are low, indicating no large fluctuations that would suggest 
partial or complete unfolding. Values are expectedly relatively greater at higher 
temperature and for sidechain atoms. Loop regions are expectedly far more mobile 
than sheet residues and those in the binding pocket. 
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5.3.2  THz difference spectra  
 
Protein and crystals were produced for use in THz spectroscopy, as detailed in 
§5.2.1.2. Dr K Tych acquired THz spectra for MUP, IBMP-MUP and hexanol-MUP in 
crystalline form at 110 K. Uncertainties in the THz absorption coefficient are 
propagated from all parameters in Equation 5.1, yet mostly arise from uncertainty in 
the crystal thickness, d. Each spectrum results from transmission of a broad-bandwidth 
THz frequency pulse through the crystal, averaged over multiple experiments, Figure 
5.6a. The frequency components measured were from 0.3 up to 7.5 THz, at intervals 
of 0.07 THz. Difference spectra were generated by subtracting absorption coefficients 
and propagating errors accordingly, Figure 5.6b. Changes above error can be seen as 
those values where the error bar does not cross the zero line. Figure 5.6c displays 
those changes above error as their absolute values. Despite the small RMSD values of 
the complexes to the apo protein, i.e. no conformational change, the crystalline 
environment and the 110 K temperature, the vibrational changes upon ligand binding 
are sufficient to generate ligand-dependent above-error difference spectra. Lists of the 
frequencies shown in Figure 5.6c are used with NMA in §5.3.3 to attempt their 
interpretation in terms of collective vibrational motion changes upon ligand binding, 
which can be related back to changes in site-specific fluctuations. 
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Figure 5.6 THz spectra and difference spectra for MUP (black), MUP-IBMP (red) and 
MUP-hexanol (blue). a) THz spectra for crystalline MUP with IBMP and hexanol. Only 
positive values are shown. Error bars arise as described in §5.2.1.2. b) THz difference 
spectra generated from a). Propagated error bars reveal which frequencies have 
changes above error, i.e. the error bars do not cross the zero line. c) Only those 
differences above error from b) are shown as absolute values. The inset shows the full 
scale of the leftmost bars. 
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5.3.3  Normal mode analysis-interpreted THz vs NMR data: 
site-specific changes in protein dynamics upon ligand 
binding 
  
The frequencies at which above-error changes were observed in the THz difference 
spectra were used to provide an NMA interpretation at residue resolution, as detailed 
in §5.2.2.3.4. This was achieved by picking the modes with corresponding frequencies, 
identifying the residues whose fluctuation is most affected by those modes, and then 
averaging these results over modes and structures, the latter for NE NMA only. Due 
to the incompleteness of the comparison NMR data, only the ten most affected 
residues were considered for comparison. This provides a higher chance of 
successfully assessing whether NMA-interpreted THz difference spectra generally 
agrees with NMR, despite the incomplete data. Here the common interpretation of 
trends in ΔS2 across the backbone is used, i.e. representing areas of differential 
flexibility, in this case upon ligand binding.34  
Results are displayed in Figure 5.7a+b, using the following colour scheme. 
Those residues with no ΔS2 values are shown in red. ΔS2 values that are zero within 
error are shown as white, whereas those above error are represented in greyscale 
according to magnitude (dark = greater change). For all three NMA, i.e. SS and NE at 
both temperatures, the interpretation of THz difference spectra was performed on 
both bound and unbound structures, because the mode-RMSF relationship will differ in 
each whilst both will contribute to the observed difference spectrum. The ten most 
affected residues are displayed as black boxes in Figure 5.7a+b, by ligand and type of 
NMA. There are 20 predictions per NMA type per ligand, 10 for apo, 10 for holo. It is 
interesting to note that irrespective of the MD temperature, the NE NMA averaging 
results in a greater spread of predictions across the protein backbone compared to SS 
NMA or even the first frame of the NE NMA, for which all predictions are in the C 
terminus.  
The alignment of these THz-NMA predictions with the NMR data is 
summarised in Table 5.2 according to two metrics: ‘incorrect’ and ‘hit sum’. ‘Incorrect’ 
represents the proportion of NMA predictions (black squares) that NMR data reveals 
to be incorrect, i.e. for residues with ΔS2 that are zero within error (white squares). 
This is measured out of 20, because there are 20 predictions per NMA type per ligand: 
10 for apo and 10 for holo. Due to there being two ΔS2 columns, each white square 
next to a black square scores half a point, i.e. if a residue is predicted for which both 
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NH and CH3 ΔS2 are zero within error, the score is 0.5+0.5 = 1. Therefore this value 
should be minimal for this technique to demonstrate utility, because the NMA 
predictions represent only the top ten affected residues, which should not have ΔS2 
that are zero within error. Table 5.2 demonstrates that in fact these values range from 
1 to 6, wherein the value decreases, i.e. improves, as SS NMA → NE NMA 110 K → 
NE NMA 298 K. To aid interpretation, the expected value from random placement of 
predictions was calculated. Only NE NMA 298 K performs better than random. ‘Hit 
sum’ represents the degree to which predictions are for residues with higher ΔS2 
values. The ‘hit sum’ value reports the sum of all above-error ΔS2 values aligning with 
predictions. Therefore the higher the value, the better the prediction of residues 
whose site-specific dynamics are known (using NMR S2 data) to change upon ligand 
binding. NE NMA 110 K has the highest total hit sum for both ligands, and NE NMA 
298 K the worst.  
Together, these metrics reveal two observations with regard to generating 
predictions closer to the most dynamically affected residues as observed by NMR; 
both that NE NMA performs better than SS NMA, and that sampling at the THz 
temperature of 110 K may be superior. The power of both metrics would scale with 
increasingly comprehensive NMR data. The mediocre performance in this preliminary 
assessment highlights the requirement for experimental systems with more complete 
NMR S2 data for conclusive assessment of this approach as a reliable probe of site-
specific changes in protein dynamics. Additionally, improving the NMA modelling of the 
system, by performing NE NMA using trajectories performed on the crystal 
asymmetric unit, and potentially optimising hydration, could lead to improvement of 
this agreement.  
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 IBMP Hexanol 
 r SS NE NMA 
110 K 
NE NMA 
298 K 
r SS NE NMA 
110 K 
NE NMA 
298 K 
Incorrect  3.4 6.0 4.0 3.0 2.7 5.5 3.5 1.0 
Hit sum  0.46 0.59 0.28  1.46 2.32 0.74 
 
Table 5.2 NMA-interpreted THz vs NMR: summary of agreement from 
Figure5.7a+b. ‘Incorrect’ reports the amount of known incorrect predictions, i.e. 
alignment with zero within error ΔS2. Given the incompleteness of the NMR dataset, 
the ‘r’ column gives the expected value if the predictions were random. ‘Hit sum’ 
reports the sum of all above-error ΔS2 values aligning with predictions, the relative 
magnitude indicating the type of NMA whose predictions best align with above-error 
ΔS2. Out of all NMA types, NE NMA 298 K has the lowest incorrect, and NE NMA 
110 K has the highest total hit sum. 
 
 
Figure 5.7a+b (next page) NMA-interpreted THz difference spectra: top 10 ΔRMSF 
residues upon ligand binding. Data are sorted by increasing residue number with 
secondary structure elements displayed. ΔS2 above error are displayed in the NMR 
columns: NH S2 and CH3 S
2 are labelled as N and C respectively. Those residues with 
no ΔS2 values are shown in red. ΔS2 values that are zero within error are shown as 
white, whereas those above error are represented in greyscale according to magnitude 
(darker = greater change). The other columns display the 10 most affected residues 
derived from the difference spectrum as black boxes, details in §5.2.2.3.4. The other 
strips of columns are single structure (SS), NE NMA 110 K (N1) and NE NMA 298 K 
(N2), with apo (unbound) and holo (bound) data represented as A and H respectively. 
a) is for IBMP binding and b) is for hexanol binding. 
 
Figure 5.7c+d (next page) NMA-only predictions of ΔRMSF upon ligand binding. 
The figure follow the same scheme as 5.7a+b Residues whose average NMA-derived 
RMSF changes upon ligand binding are above error are shown as black boxes in the 
relevant columns. These run in the order of single structure, NE NMA 110 K and NE 
NMA 298 K (labelled S, 1 and 2 respectively), firstly averaged over 1000 modes (1k), 
then averaged over 7000 modes (7k). a) is for IBMP binding and b) is for hexanol 
binding. 
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5.3.4  Changes in positional fluctuations upon ligand binding 
using only normal mode analysis 
  
The capacity of and difference between SS and NE NMA in blindly predicting changes 
in RMSF upon ligand binding, in this system where little conformational change occurs, 
was considered against the NMR data. The RMSF of a given atom as a function of a 
given mode or range of modes can be calculated. MUP has a maximum number of 
modes, i.e. 3N-6, corresponding to ~ 7500. Ligand-induced changes in RMSF were 
calculated using two different mode ranges: the first 1000 modes (1k), representing 
more global modes, and the (almost full) 7000 modes (7k). The per-residue variance 
(calculated over all 100 structures in NE NMA) was used as an error, and propagated 
when the differences between bound and unbound were calculated. Above-error 
changes are displayed as black boxes in Figure 5.7c+d. As in §5.3.3, NMA predictions 
aligning with red or greyscale NMR values indicate either no data or known agreement 
respectively, whereas alignment with white boxes represent known disagreement, i.e. 
NMR ΔS2 is zero within error. 
Generally more changes are observed when considering all 7000 (7k) modes as 
compared to just the first 1000 (1k), wherein almost no changes are observed.  This is 
unsurprising when considering that the higher modes are more localised, and therefore 
can differ as a result of the smaller structural changes, as in this case, where RMSD > 
0.7 Å. Alternatively, the more global first 1000 modes require a more dramatic 
conformational change to differ. Due to this sensitivity, the results for SS NMA are less 
trustworthy than for NE NMA, due to the prominence of idiosyncratic modes. This is 
evidenced by 7k SS NMA’s prediction of many residues that are observed by NMR not 
to change. Considering only the 7k NE NMA results, hexanol binding results in no 
changes at 110 K and only at two residues at 298 K, despite clear ΔS2. Conversely, 
IBMP shows many changes, especially at 110 K. A large number of these predictions 
align with residues where ΔS2 was measured as zero within error, i.e. white boxes in 
the NMR columns. These results demonstrate that NMA alone, SS or NE, is incapable 
of predicting important changes upon ligand binding. 
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5.3.5  Differences in normal mode densities between single 
structure and native ensemble normal mode analyses 
 
 
 
 
Figure 5.8 Normal mode densities for NE and SS NMA for MUP, MUP-IBMP and 
MUP-hexanol over the 0 to 6 THz range. Normal mode densities are presented as 
histograms of bin width = 0.05 THz. The apo and holo normal mode densities all 
overlay, revealing no distinguishing features. The lower solid lines are from SS NMA. 
The higher non-smooth lines represent the first frames of the trajectories, dashed is 
110 K, solid is 298 K. The higher smooth lines represent the NE NMA, where again 
110 K is dashed and 298 K solid. The temperature refers to the temperature of the 
trajectory from which the NE NMA structures were sampled. Difference between the 
first frame of the NE NMA and the SS NMA is due to the difference in hydration. 
 
 
Normal mode densities are shown for SS NMA, NE NMA, and the first frames of the 
NE NMA trajectories, Figure 5.8. Comparing SS NMA to the first frame reveals a 
marked difference between asymmetric unit hydration and the 5 Å solvent shell used 
for each NE NMA structure. Increased hydration in the NE NMA structures than in 
the asymmetric unit increases the number of low frequency modes and is associated 
with clearer features at 1 and 3.5 THz. Therefore this initial estimate of an appropriate 
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symmetrical hydration shell, based on the average amount of asymmetric unit 
hydration, will need further optimisation. This could result in a large impact on the 
quality of agreement between NMA-interpreted THz difference spectra and NMR seen 
in 5.3.3. It is also observed that NE NMA produces much smoother curves with 
clearer features, though these are generally the same as for the first frame, due to the 
effect of the averaging over multiple minima. The difference in predictions arising from 
NE NMA at the two temperatures and for both ligands, §5.3.3, revealed that modes at 
equivalent frequencies contained non-equivalent collective motions. The equivalence of 
the mode densities for all structures and temperatures, and their difference to SS 
NMA, therefore indicates that mode density comparisons are useful for optimising 
hydration in NMA. 
 
 
 
5.4  Summary and Conclusions 
 
Changes in protein positional fluctuations upon ligand binding can constitute an 
important entropic contribution to binding thermodynamics. Currently, NMR S2 values 
are the best experimental method for observation of these changes. However, 
obtaining S2 values is a lengthy and sometimes difficult process. Frequencies observed 
in THz difference spectra reveal which collective protein vibrational modes are most 
affected by ligand binding. Normal mode analysis (NMA) is an MD-based technique that 
analyses the collective vibrational modes in atomic detail, providing a tool for 
interpreting the global THz-derived information as changes in positional fluctuations. A 
new THz spectroscopy system allows the acquisition of spectra using protein crystals 
at 110 K. Unlike NMR, this system requires no protein labelling, spectra are quick to 
obtain, and dynamics of the entire protein are captured. For the first time in protein 
THz spectroscopy, the protein structure and hydration in the experimental sample is 
accurately known, and the spectra are acquired below the anharmonic limit. Because 
NMA makes a harmonic approximation regarding the collective motions, and is 
dependent on the hydration and structure of the protein analysed, this is the best THz 
system for interpretation using NMA.  
 This work constitutes a preliminary investigation of the capacity of NMA-
interpreted THz difference spectra to predict changes in positional fluctuations upon 
ligand binding, using MUP binding to IBMP and hexanol, and NMR S2 data (acquired at 
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298 K) as a benchmark. Despite negligible structural differences between the apo and 
holo crystal structures of MUP bound to IBMP and hexanol, the low (110 K) 
temperature and the crystal packing constraints, the dynamic changes upon ligand 
binding are sufficient to generate above-error THz difference spectra that can be 
analysed by NMA. The difference spectra are also different dependent upon the ligand 
bound, despite the negligible structural differences between the crystal structures of 
the two complexes. 
Traditional normal mode analysis uses a single structure (SS NMA), whereas 
the protein native state is defined by an ensemble of structures. Averaging normal 
modes for an ensemble of native structures enhances those modes representative of 
the native ensemble, and diminishes modes idiosyncratic to one particular structure. 
Native ensemble normal mode analysis (NE NMA) was herein performed using 
structural ensembles extracted from MD trajectories produced at both 110 and 298 K.  
NMA was used to predict the ten most likely changes in positional fluctuations 
upon ligand binding (MUP to IBMP and hexanol), by analysing the apo and holo 
collective vibrational motions corresponding to the THz difference spectrum 
frequencies. NE NMA predictions are spread across the protein, whereas SS NMA 
predictions cluster at the C terminus. This pattern is also observed for the first NE 
NMA frames, thus demonstrating the benefit of the ensemble averaging of NE NMA, 
which diminishes the unrepresentative idiosyncratic modes of single structures. NE 
NMA 298 K was the only type of NMA better than random at avoiding incorrect 
predictions, i.e. for those residues where ΔS2 is zero within error. However, the 
structural ensemble generated at the THz experimental temperature of 110 K (NE 
NMA 110 K) generated predictions that align best with the largest changes in 
positional fluctuations described by the NMR S2 data. This may indicate that better 
agreement could arise through ensuring that NE NMA sampling better represents the 
experimental sample, such as through generating ensembles from trajectories 
performed for the crystalline asymmetric unit or full unit cell, both of which are being 
considered. The quality of the comparison between NMR S2 and the NMA-interpreted 
THz difference spectra is restricted by the incompleteness of the NMR data, suggesting 
that further assessments may be best performed using systems with more 
comprehensive NMR S2 data. Without using THz difference spectra as a guide, NMA 
alone is incapable of predicting important changes upon ligand binding. 
Normal mode densities differed between NE and SS NMA due to hydration. SS 
NMA used the crystal asymmetric unit hydration, i.e. that of the experimental sample. 
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This mode density discrepancy therefore reveals that the NE NMA hydration is not 
equivalent to the experimental sample, and that optimisation of the hydration shell for 
NE NMA structures extracted from solvated MD trajectories may result in better 
performance of NMA-interpreted THz. 
This work reveals that proteins in a crystal lattice at 110 K exhibit changes in 
harmonic fluctuations as a result of ligand binding, even with a negligible structural 
difference between apo and holo crystal structures. These changes are also ligand 
dependent, despite the similarly negligible difference between the holo crystal 
structures. Nonetheless, decreasing the THz absorption coefficient error through 
improved measurements of crystal dimensions may generate better resolved difference 
spectra and is therefore worthy of attention. This system is limited to studying 
crystallisable systems which undergo crystallographically tolerable changes, e..g ligand 
binding. Proteins that are difficult to crystallise may not benefit from the relative ease 
and speed of the proposed system compared to NMR. However, on chip THz systems 
showing increased resolution and sensitivity could constitute an avenue for low-
temperature THz of non-crystalline proteins.154  
Additionally, this work reveals the benefit of averaging over the native 
ensemble in producing representative normal mode analyses. Though this preliminary 
study resulted in only moderate performance, improvements can be made to the 
sampling and hydration of the NMA structures, allowing conclusive validation of the 
potential for this approach as a novel probe of changes in protein dynamics upon ligand 
binding.  
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Chapter 6 
 
Summary and Future Work 
 
 
The work presented in this thesis addressed four issues regarding the dynamics and 
thermodynamics of protein-ligand binding, with the goal of improving our 
understanding of biomolecular associations. MUP is used for this work both because it 
enables a tractable perturbation and therefore thermodynamic decomposition 
approach, and also due to its wealth of pre-existent interaction thermodynamics data. 
A range of established techniques were brought to bear, namely ITC, NMR, x-ray 
crystallography and MD, whilst the preliminary assessment of a new probe of protein 
dynamic changes upon ligand binding was addressed, NMA-interpreted THz difference 
spectra.  
 The fundamental, yet insufficiently thermodynamically described, role of water 
in biomolecular interactions was the focus of §2.16 A better entropic estimate of water 
ejection from the MUP binding site was sought to both aid future decomposition in 
MUP and to address the suggestion of entropic desolvation in this system, as observed 
in other proteins with non-polar pockets.12,15,21,28 Previous estimates suggested 
conflicting values of 0.1 or -5.8 kJ mol-1 desolvation entropy per water molecule in 
MUP.18,21 The difference in binding thermodynamics between two interactions that 
differ by the ejection of a single water molecule and a potential change in sidechain 
entropy was obtained. Accounting for the sidechain contribution is possible using NMR 
experiments, however these were aborted due to a defective sample. Therefore the 
production of new sample and repeat experiments are required to determine the 
better thermodynamic estimate desired. More than 6.9 kJ mol-1 of sidechain entropy 
would have to be lost upon ligand binding to render desolvation entropic, due to a 
difference of 3.9 ± 3.0 kJ mol-1 being observed between the interactions by ITC. 
 Lipocalins, such as hydrophobic binder MUP and hydrophilic binder HBP, are 
used as structural scaffolds for biotechnological applications due to their structural 
stability and capacity to tolerate functional mutations in loop regions.67,68 Engineering 
MUP for a novel capacity, to enable histamine binding in a mode similar to related 
hydrophilic HBP, was previously attempted. This was performed by introducing either 
or both the polar sidechain Ser103 and the ionisable sidechain Asp40 into the MUP 
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binding pocket. Crystal structures of the series of MUP mutants, all obtained to a 
resolution of below 2.1 Å, revealed an increased apo pocket water content, 
accompanied by capacity to bind histamine, charged at the crystal pH of 5.5, and a 
partial incapacity to bind IBMP.  
Crystallography is an attractive screening strategy for monitoring mutation-
derived changes in MUP binding profile because large quantities of crystals can be 
produced with a small amount of protein. An attempt was made to validate this 
approach by performing ITC on the MUP variants binding IBMP and histamine, to 
assess whether the same trends in binding across the panel of MUP mutants are 
observed. The ITC solution conditions were changed to partially mimic the crystalline 
conditions, to attempt the closest possible comparison between the techniques: 
namely the pH was lowered to 5.5, but the salinity was not increased due to the 
potential risk of aggregation. Computational methods predicted a rare high pKa for the 
D40 residue in MUP, presenting a risk of neutralisation at pH 5.5 that would likely 
ablate the binding of charged histamine. 
Contrary to the crystallographic observations, no change in IBMP or histamine 
affinity were observed across the series, with histamine affinity being consistently very 
weak. These data appear to support the computational predictions that D40 is 
neutralised at pH 5.5. Possibly the salinity needs to be adjusted to replicate the binding 
trends observed crystallographically, as it affects pKa values and differs between ITC 
and crystallography. Alternatively, the trends may be reproducible at higher pH. An 
attractive avenue for ongoing work is to directly measure the in situ D40 pKa using 
NMR, by performing a pH titration on a 15N-13C labeled protein sample and monitoring 
the chemical shift of the D40 sidechain atoms. In summary, this study has 
demonstrated that validating the use of crystals to screen interactions that are heavily 
pH dependent is non-trivial. The validity of the crystallographic observations in this 
case remains unresolved. 
 The first systematic experimental evaluation, in a protein-ligand system, of the 
often voiced yet rarely and inconsistently observed entropic and affinity benefits of 
decreasing rotor numbers in a ligand molecule was performed in §3.6,7 Removing a 
single ligand rotor was investigated by comparing MUP binding within and between 
panels of saturated and unsaturated alcohols, which allowed two methods for 
decreasing rotor numbers to be assessed: rotor removal through shortening the 
molecule by one methylene group ('remove'), and rotor rigidification through 
introduction of a double bond ('restrict'). Restrict modifications were also assessed in 
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both cis and trans isomers, and with the double bond placed at different positions. 
Entropically, previously predicted penalties for rotamerically ‘freezing’ a single ligand C-
C bond upon binding, used for important decisions in drug development and 5 to 6 kJ 
mol-1 in magnitude, were vindicated as an average 5.4 kJ mol-1 TΔΔS°i benefit from 
methylene removal across multiple ligand series.5,82-85 The introduction of a terminal 
double bond gives a similar result of 4.5 kJ mol-1, suggesting that methylene removal is 
effectively the deletion of a rotor in terms of intrinsic entropy. However, a significantly 
higher TΔΔS°i benefit of 11.5 kJ mol-1 is obtained by introducing an internal double 
bond. This is likely due to an increase in bound ligand conformations with these 
modifications. All observed gains are considerable in terms of ligand design, where 5.7 
kJ mol-1 represents an order of magnitude in affinity. However, reproducing the 
enhanced intrinsic entropic benefits of restriction over removal observed in this 
system will be unlikely if this effect does arise from an increase in the flexibility of 
bound ligand, because most other systems will not have similarly spacious and non-
specific binding pockets. Differential desolvation and intrinsic enthalpy conspire to 
generate unfavourable changes in affinity for both of these modification types. Analysis 
of crystal structures indicates a contribution from differential protein dynamics to 
intrinsic entropy changes, which would likely be insufficiently resolved by NMR 
relaxation experiments. Despite being the first systematic investigation of its kind, and 
more comprehensive than other work in the field, there is still too little data to 
identify conclusive and reliable trends. Encouragingly, in a peptide-protein interaction, 
the introduction of an internal double bond into the ligand was reported to result in a 
ten-fold improvement in affinity.102 
Loss of ligand rotational and translational entropy, a major contributor to 
binding thermodynamics, estimated at -40 to -60 kJ mol-1, was addressed in §4.5 The 
previous assumption used in thermodynamic decomposition was that IBMP lost almost 
all rotational and translational degrees of freedom upon binding to MUP.18,23 This was 
recently challenged by 1 µs MD simulations that observed significant IBMP movement 
in the MUP pocket when bound.26 Consequently, the first attempt to directly observe 
and assess residual ligand motion was undertaken using a combination of NMR NOE 
and rdc measurements obtained for a sample of 15N-MUP protein and 13C-15N IBMP. 
Labelled IBMP was synthesised successfully. Strong butyl peaks were observed for the 
bound ligand, with dispersion of methyl resonances indicating a restriction of rotation 
and translation compared to bulk.  
NOE measurements for a sample containing 13C-15N MUP and an excess of 
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unlabelled ligand allowed assignment of pocket residue protons with NOEs from the 
ligand. This enabled comparison of simulated NOES from the 1 µs trajectory with 
those observed experimentally. The simulated NOEs were calculated taking spin 
diffusion into account. The analysis indicated that orientations close to that observed 
crystallographically resulted in simulated NOEs in close qualitative and quantitative 
(relative intensity) agreement with experimental NOEs.  Clustering of ligand poses 
from the 1 µs MD simulations (Dr Charlie Laughton, personal communication) reveals 
that most of the extensively populated clusters represent poses with poor 
experimental agreement. Thus, the NOE analysis concludes that the trajectories 
inaccurately sample motion of bound IBMP. Analysis of the first 100 ns of the 
simulations shows closer sampling to the crystal pose, suggesting that only at long 
timescales is ligand behaviour inaccurate. This is likely due to previously unrevealed 
limitations of the forcefield.  Reproducing the first 100 ns with a second forcefield, 
CHARMM, showed less movement, but a comparison at timescales beyond 100 ns is 
needed. 
Residual dipolar coupling measurements for butyl chain bond vectors were 
acquired by Dr Arnout Kalverda and Phil Morrison. Whilst the rdc values are low, they 
disagree with predicted rdc values calculated by Dr Gary Thompson using the protein 
backbone couplings and the crystal structure (PDB 1QY1). This reveals these bond 
vectors to be sampling non crystallographically-observed orientations. However, this 
does not necessarily indicate that the ligand samples multiple orientations. These 
observations remain consistent with the NOE simulations, which show that the butyl 
chain can sample multiple conformations whilst the ligand remains in effectively the 
same pose. However, residual ligand motion may not be completely absent. More 
extensive measurement of ligand rdcs in the complex are being sought, and should 
provide a better picture of the amount of residual motion present.  
Therefore, whilst protein behaviour seems to remain well reproduced26 by 
increasingly commonplace long timescale simulations, these experiments provide 
unique data that questions the validity of ligand behaviour observed at longer MD 
timescales. This work therefore highlights the necessity to continuously experimentally 
corroborate evolutions in MD simulations, despite the practical difficulty of obtaining 
such data. Otherwise, the attraction of MD as a technique can be undermined by its 
inaccuracy. 
Changes in protein positional fluctuations upon ligand binding can constitute an 
important entropic contribution to binding thermodynamics. A preliminary 
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investigation of a potential novel protein dynamics probe was the focus of §5. The 
capacity of normal mode analysis (NMA) interpretation of THz spectroscopy 
difference spectra to identify residues whose fluctuations change upon ligand binding 
was investigated. NMR S2 data, which reveal site-specific changes in dynamics upon 
ligand binding, were used as a benchmark for the study of IBMP and hexanol binding to 
MUP. Currently, NMR S2 values, which are lengthy and sometimes difficult to obtain, 
are the best experimental method for observation of these changes. Unlike NMR, THz 
spectroscopy requires no protein labelling, spectra are quick to obtain, and dynamics 
of the entire protein are captured.  
A new THz spectroscopy system, developed in Leeds by Dr Kasia Tych, allows 
the acquisition of spectra using protein crystals at 110 K. It was firstly demonstrated 
that ligand-dependent THz difference spectra are obtainable between unbound and 
bound protein crystals, despite the crystalline environment, the 110 K temperature 
and the close overlay of the apo and holo structures for these interactions (RMSD > 
0.7 Å). Likewise, difference spectra are also ligand-dependent, despite the negligible 
structural differences between the crystal structures of the two complexes. Successful 
acquisition of difference spectra allowed changes in harmonic vibrations to be analysed 
using NMA for similar patterns of differential residue flexibility to those observed by 
NMR S2. Harmonic vibrations were analysed using both traditional single-structure (SS) 
NMA, and native ensemble averaged (NE) NMA. Averaging normal modes for an 
ensemble of native structures enhances those modes representative of the native 
ensemble, and diminishes modes idiosyncratic to one particular structure. NE NMA 
used structures generated by MD trajectories performed at NMR and THz 
experimental temperatures of 110 K and 298 K.  
Those residues most affected by changes in collective motions indicated by the 
THz difference spectra were compared to NMR ΔS2, resulting in moderate agreement. 
NE NMA performs better overall than SS NMA, demonstrating the benefit of the 
ensemble averaging of NE NMA, which diminishes the unrepresentative idiosyncratic 
modes of single structures. NE NMA 298 K is the only NMA that performs better than 
random at avoiding incorrect predictions. In generating predictions that align best with 
the largest changes in positional fluctuations described by the NMR S2 data, for both 
ligands NE NMA 110 K performs best. This improvement in predictions when using a 
native ensemble generated at the THz experimental temperature is encouraging, and 
may indicate that better agreement could arise by generating NE NMA sampling more 
representative of the experimental sample. This may be achieved by generating 
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ensembles from trajectories performed for the crystalline asymmetric unit or full unit 
cell, both of which are being considered. Without using THz difference spectra as a 
guide, NMA alone was demonstrated to be incapable of predicting important changes 
upon ligand binding. 
Optimisation of the hydration level for NE NMA structures derived from 
solvated trajectories could also improve agreement. Scope for hydration optimisation 
was revealed by the difference in normal mode densities between SS NMA and a single 
NE NMA structure, which differ in little other than hydration. The SS NMA is 
hydrated according to the crystal asymmetric unit and is therefore more 
representative of the experimental sample. Therefore optimisation of symmetric with 
respect to asymmetric hydration may be achieved through comparison of mode 
densities.  
Though this preliminary study reveals moderate performance, work continues 
on improving the NMA models to conclusively validate the potential for this approach 
as a novel probe of changes in protein dynamics upon ligand binding. Further work 
needs to be done improving the experimental comparability of the NMA model by 
varying NMA structural sampling and hydration level. Uncertainty in the THz 
absorption coefficient error could also be improved through increasing the accuracy of 
crystal dimension measurements. To aid comparison with NMR S2 data, systems 
whose NMR S2 data are more complete are being considered for further investigation. 
Hopefully the work contained in this thesis, which has addressed previously 
unaddressed or unanswered questions, opens up further avenues of questioning and 
contributes to a better understanding of the different contributions to the dynamics 
and thermodynamics of protein-ligand interactions.  
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Appendix I 
 
Analysis of intermediates in IBMP 
organic synthesis (§4.2.1) 
 
Figure A1.1  1H NMR of 13C-15N Boc-L-Leucine. 13C and 15N atoms are circled on 
the molecule. δH (500 MHz, CDCl3); 7.28 (s, 1H, CHCl3), 4.88 (d of m, 1H, JCH 91 Hz, 
CαH), 4.34 (d, 1H, JCH 141 Hz, CH), 1.95-1.5 (br m, 2H, CH2), 1.48 (s, 9H, BOC), 0.99 
(d of m, 6H, JCH 124.88 Hz, CH3). 
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Figure A1.2  1H NMR of 13C-15N Boc-L-Leucine amide. 13C and 15N atoms are 
circled on the molecule. δH (500 MHz, CDCl3); 7.3 (s, 1H, CHCl3), 6.25 (d, 1H, JNH 
89.8 Hz, CONH), 5.61 (d, 1H, JNH 89.2 Hz, CαNH), 4.95 (dd, 1H, JHH 8.02 Hz, JCH 90.2 
Hz, CαH), 4.19 (d, 1H, JCH 129.6 Hz, CH), 4.06 (s, 9H, trimethoxy triazine), 1.95-1.5 (br 
m, 2H, CH2), 1.47 (s, 9H, BOC), 1.28 (s, 2H, grease), 0.97 (d of m, 6H, JCH 124.4 Hz, 
CH3). 
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Figure A1.3  1H NMR of 13C-15N L-Leucine amide. 13C and 15N atoms are circled on 
the molecule. δH (500 MHz, CD3OD); 4.88 (s, 1H, CD3OH), 4.04 (s, 9H, trimethoxy 
triazine), 3.89 (d of m, 1H, JCH 145 Hz, CαH), 3.34 (s, 3H, CD2HOD), 1.74 (d of m, 3H, 
JCH 125.9 Hz, CH and CH2), 1.04 (d of m, 6H, JCH 125 Hz, CH3).  
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Figure A1.4  1H NMR of 13C-15N 2-hydroxy-3-isobutyl-pyrazine (IBHP). 13C and 15N 
atoms are circled on the molecule. δH (500 MHz, CDCl3); 7.45 (m, 1H, ArH), 7.29 (m, 
1H, CHCl3), 7.17 (s, 1H, ArH), 5.33 (s, 2H, DCM), 4.06 (s, 9H, trimethoxy triazine), 
2.73 (d of m, 2H, JCH 127.50 Hz, CH2), 2.28 (d of m, 1H, JCH 128.68 Hz, CH), 1.01 (d of 
m, 6H, JCH 124.75 Hz, CH3). 
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Figure A1.5  1H NMR of 13C-15N 2-methoxy-3-isobutyl-pyrazine (IBMP). 13C and 15N 
atoms are circled on the molecule. δH (500 MHz, CDCl3); 7.21 (s, 1H, CHCl3), 7.15 
(m, 1H, ArH), 6.93 (m, 1H, ArH), 5.23 (s, 2H, DCM), 3.96 (s, 9H, trimethoxy triazine), 
3.44 (s, 3H, OCH3), 2.62 (d of m, 2H, JCH 127.6 Hz, CH2), 2.15 (d of m, 1H, JCH 128.7 
Hz, CH), 1.74 (s, 8H, THF), 0.89 (d of m, 6H, JCH 124.7 Hz, CH3). 
 
ESI-HRMS (Electrospray ionisation high resolution mass 
spectrometry) of 13C-15N 2-methoxy-3-isobutyl-pyrazine (IBMP) 
C3H14NaO
15N2
13C6, calculated 197.1141, observed 197.1140. 
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Figure A1.6  1H NMR of commercially available 2-methoxy-3-isobutyl-pyrazine 
(IBMP, Sigma-Aldrich). δH (500 MHz, CDCl3); 8.04 (m, 1H, ArH), 7.92 (m, 1H, ArH), 
7.27 (s, 1H, CHCl3), 3.96 (s, 3H, OCH3), 2.69 (d, 2H, JHH 7.2 Hz, CH2), 2.17 (m, 1H, 
CH), 0.94 (d, 6H, JHH 6.7 Hz, CH3). 
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